ࡱ>  jl]^_`abcdefghi  bjbjT~T~ &66C8$;#ch12(22288T99,m=Ay7"7|=A=A22DDD=A>R2{82D=ADD^Y""20 N{Cn30cV#?D(?"?"de9R;D_=T>e9e9e9De9e9e9c=A=A=A=A?e9e9e9e9e9e9e9e9e9 :  Clinical Contract Crib Sheet September 6, 2010 Most recent updates, announced September 6, 2010 Price Increase Surgical Services announcement that Medtronic USA Inc. has implemented an annual price increase for neurosurgical products on agreement PP-OR-477, effective September 2, 2010. Price increase impacts Tier 1, 2 and 3 at an aggregate increase of 3%. Recall Surgical Services announcement that Olympus America Inc. (PP-OR-505) has recalled camera heads, OTV-S7H-1D-LO8E and OTV-S7H-1D-F08E. These camera heads have been incorrectly labeled as meeting CF type electrical safety standards. Nursing Product Notice announcement that Baxa Corporation (PP-IV-041) has learned that the fill port cap on select EVA bags may have become detached. Nursing announcement new agreement for Glucose Management Systems with Hospira Worldwide. This is PC-based system that provides caregivers with patient-specific insulin dosing requirements and is independent of IV pumps. Agreement effective September 1, 2010, through August 31, 2013 SupplierNew contract number Previous contract numberHospira WorldwidePP-NS-625New Recall, Nursing announcement that Cardinal Health (PP-NS-566) is recalling the Medi-Vac Non-Conductive Tubing. There is a possibility that packaging seals may be compromised. Product catalog numbers below; Catalog numbers: N510, N512, N56A, N610, N612 N66A, N710, N712, N76A, NEX510; NEX512; NEX56A; NEX610; NEX612 NEX66A; NEX710, NEX712; NEX76A Lot number: All lot numbers prior to Y10KXXXX Nursing announcement that Carefusion (PP-IV-010) is offering a rental program and operating lease through Med One with flexible multiple options, August 1, 2010 through February 28, 2011. Program details: Operating lease for 60 or 84 months exclusively offered to Premier members At the end of the lease, the customer may choose from any of the following options: Extend the lease term and continue to lease Purchase the equipment for its fair market value Return equipment to Med One Rental program Rent for 12 months with the option to go month-to-month or to purchase equipment with a credit of 50 percent of all rental paid through the date of purchase. Nursing announcement that Carefusion is offering the Alaris Rapid Conversion Program for Premier Members (PP-IV-010). Promotion starts August 1, 2010 through February 29, 2011. Promotion is for members making whole house conversions with a minimum purchase of 75 PC units. Contact your Client Services Executive for details. Laboratory Correction announcement that LifeScan (PP-LA-260) has issued a correction on the One Touch DataLink Data Management System. This device correction was issued to make users aware of the possibility of data loss under very specific circumstances when downloading SureStepPro or SureStepFlexx Meters to One Touch DataLink software. There is no impact on the accuracy of patient blood glucose tests. Recall, Women and Children announcement that Madela Inc. has issued a recall for their hospital kit products. Medela has determined that the sterility of these products may be compromised, even though the packaging appears intact. As a precaution, they strongly recommend that you do not use these products. Product description: 67093S Universal Double Pumping System (Sterile) 67094S Lactina Double Pumping System (Sterile) 67099S Symphony Double Pumping System (Sterile) 67116S Symphony & Lactina Double Pumping System (Sterile) Nursing announcement of new agreements for Hot and Cold packs with incumbent Cardinal Health 200 (PP-NS-626) and new supplier Hospital Marketing Services Company (PP-NS-627). Agreements effective December 1, 2010 through November 30, 2013. Nursing announcement that Carefusion is offering an Alaris Rapid Conversion Program (PP-IV-010). This program is extended to facilities making whole house conversions with a minimum purchase of 75 units. Start date August 1, 2010 through February 28, 2011. Nursing announcement that Ecolab (PP-NS-559) is offering 75% savings off direct orders for waterless hand sanitizers while supplies last. Promotion starts August 13, 2010 through September 17, 2010. Nursing announcement that B. Braun is offering a trade-in incentive plus limited options and flexible lease plans with their Infusion Pump Transition Program and rebates with on their Disposable Program (PP-IV-012). Nursing announcements of The Infusion Device RFI Tool. This is a critical for any facility looking to purchase new IV pumps. There are over 130 key questions and answers covering the full range of capabilities of the infusion devices and their dose error reduction systems. To find this tool, go to Premier website, HYPERLINK "http://www.premierinc.com"www.premierinc.com, Supply Chain Advisor and search Infusion Device RFI Baseline tool. . Nursing - announcement that Carefusion has added Maximus IV disposable products to their infusion agreement (PP-IV-020). These products include needleless access connectors, extension sets and gravity and secondary sets. Nursing Recall announcement that Hospira Inc. (PP-IV-015) has issued a voluntary recall on certain GemStar pump sets. Reason reports of under-delivery during critical use. Contact Hospira Customer Services or your Hospira Executive Rep for details. Laboratory Recall announcement that Abbott Point of Care (PP-LA-236) has initiated a recall on specific lots of i-STAT CG8+ Cartridges. Product numbers 03M86-01 and 03M86-02) lot number T10036A and on i-STAT G3+ (product numbers 06F03-1 and 06F03-2) lot number P10033. iSTAT CG8+ Cartridges and G3+ Cartridges. Surgical Services announcement of new agreements for Surgical Automatice Tourniquet Systems and Accessories. Effective November 1, 2010 through October 31, 2013. An automatic tourniquet is a device used to stop or control a patients blood flow during a surgical procedure SuppliersNew contract numberExpiring contract numberDelfi PP-OR-686NewSammons PrestonPP-OR-684NewStrykerPP-OR-685NewZimmerPP-OR-683 PP-OR-351 Surgical Services announcement that Cardinal Health (PP-OR-452) will be consolidating Surgical and Isolation Mask codes starting September 1, 2010. DISCONTINUED Product CodeSUBSTITUTE Product CodeAT51135AT54635AT63001AT70021AT70061AT70021AT71061AT71021AT71135AT74635AT71311AT74631AT71335AT74635AT74435AT74535AT74439AT74535AT74835AT74535AT74935AT74635AT7511-FFAT7511AT7511-GAT7511AT7511-PKAT7511AT7511-WAT7511AT79031AT771211AT79035AT771141AT75435AT74535 Surgical Services announcement of new agreements for General Orthopedic Trauma products. Effective November 1, 2010 through October 31, 2013. SupplierNew contract number  Expiring contract number DeRoyalPP-OR-690PP-OR-651OrthofixPP-OR-691PP-OR-377ZimmerPP-OR-692PP-OR-378 Trauma implants and instruments are used for the surgical treatment of fractures and deformities of the arm, legs, shoulders, hands, feet and pelvis. Products include: plates screws cannulated screws intramedullary nails instruments external fixators products for the hip and condyles Surgical Services announcement that a price reduction agreements with Medline has been reached for Surgeon Gloves (PP-OR-626) and Customer Procedure Trays (PP-OR-482) for committed customers. Reduced pricing is effective August 1, 2010 and remain effective through the expiration of each agreement. Surgeon Gloves - .25 percent line item discount Customer Procedure Trays (CPT) - .75 percent of net purchase at Tier 4, 5 and 6. Nursing Certificate of Necessity now available from Baxter Forms must be completed and returned to Baxter by November 14, 2010 In a letter dated August 4, 2010, addressed to hospital administrators of facilities currently using Colleague pumps, Baxter Healthcare provided the latest information regarding the transition from Colleague pumps following the final consent decree from the U.S. Food and Drug Administration to recall these devices from the U.S. market. The communication includes a Certificate of Necessity (CN) form and instructions. All current Colleague users must complete the CN by November 14, 2010, to be able to continue using the pumps during the 24-month transition period. It is important that this information reach all users of Colleague pumps. Your hospital administrator, CEO, COO, CMO or CNO should receive the letter by next week. Contact your local Baxter sales representative, or call Center for One Baxter at 800.422.9837 with any questions. Nursing announcement that Masimo has added Rainbow SET Pulse Co-Oximetry to their agreement (PP-NS-557). This technology measures blood constituents and fluid responsiveness that previously required an invasive procedure. Nursing announcement the EZ Way has added two new lifts to their agreement (PP-NS-557), Light Lift and Light Stand. Laboratory Recall announcement that Cepheid (PP-LA-226) is initiating a recall on all lots of Xpert MRSA/SA BC (GXMRSA/SA-BC-10) and Xpert MRSA/SA BC CE-IVD (GXMRSA/SA-BC-CE-10). These MRSA/SA BC (GXMRSA/SA-BC-10) and Xpert MRSA/SA BC CE-IVD (GXMRSA/SA-BC-CE-10. This recall is a corrective action, which does not require return of product to the manufacturer. Customers may continue to use the product; however, when a MRSA negative/SA positive result is obtained, the result should be interpreted as "MRSA indeterminate/SA positive, antimicrobial susceptibility testing pending." Further testing should be performed using an FDA-cleared, phenotypic antimicrobial susceptibility testing method on isolated colonies recovered from the blood culture bottle, as instructed in the Corrective Action Notice dated July 1, 2010. Suggested action steps: Hospitals or laboratories that have purchased the Xpert MRSA/SA BC product subject to this corrective action, may continue to use all product within their inventory subject to the new instructions stated in the Corrective Action Notice as of July 1, 2010. Customers should contact Cepheid technical support at 888.838.3222 if they have questions regarding this corrective action. Nursing - Please complete the short survey regarding the Colleague infusion pump. The Premier healthcare alliance wants to know how many of our members are affected by the recall of Baxter Colleague infusion pumps. Please take a few minutes to respond to this HYPERLINK "https://www.surveymonkey.com/s/53S5LPC"short five question survey by August 31, 2010. Surgical Services announcement of new agreements for Orthopedic Autotransfusion have been awarded. Effective November 1, 2010 through October 31, 2013. These systems are used to collect and reinfuse autologous shed blood following orthopedic surgery. SupplierNew contract number  Expiring contract number StrykerPP-OR-677PP-OR-352ZimmerPP-OR-676PP-OR-353 Surgical Services announcement of new agreements for Maxillofacial Plating Systems has been awarded to incumbent Stryker Leibinger Inc. effective November 1, 2010 through October 31, 2013. These products are used for the fixation of orthagnathic or midface fractures and for the stabilization of osteotomies and bone grafts required in reconstructive surgery of the face. Surgical Services announcement of new agreements for Surgical Implantable Infusion Ports has been awarded effective November 1, 2010 to October 31, 2013. An implantable infusion port is a device used to deliver medications, (often antibiotics or chemotherapy) into the bloodstream for patients who need long-term therapy. SuppliersNew contract numberExpiring contract numberBard AccessPP-OR-698PP-OR-426Medical ComponentsPP-OR-700NewNavilystPP-OR-701PP-OR-427Smiths MedicalPP-OR-699PP-OR-425 Surgical Services announcement Orthopedic Total Joints and Bone Cement contracts have been extended. Pricing tiers and terms and conditions have not changed in the extended agreements for; Advance Biomaterial Systems, Inc. (PP-OR-458) Biomet (PP-OR-442), Exactech Inc. (PP-OR-447, PP-OR-457), Stryker Orthopaedics (PP-OR-443, PP-OR-455) Zimmer US, Inc. (PP-OR-444, PP-OR-456). All extensions are effective April 1, 2011 through March 31, 2012. Surgical Services announcement of new agreements for Incise Drapes have been awarded. Effective October 1, 2010 through September 30, 2013. SuppliersNew contract numberExpiring contract number3M CompanyPP-OR-657 PP-OR-414LSL Industries Inc.PP-OR-658New supplier Surgical Services announcement of new agreements for Orthopedic Helmets. Effective November 1, 2010 through October 31, 2013. These products include Surgical Helmet Systems that protect patients from surgical site contamination during lengthy, invasive surgical procedure.  Suppliers New contract numberExpiring contract number Microtek Medical Inc. PP-OR-682PP-OR-349 Stryker Instruments PP-OR-681PP-OR-348  Surgical Services announcement of new agreements for Casting and Splinting products. Effective November 1, 2010 through October 31, 2013. These products include plaster, synthetic and fiberglass materials used to form splints and cast. Also includes soft goods of sheet wadding and stockinettes. SupplierNew contract number  Previous contract number BSN Medical Inc.PP-OR-678PP-OR-4243M CompanyPP-OR-679PP-OR-423*Parker Medical AssociatesPP-OR-680SD-OR-003 SEEDS"! agreement added to the national contract: 10/1/09 Surgical Services announcement of new agreements for ENT Products. Effectives November 1, 2010 through October 31, 2013. This is product category includes products used in head and neck surgeries, otology and rhinology. SupplierNew contract number  Expiring contract number Grace MedicalPP-OR-694PP-OR-397Gyrus ACMIPP-OR-696PP-OR-399SSIPP-OR-695PP-OR-398Stryker Corp.PP-OR-697PP-OR-400 Surgical Services Reminder announcement to please submit the Exhibit N Market Share document for the second year of Medtronics Spinal Implant (PP-OR-546) and Bone Tissue (PP-OR-543) contracts. This document is required by Medtronic to be signed each year, for each contract, in order to be eligible for all non-standard rebates. Non-standard rebates include the Committed Tier and/or Market Share Growth rebates on the Spinal Implant agreement ((PP-OR-546), and the Committed Tier rebate on the Bone Tissue agreement (PP-OR-543). Standard rebates include the quarterly rebates for both of these contracts, and an Exhibit N does not have to be re-signed for the quarterly rebates. The second year submission period for these contracts is from 7/1/10 to 9/30/10. Exhibit N can be found in the Attachments section on the Details tab of each contract in Supply Chain Advisor. Instructions for submitting Exhibit N can also be found on the Details tab. To submit for year two, please fax a completed Exhibit N to Medtronic at 901.344.1566. Nursing announcement of new contract awards for IV Site Management to incumbents Cardinal Health 2000 LLC, LSL Industries Inc. and Medical Action Industries Inc. Effective December 1, 2010 through December 31, 2013. This category of products includes IV start kits, dressing trays for central lines, PICCs and vascular access. SupplierNew Contract NumberPrevious Contract NumberCardinal Health 200 IncPP-NS-623PP-NS-474LSL Industries Inc*PP-NS-624PP-NS-420Medical Action Industries IncPP-NS-622PP-NS-475 Laboratory announcement of new agreements for Automated Microbial Identification and Susceptibility Analyzers, Reagents, Consumables and Service. Effective November 1, 2010 through October 31, 2013. SupplierNew contract number  Previous contract number bioMerieux Inc.PP-LA-278PP-LA-218Siemens Healthcare Diagnostics Inc.PP-LA-279PP-LA-217 Laboratory announcement of new agreements for Automated Blood Culture and Mycobacterial Recovery Analyzers, Reagents, Consumables and Service. Effective November 1, 2010 through October 31, 2013. SupplierNew contract number Previous contract number Becton, Dickinson and CompanyPP-LA-275PP-LA-219bioMerieux Inc.PP-LA-276PP-LA-220TREK Diagnostic Systems Inc.*PP-LA-277NEW Laboratory announcement that Beckman Coulter is offering hematology service pricing on new instruments (PP-LA-204). Promotion starts May 1, 2010 to December 31, 2010. Women & Children announcement of a contract award to Clinical Innovations LLC for its AccuCirc single action circumcision device, PP-WC-049. This contract will be co-terminus with the agreements that make-up the Disposable Labor and Delivery Product category. SupplierContract NumberEffective DatesClinical Innovations LLCPP-WC-0498/1/2010 - 8/31/2011Mabis Healthcare IncPP-WC-0179/1/2008 - 8/31/2011Tyco Healthcare Group LP, Kendall LTP PP-WC-0169/1/2008 - 8/31/2011Electro Medical Equipment Co. (EME)*PP-WC-0189/1/2008 - 8/31/2011 Recall Nursing - B. Braun announced that it is initiating a recall on their 13 mm and 20 mm addEase Binary Connectors. B. Braun has received reports of particular matter being generated upon the insertion of the B. Braun addEase Binary Connector (N7790 and N7993) into a PAB container. During this insertion, fragmentation of the PAB container stopper may occur, resulting in a small amount of visible particulates in the solution. There is a risk of potential injection of particulates which could result in life-threatening injuries, such as pulmonary embolism, stroke, heart attack and/or death. This is available through Premier agreement PP-IV-045. Because of this issue, B. Braun is initiating a voluntary recall for the following materials: Catalog # Lot # Description N7990 See attachment 20 mm addEase Binary Connector N7993 See attachment 13 mm addEase Binary Connector Imaging Contrast Media announcement from Covidien, Due to the number of short-term product shortages affecting the supply of contrast media (caused by raw material shortages, manufacturing issues, and third party supplier issues, to name a few), Covidien has begun to provide status updates to its customers to keep them informed on current availability.Keep in mind that the term supply disruption as used in the update indicates a less than normal availability to be expected, and not total unavailability.The first notice of this kind is attached here.Future updates will be posted in SCA under both Covidien contrast media agreements PP-IM-071 and PP-IM-072. Imaging - Covidien has announced the discontinuance of Xe-133 xenon gas due to diminishing customer demand and rising production cost. This product can be found on PP-IM-075, with SKU numbers N097KO and N098KO. Clinically appropriate substitutes can be found on the same agreement. Consult your Nuclear Medicine department for guidance. Recall Surgical Service announcement that ConMed Linvatec (PP-OR-630) announced they are initiating a recall of the 87000 Tube Set, Arthroscopy Cassette for use with the 87000 Pump. These products may have a breach in the seal between the Tyvek lid and tray, thereby potentially compromising the sterility of the device. This recall is being conducted to the distributor and user level. PLEASE DISCONTINUE USE OF THE IDENTIFIED PRODUCT LOT NUMBERS BEGINNING WITH 0904151 THROUGH AND INCLUDING 1005201. Surgical Services Price Increase announcement that Osteotech is taking a price increase on their Bone Tissue Products (PP-OR-541) effective October 1, 2010. Increase 2% on all products. Recall announcement that Baxter has been given two years to recall all Colleague Infusion Pumps and to provide refunds or replacement pumps. Certificate of Necessity (CN) must be returned to Baxter by November 2010 In a letter dated July 13, 2010, the U.S. Food and Drug Administration (FDA) issued its final order to Baxter Healthcare Corporation regarding the recall of the Colleague volumetric infusion pumps from the domestic market. The pumps are being recalled due to persistent safety problems that have resulted in serious patient injuries and more than 500 deaths. The FDA ordered Baxter to recall and destroy all Colleague pumps currently in use in the U.S. and provide a refund or a replacement Baxter device to all Colleague infusion pump owners with no delivery, installation or training costs to the customer. Additionally, all lessees may terminate their lease with Baxter or one of its authorized agents without penalty. Baxter has until July 14, 2012 to carry forth the actions outlined in the final order of the Consent Decree. During this transition period, customers may continue to use Colleague pumps but the FDA recommends replacement of Colleague infusion pumps as soon as practicable. Customers have until mid-November 2010 to submit the Certificate of Necessity (CN). The CN must be returned within the specified timeframe in order for the customer to be eligible for either the refund or replacement programs. While the FDA has set a 24-month transition period, it is imperative that members begin planning their process as soon as possible as there are some rather involved steps within the evaluation, selection and implementation phases. Premier will continue working closely with Baxter and other suppliers offering suitable alternatives to the Colleague infusion pump so expect our updates to be on-going. Baxter will publish an FDA-approved Transition Guide by September 11, 2010. While not all-inclusive, the document will provide guidance for minimizing disruption and patient risk, offer suitable FDA approved or cleared alternatives to the Colleague infusion pumps and give greater detail on the refund and replacement programs. Until the guidance document is available, members are encouraged to review all of the information that is currently available through the resources below. Recommended actions: Thoroughly read through all available information from the FDA and Baxter Begin taking inventory of all Colleague pumps, batteries, spare parts and consumables. This should include required information for the CN: serial number, model, owned/leased status, leasing company, and details of other large volume infusion pumps currently used at the facility. Complete the CN no later than mid-November 2010. The CN form will be available when the Transition Guide is published no later than September 11, 2010. Sources: FDA Q&A about the Baxter Colleague Recall, Refund, and Replacement Action: HYPERLINK "http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm210768.htm" \o "FDA Q&A"http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm210768.htm FDA's Final Order to Baxter to Recall, Refund, or Replace the Colleague Infusion Pumps: HYPERLINK "http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm218753.htm" \o "FDA's Final Order"http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm218753.htm FDA News Release: HYPERLINK "http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm218889.htm" \o "FDA News Release"http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm218889.htm Baxter Press Release: HYPERLINK "http://www.baxter.com/press_room/press_releases/2010/07_13_10_colleague.html" \o "Baxter Press Release"http://www.baxter.com/press_room/press_releases/2010/07_13_10_colleague.html Nursing Price Increase announcement that Edwards Lifesciences (PP-NS-526) has implemented a price increase for their Central Venous Access agreement, effective August 1, 2010. Increase is on all tiers and is a weighted average of 3% increase. Imaging announcement that Konica Minolta (PP-IM-133) is offering $3,000 rebate for converting to a Konica Minolta digital solution. Cardiology announcement that CardiacAdvisor has been updated to assist with purchasing decisions related to Core Cardiology; Drug Eluting Coronary Stents, Non-Drug Eluting Coronary Stents and Diagnostic and Interventional Cardiology Products. Nursing announcement of a SEEDS contract launch for Soaps, Lotions, and Waterless Hand Rinses with Research Technologies (SD-NS-003). Research Technologies Inc. is a minority-owned business (MBE) that specializes in packaging and private labeling of instant hand sanitizers and anti-microbial soap. This 51-month contract is effective July 1, 2010, through September 30, 2014. Pricing is firm throughout the term of the agreement. Materials Management - announcement of a SEEDS contract launch for Medical and Surgical Products Distribution contract with Van Zandt Distributing Inc. (SD-DS-004). Van Zandt Distributing Inc. is a minority-owned business (MBE), headquartered in North Saint Paul, MN. Van Zandt Distributing Inc. offers products to continuum of care facilities which include: hospitals, surgery centers and alternate care sites. The 18-month agreement is effective July 1, 2010, through December 31, 2011. Pricing is firm throughout the term of the agreement. Cardiology announcement that St. Jude (PP-CA-161) is offering a $1000 rebate for ICD or CRT-D high voltage generator implant swap. Cardiology announcement that Gambro CHF Solutions (PP-CA-130) is extending their Aquapheresis therapy promotion for two more weeks. The offer is 35% off list price. Surgical Services announcement of new agreements awarded for Instrument Cleaners and Enzymatics. Effective October 1, 2010 through September 30, 2013. SuppliersNew Contract NumberExpiring Contract NumberCareFusion PP-OR-661Cardinal PP- OR- 410Case PP-OR-663NewEcolabPP-OR-662NewGetingePP-OR-660PP- OR - 411 SterisPP-OR-659 PP- OR- 413  Surgical Services announcement of new agreements for Surgical Blades effective October 1, 2010 through September 30, 2010. SupplierNew contract number  Previous contract number Becton, Dickinson and Company (BD) PP-OR-653PP-OR-407DeRoyal IndustriesPP-OR-654PP-OR-190MYCO Medical Supplies Inc.*PP-OR-656NewSklar Surgical Instruments*PP-OR-655New Surgical Services Price Increase announcement that Musculoskeletal Transplant Foundation (MTF) is taking a price increase on their Bone Tissue products (PP-OR-542), effective August 1, 2010. Surgical Services announcement that Johnson & Johnson is instituting a change to two consumable products (code #s 20398 and 22591) on its Automated Endoscopic Reprocessor contract, PP-OR-537. Effective July 1, 2010,Johnson & Johnson will sell these two codes through distributors. These codes were previously sold Direct only. Surgical Services announcement for new agreements for Surgical Energy Products. The previous product category for these products was Electrosurgical Units. Effective September 1, 2010 through August 31, 2015. Surgical Services announcement of new agreements for Surgical and Biological Mesh. Effective October 1, 2010 through September 30, 2013. Field Guide is available upon request CategorySupplierNew Contract NumberPrevious Contract NumberSurgical (Synthetic) MeshAtrium PP-OR-670PP-OR-363CovidienPP-OR-672NEWDavolPP-OR-673PP-OR-365MedlinePP-OR-674NEWBiological MeshCookPP-OR-687NEWCovidienPP-OR-689NEWDavolPP-OR-688NEW Nursing announcement of new agreements for Bandages, Dressings and Gauze Effective October 1, 2010 through September 30, 2013. SuppliersNew Contract NumberExpiring Contract NumberAMD-Ritmed -SBEPP-NS-608  NewTyco Healthcare Group, LP (dba Covidien)PP-NS-605 PP-NS-496 Medi-Tech International Corp - SBE/WBEPP-NS-607  NewTetra Medical Supply Corp. - WBEPP-NS-606  PP-NS-497Tytex, Inc.PP-NS-609 New Nursing announcement of new agreements for Standard Hypodermics, Safety Hypodermics and Safety IV Catheters have been awarded. This is a portfolio offering, effective October 1, 2010 through September 30, 2013. CategorySupplierNew ContractPrevious ContractEffective DatesStandard Hypodermics Includes saline and heparin flush syringesBecton Dickinson and CompanyPP-NS-618PP-NS-46010/1/10 - 9/30/13 (36 months)Tyco Healthcare (Kendall brand)PP-NS-619PP-NS-462Medefil Inc.*PP-NS-621PP-WC-43 Pediatric Flush SyringeNeoMed Inc.*PP-NS-620NewSafety HypodermicsBecton Dickinson and CompanyPP-NS-614PP-NS-461Tyco Healthcare (Kendall brand)PP-NS-615PP-NS-463Retractable Technologies Inc.*PP-NS-617PP-NS-466Smiths Medical ASDPP-NS-616PP-NS-465Safety IV CathetersB Braun Medical Inc.PP-NS-611PP-NS-471Becton Dickinson and CompanyPP-NS-610PP-NS-472Retractable Technologies Inc.*PP-NS-613NewSmiths Medical ASDPP-NS-612PP-NS-473 Laboratory announcement of new agreements for Clinical Reference Laboratory Testing Services has been awarded to incumbents ARUP Laboratories, Lab Corporation of America (LabCorp) and Quest Diagnostics. Effective October 1, 2010 through September 30, 2015. SupplierNew contract numberPrevious contract numberARUP LaboratoriesPP-LA-272 PP-LA-215Laboratory Corp (LabCorp)PP-LA-273PP-LA-216  Laboratory announcement of agreements for point of care coagulation meters, reagents, consumables and services with incumbent International Technidyne Corporation (ITC), PP-LA-271. Effective September 1, 2010 through August 31, 2013. Core Cardiology announcement of contract awards for Core Cardiology. Contract categories consist of Drug Eluting Coronary Stents (DES), Non-Drug Eluting Coronary Stents (Non-DES) and Diagnostic and Interventional Cardiology Products (DIC). Agreements are effective September 1, 2010 through August 31, 2012. Contact your Client Services Executive for details. Field Guide is available upon request. CategorySupplierNew contract numberPrevious contract numberDrug Eluting Coronary StentsAbbott Laboratories Inc., Abbott Vascular DivisionPP-CA-165PP-CA-144Boston Scientific CorporationPP-CA-166NEWMedtronic USA Inc.PP-CA-167NEWNon-Drug Eluting Coronary StentsAbbott Laboratories Inc., Abbott Vascular DivisionPP-CA-168PP-CA-124Boston Scientific CorporationPP-CA-169NEWMedtronic USA Inc.PP-CA-170PP-CA-123Diagnostic and Interventional Cardiology ProductsAbbott Laboratories Inc., Abbott Vascular DivisionPP-CA-171PP-CA-117Boston Scientific CorporationPP-CA-172NEWJohnson & Johnson Healthcare Systems Inc./CordisPP-CA-173PP-CA-120Medtronic USA Inc.PP-CA-174NEWMerit Medical Systems Inc.PP-CA-175PP-CA-122 Cardiology announcement that HemCon (PP-CA-156) is offering free patches for new and existing customers. Promotion started July 1 through September 30, 2010. Recall announcement that Medivators Reprocessing Systems announced that is it initiating a recall involving the use of the Medivators DSD-110-HU0109 Endoscope Hookup to connect the Pentax EG-3630U Ultrasound Endoscope to a Medivators DSD endoscope reprocessor or Medivators Scope Buddy Endoscope Flushing Aid. These hookups are available through Premier agreement PP-OR-517, Automated Endoscopic Reprocessors. This recall has been initiated due to a misprinted DSD Hookup Application Guide (MG04-0001 revision M) that recommended the use of the DSD-110-HU0109 instead of the DSD-110-HU0144 and CLM-110HU0145 hookups. Use of the DSD-110-HU0109 for reprocessing of the Pentax EG-3630U Ultrasound Endoscope in conjunction with the DSD may result in inadequate high-level disinfection of either the balloon filling channel or the elevator wire channel depending on the method of connection. Suggested action steps: Immediately examine your Pentax EG-3630U Ultrasound Endoscope hookup, and inform all staff of this notice to ensure that the DSD-110-HU0109 is not used with the Pentax endoscope. Return of the DSD-HU0109 hookup is not being requested, and customers can continue to use the DSD-110-HU0109 hookup except where the Pentax EG-3630U Ultrasound Endoscope is concerned. Smoke Evacuation Systems and Related Products announcement that a agreement has been awarded to incumbents Buffalo Filter and Microtek and a new Supplier Medline Industries Inc. Effective September 1, 2010 through August 31, 2013. SupplierNew contract number  Expiring contract number Buffalo FilterPP-OR-667PP-OR-383MedlinePP-OR-669NewMicrotekPP-OR-668PP-OR-385 Surgical Services announcement of a new agreement for Sterilization Pouches. The agreement has been awarded to incumbent Cardinal Health 200, LLC. (PP-OR-675) effective October 1, 2010 through September 30, 2013. Surgical Services announcement that BD is selling certain assets including surgical blades and scalpels. The assets include their Ophthalmic Systems business unit and surgical blades, critical care and extended dwell catheter product platforms. The Bard-Parker"! surgical blades and scalpels products, currently available on Premier agreement (PP-OR-407), will be acquired by Aspen Surgical Products. BD anticipates closing this transaction by September 30, 2010. Members may continue purchasing these products from BD exactly as they do currently. Surgical Services announcement that Ecolab (PP-NS-559) is offering a program with conversion incentives, free installation plus 15% of opening order. Contact you local Representative or Client Services Executive for details. Nursing announcement of an annual price increase from Johnson & Johnson for their Anti-infection Site Disc Dressing (PP-NS-549), effective August 1, 2010. Price increase of 2.9% is per line item. Nursing announcement of price increase from Edwards Lifesciences Corporation on their Hemodynamic Monitoring Products and Accessories (PP-NS-508), July 1, 2010. Average price increase is 3% on all tiers. Surgical Services announcement of a new agreement for Sterilization Assurance has been awarded to incumbent 3M Company (PP-OR-652). Effective October 1, 2010 through September 30, 2013. Surgical Services announcement of new agreement for Incise Drapes have been awarded. Effective October 1, 2010 through September 30, 2013. SuppliersNew contract numberExpiring contract number3M CompanyPP-OR-657 PP-OR-414LSL Industries Inc.PP-OR-658New supplier Surgical Services announcement that Datex-Ohmeda, (PP-OR-642) has been added to the Anesthesia Equipment portfolio effective July 1, 2010. Surgical Services announcement of a pending price increase from Musculoskeletal Transplant Foundation (MTF) for their Bone Tissue (PP-OR-542). The increase will start August 1, 2010. Increase is on all tiers, 3.5%. Clinical Laboratory announcement of a SEEDS agreement for Rapid Diagnostic Test Kits with MedGyn (SD-LA-001), effective June 1, 2010 through October 31, 2012. Surgical Services In recognition of National TIME OUT Day, June 16, Sandel Medical Industries (PP-OR-552) is offering 10 percent off customers first order of the Non-Woven TIME OUT Beacon sterile (Reorder # 811-E), a disposable, biodegradable, economical way to remind your whole team to implement the Universal Protocol and help prevent wrong-site surgery. The special savings is offered on up to five cases. This promotion is only valid when ordering direct from Sandel Medical. This product was recently added to the Premier agreement. Pricing is available in Supply Chain Advisor. Nursing announcement, Smiths Medical (PP-NS-465) is offering a conversion promotion for TB and insulin safety syringes, Fix Your Savings: Save on Fixed Needles. Product numbers on the promotion: 4425-TB, 4426-TB, 4427-TB, 4428-1, 4428-5, 4429-1, 4429-5, 4429-3, 4430-5, 4430-3. Promotion dates, June 1, 2010 through September 30, 2010. Materials Management announcement, Hill-Rom (PP-MM-082) is offering trade-ins for bed frames and surfaces during a limited time Cash for Crankers II promotion. Promotion dates, May 1, 2010 through May 31, 2010. Lab announcement of a contract awards for; Hematology Analyzers, Automation, Reagents, Consumables and Services. Hemostasis Analyzers, Reagents, Consumables and Services Urinalysis Analyzers, Reagents, Consumables and Services Agreement effective August 1, 2010 through July 31, 2013. CategorySupplierNew contract numberPrevious contract numberHematology Analyzers, Automation, Reagents, Consumables and ServiceAbbott Laboratories Inc.PP-LA-263PP-LA-205Beckman Coulter Inc.PP-LA-264PP-LA-204Sysmex America Inc.PP-LA-265PP-LA-203Hemostasis Analyzers, Reagents, Consumables and ServiceBeckman Coulter Inc.PP-LA-266PP-LA-207Siemens Healthcare Diagnostics Inc.PP-LA-267PP-LA-206Diagnostica Stago Inc.*PP-LA-268PP-LA-208Urinalysis Analyzers, Reagents, Consumables and ServiceIris Diagnostics*PP-LA-269PP-LA-210Siemens Healthcare Diagnostics Inc.PP-LA-270PP-LA-209 Imaging Premier has announced a Radiation Oncology portfolio. The first categories to be included in the portfolio are brachytherapy systems, external beam radiation therapy systems, radiation oncology information systems, and radiation treatment planning systems. Individual category launch summaries containing products, financial and contract information is available in Supply Chain Advisor. Agreements effective May 15, 2010 through February 28, 2013. Recall announcement that Olympus America Inc. has initiated a recall of Electrosurgical Snares, PP-OR-505. Inspect snare inventory and identify. If snare is one of the lot numbers, discard and contact Olympus Customer Center. Surgical Services announcement that Mallinckrodt has discontinued its earlier generation of Hi-Lo Evac Endotracheal tubes (124160, 124165, 124170, 124175, 124180, 124185 and 124190) effective July 1, 2010. The Mallinckrodt TaperGuard Evac or TaperGuard endotracheal tubes are suggested replacements for the discontinued products. All aforementioned products are available through Premier agreement PP-OR-582. Hospitals should begin to shift to the TaperGuard Evac and TaperGuard tubes prior to the discontinuation date of the Hi-Lo Evac tube. Cross-Reference Chart; Next Page Size (ID)Mallinckrodt Hi-Lo Evac tubeMallinckrodt TaperGuard Evac tubeMallinckrodt TaperGuard tube6.0 mm12416018860187606.5 mm12416518865187657.0 mm12417018870187707.5 mm12417518875187758.0 mm12418018880187808.5 mm12418518885187859.0 mm1241901889018790 Surgical Services announcement that Ansell Healthcare (PP-OE-626) is offering free product for evaluation and conversion to Derma Prene synthetic surgical gloves. Nursing announcement that Innovation Healthcare Corporation (IHC) Exam Gloves are now available through Cardinal Healthcare, (PP-NS-594). Nursing announcement that Joerns Healthcare is offering 1 month free supply of Bio-Clinic Positioners with a years commitment conversion. PP-NS-580. Effective April 30, 2010 thru June 30, 2010. Imaging announcement that GE is offering member discounted pricing options on selected radiography, R&F and mammography systems based on LOPs received by GE, PP-IM-087, PP-IM-090, GB-IM-087F and GB-IM-090C. General Orthopedic Trauma announcement that DeRoyal Industries Inc. has been added to this agreement, effective May 15, 2010. STERIS announcement that Healthcare facilities using the STERIS System 1 processors (SS1) must submit a completed Certificate of Medical Necessity (CN) for each facility to STERIS on or before June 18, 2010. Certificate is available on the STERIS website. The CN must be signed by one of the following: Head of Institutional Review Board, CEO, President, Chief Operating Officer or Chief Medical Officer. The CN must include a brief statement of your need for continued use (e.g., maintain patient care as complete transition to legally marketed alternative devices, etc.). The number of System 1 units in your facility. Hospital/facility information. Members/customers must obtain the Certificate of Medical Necessity to get parts, components, accessories and service during the transition period which ends August 2, 2011. Surgical Services announcement that the Anthroscopy contract launch material have been modified to reflect changes in the Smith and Nephew agreement. Nursing announcement of new agreements for Oral Care with incumbent Sage Products Inc. and new Supplier Kimberly Clark Global Sales LLC, effective August 1, 2010 through July 31, 2013. Ventilator Acquired Pneumonia (VAP) has been on the Centers for Medicare and Medicaid (CMS) list of proposed never events and continues to be monitored as a candidate for modified payment. SupplierNew Contract NumberPrevious Contract NumberKimberly-Clark Global Sales LLCPP-NS-604NewSage Products Inc.*PP-NS-603PP-NS-458 Kimberly-Clark is the new low-cost supplier with a full line of products launched in 2008. The new Kimberly-Clark agreement offers significant price savings and a time-sensitive conversion incentive. Sage has taken its first limited price increase in 9 years, with an aggregate 2.5 percent increase. All pricing is firm for the term of the new agreements. Nursing announcement that Tronex Healthcare Industries (PP-NS-597) has decreased prices on their Exam Gloves, 10-15%. Surgical Services - announcement of new agreement for Instrument Containers, effective August 1, 2010 through January 31, 2013. SupplierNew contract numberExpiring contract numberAesculapPP-OR-647PP-OR-314CareFusionPP-OR-646PP-OR-315Case MedicalPP-OR-649PP-OR-316MedlinePP-OR-648PP-OR-317SSIPP-OR-650New Recall announcement that Smith & Nephew endoscopy division has recalled certain lots of EndoFemoral Aimers (sizes 3mm, 4mm, 5mm, 6mm and 7mm. Products are on PP-OR-632). Refer to your Smith & Nephew representative for further information. Price Increases announcements of price increases; Biomet Inc. Orthopedic Total Joints (PP-OR-442) effective May 1, 2010. The price increase impacts all tiers primary implants, 3% and 6% for revisions. EV3 Neurovascular Inc. (PP-OR-480) effective June 1, 2010. Increase on all tiers, 1.6%. Recall Reminder announcement Baxter Healthcare Corporation will recall its Colleague infusion pumps from the domestic market. Members using Baxters Colleague pumps will receive further instruction and information for Baxter and the FDS regarding the transition. Product Recall announcement that ConMed (PP-OR-388) has is initiated a recall on its Goldline Rocker Switch Pencils. The pencil has the potential for the pencils activation switch to remain in the on position. Affected catalog numbers; 130301A130304A130307A130319A130327A130337A130339A131307A131319A131327A60-6829-001A60-6829-005A Reprocessing Services announcement that SterilMed, PP-OR-433, is offering customized savings guarantee promotion including conversion and volume incentives. Effective April 15, 2010 through January 31, 2011. Contact Sandra Carter at SterilMed for questions and forms. Product Alert announcement that Hospira (PP-IV-015) has issued an alert regarding Symbiq infuser pumps, #16026 and #16027. These pumps are not detecting air in the line at the end of an infusion. Avoid over-programming the volume to be infused by relying on Air in Line alarm to indicate the end infusion. Use an administration set or extension set with an air eliminating filter where clinically acceptable. Endotracheal Tube announcement that in a letter dated April 1, 2010, Covidien informed Premier that they are discontinuing the earlier-generation Mallinckrodt Hi-Lo Evac Endotracheal tube (124160, 124165, 124170, 124175, 124180, 124185 and 124190) effective July 1, 2010. The Mallinckrodt TaperGuard Evac or TaperGuard endotracheal tubes are suggested replacements for the discontinued products. All aforementioned products are available through Premier agreement PP-OR-582. Hospitals should begin to shift to the TaperGuard Evac and TaperGuard tubes prior to the discontinuation date of the Hi-Lo Evac tube. Surgical Services announcement of new agreements for OR Equipment Drapes. Effective April 1, 2010 through March 31, 2013. Awarded supplierNew contract numberPrevious contract numberMicrotek MedicalPP-OR-586PP-OR-354SEEDS awarded supplierNew contract numberPrevious contract numberAdvance Medical Designs(SBE)SD-OR-010PP-OR-355Contour Fabricators Inc.(VET)SD-OR-011NewPreferred Surgical Services(WBE)SD-OR-012New Surgical Services announcement of a new product category for disposable wound protection retractor. Allied Medical (PP-OR-606) has awarded a three year contract, effective May 1, 2010 through April 30, 2013. Surgical Services announcement that Midbrook (SD-OR-007) has been added to the Washer and Decontaminators portfolio. Effective May 1, 2010 through February 29, 2012. This organization is a minority business enterprise. Imaging announcement that due to the challenges in supplying Molybdenum-99 anticipated throughout the month of May, Covidien (PP-IM-075) has decided to postpone the sale of its radiopharmacies to Triad Isotopes Inc. until late May. Originally scheduled to close on April 23, the delay will allow both organizations to focus on patient needs during this trying time Continuum of Care announcement of two new agreements for Non- invasive ventilators. Effective July 1, 2010 through June 30, 2013 SupplierNew Contract NumberExpiring Contract NumberRespironics California Inc. (Philips)PP-MM-101PP-MM-027Allied Healthcare Products Inc. *PP-MM-102New Cardiology announcement that Gambro CHF Solutions Inc. is offering 35% off list price for a limited time and limited supply of Aquapheresis therapy products. Contact CHF Solutions customer service at 1.886.709.4030 for details. Ophthalmology Abbott Medical Optics has announced that they will be changing their packaging and product labeling to reflect their name change from Advanced Medical Optics to Abbott Medical effective February 26, 2009. These products are found on PP-OR-467. Rental Beds, Mattresses and Therapeutic Surfaces announcement that ArjoHuntleigh (PP-MM-085) is offering a special promotion to new and existing customers who are willing to commit all their rental volume to them. During this same period the Group Buy savings of 5 % off the national award will be extended. Notify your ArjoHuntleigh Rep if interested Reprocessing Services announcement that Sterilmed is offering customized savings guarantee promotion including conversion and volume incentives (PP-OR-433). Promotion starts March 1, 2010 through January 31, 2011. Conversion incentive 5 percent rebate on purchases. Total savings guarantee $550 per bed annual savings Volume incentive 3 percent rebate on all purchases Recall announcement that Covidien, Nellcor Puritan Bennett Inc. has initiated a voluntary recall of specific lots of cuffed Shiley tracheostomy products (PP-OR-633). The recall applies to the 62 product codes. Lot numbers are configured as follows YYMMXXXXXX where YY is the year, MM is the month, XXXXXX is a sequential number. Action Steps; Review inventory and segregate any product with the affected lot numbers. Return unused affected product according to the directions in the attachment. Replace cuffed Shiley tracheostomy tube from an affected lot already in use in a patient with a tube that is not included in the affected lots as soon as the patients physician determines it is clinically appropriate. If the physician advises leaving the tracheostomy tube in place for any period of time, it is strongly advised that the frequency and intensity of monitoring the cuff inflation system be increased. Please do not return product without an RGA number, as it may delay providing issuance of credit to your facility. If product was purchased from a distributor, please contact your provider for their return process. Recall announcement that ConMed is initiating a recall on their GoldLine rocker switch pencil. Some of affected items are contained in the Avid contract for custom procedure packs (PP-OR-483). The recall involves the potential for the pencils activation switch to remain on. Action steps: Discontinue use of device Review you inventory for affected devices Complete and return Business Reply Foam to ConMed. Nursing - Members converting from liquid soap to foam products may save as much as 40 percent. Category Soaps, lotions and waterless hand rinse products. Suppliers Ecolab Inc (PP-NS-559), Medline Industries (PP-NS-560). Duration of contracts 5 years: 10/1/09-9/30/14. Ecolab and Medline both offer tremendous conversion incentives and support, including programs to cover costs for dispensers and installation as well as hand hygiene compliance programs. Ecolab also offers universal backplates with pre-drilled holes that match up to existing industry dispensing options, allowing for easier conversion. Imaging announcement, new Brachytherapy Seeds agreement awarded to incumbents Best International Inc. and Oncura Inc. and new Supplier IsoAid LLC. Effective August 1, 2010 through July 31, 2013. Pricing firm. SupplierNew Contract NumberExpiring Contract Number Best MedicalPP-IM-148PP-IM-082 PP-IM-081*IsoAidPP-IM-149NEWOncuraPP-IM-150PP-IM-080 Price Increase announcement that KCI USA, Inc. will implement a price increase for on their Negative Pressure Wound Therapy (PP-NS-438) products effective May 1, 2010. Increase on all tiers is 2.6% by line item. Women and Children announcement of a new contract category launch, Simulation Training Equipment and Centers. Agreement has been awarded to Laerdal Medical Corporation, PP-WC-048. Effective April 1, 2010 through November 30, 2012. Price Increase announcement of a Biomet Inc. annual price increase for Orthopedic Total Joints (PP-OR442), effective May 1, 2010. Average increase for primary implants in 3% and an average of 6% for revision. Automated Endoscopic Reprocessors announcement that the current Johnson & Johnson agreement PP-OR-537 has been extended to April 30, 2011. The overall price increase for all tiers is 1.14% External Defibrillators and Related Products announcement of new agreements with incumbents Medtronic and Zoll Medical and new Supplier Philips Healthcare. Effective June 1, 2010 through May 31, 2013. SupplierNew contract number  Previous contract number Medtronic, USA Inc. (Physio Control)PP-CA-162PP-CA-110Philips HealthcarePP-CA-163NEWZoll Medical CorporationPP-CA-164PP-CA-111 Auditory Products and Related Accessories announcement of new agreements with incumbent suppliers, effective May 1, 2010 through April 30, 2013. SupplierNew contract number Previous contract numberNatus Medical Inc.*PP-WC-044PP-WC-001 Natus / Algo productsPP-WC-002 Bio-Logic / ABaer productsOtodynamics Ltd.PP-WC-047New Bone Tissue Synthetic Implantable Products - announcement that MTF (PP-OR-542) has added three new products categories to their contract. Categories are Core Tissue products, Sports Medicine products, and Trinity Evolution (stem cell based allograft) products. Participating members must sign a PMDF with these new categories to be eligible for these new products. Spinal Implant and Related Products Price Increase announcement that Medtronic (PP-OR-546) will implement an annual price increase effective May 1, 2010. The increase affects only Mastergraft Ceramic Granules, Mastergraft Matrix and Mastergraft Putty products. Increase of .13 % effects tiers 1 through 3 only. Annual Price Increases Zimmer US Inc. has announced the following price increases; Surgical Automatic Tourniquet Systems (PP-OR-351), effective April 1, 2010. Prices increase is for all tiers and is 2% per line item. Bone Cement and Accessories and Pulse Lavage (PP-OR-456), effective April 1, 2010. Price increase is for all tiers and is 2% per line item. Orthopedic Total Joints (PP-OR-444), effective April 1, 2010. Price increase is for all tiers. 4% for Hips and Knees and 2% for Extremities. Tracheostomy Tubes announcement that effective May 1, 2010 Smiths Medical pricing on contracts PP-OR-585 & AS-OR-585 will change to reflect the multi-source award. Smiths will honor the current sole pricing for any member who executes a PMDF or price activation by April 30, 2010. All PMDFs / PAs executed prior to May 1 will get/keep sole pricing. As of May 1, 2010, pricing across all tiers will increase by an average of 4% - including the ASCEND agreement. All activations on or after this date will get the new pricing. Contact your Client Services Executive to assist with your activations. Surgical Mesh announcement that the FDA identified specific types of counterfeit flat sheets of polypropylene surgical mesh labeled C. R. Bard/Davol. These meshes are NOT Bard-manufactured. Check the identified lot numbers below; ProductLot0112650 Bard Flat Mesh 2" x 4"Lot 48HVS036 Lot 43APD0070112660 Bard Flat Mesh 10" x 14"Lot HUSD0629 Lot HURL03360112680 Bard Flat Mesh 3" x 6"Lot 43HPD027 Lot 43HPD032 Lot HUSG0540 Lot 43HDP027 Lot HUSE0532 Lot 43LPD507 Lot HUSF0763 Lot 43IOD011 Lot 43IPD0380112720 Bard Flat Mesh 6" x 6"Lot 43FQD327 Contact Bard at 1.800.556.6275, if you have one of these products. Surgical Services announcement that ConMed has issued a corrective action regarding their video carts with AC power cord reels and cord reel accessories/replacements, PP-OR-370. The FDA has issued a safety alert. Contact your local ConMed Sales Representative for suggested next steps. Huber Needle Extension Sets announcement that Baxter Healthcare Corporation has discontinued their INTERLINK System Huber Needle Extension Sets, PP-IV-023. Product codes 2N3707, 2N3709, 2N3710, 2N3712 and 2N3714 will not be sold in the U.S. after Monday, June 7, 2010. Distributors may continue to sell their inventories until depleted. These five products are in addition to the five (2N3700, 2N3703, 2N3706, 2N3708 and 2N3716) communicated in November and, together, constitute Baxter's entire portfolio of Huber needle extension sets. Laboratory announcement that Beckman Coulter has initiated a product corrective action on UniCel DXC Systems, PP-LA-198. This issue is excessive build-up of protein, bacteria and sample tube additives in the ISE flow cell that may cause erroneous sodium, protein, chloride and calcium test results. Questions should be address by contacting your Sales Representatives. Laboratory announcement that Beckman Coulter, sole source in the Flow Cytometry category, will not be submitting a new bid. Therefore, agreement PP-LA-213 will not be sourced again. Current agreement expires 6/30/10. Price Increases announcement that Zimmer US Inc. has exercised its right to the following increases; Surgical automatic tourniquet systems (PP-OR-351), effective April 1, 2010, all tiers 2% increase. Bone Cement and Accessories and Pulse Lavage Products (pp-OR-456), effective April 1, 2010, all tiers 2% increase. Orthopedic Total Joints (PP-OR-444), effective April 1, 2010, all tiers 4% increase for hips and knees and 2% for extremities. Patient Cleansing and Skin Care announcement of new agreement in two categories; Patient Cleansing and Skin Care and Traditional and Patient Cleansing and Skin Care-bag based. Effective June 1, 2010 through May 31, 2013. CategorySupplierNew Contract NumberPrevious Contract NumberPatient Cleansing and Skin Care - TraditionalConvaTec Inc.PP-NS-600PP-NS-450Geritrex Corporation*PP-NS-602NewSmith & Nephew Inc.PP-NS-601PP-NS-452Patient Cleansing and Skin Care Bag-BasedSage Products Inc.*PP-NS-598PP-NS-440Innovative Healthcare Company (IHC)*PP-NS-599New Exam Gloves and Surgeon Gloves announcement of new agreements effective May 1, 2010 through April 30, 2013. The Exam Gloves category provides a special Sourcing to Specification tier offering up to 32 % savings in aggregate compared with current Premier pricing. (contact your Client Services Executive for details) CategorySupplierNew Contract NumberPrevious Contract NumberEffective DatesHYPERLINK "https://purchasing.premierinc.com/sca/catalog/ViewContent.action?contentId=/Contract_Launch/Exam_Gloves_Launch_Effective_05.01.10.xml"Exam GlovesCardinalPP-NS-591PP-NS-442May 1, 2010 through April 30, 2012 (24 months)DigitcarePP-NS-596PP-NS-444Innovative Healthcare CorporationPP-NS-594NEWKimberly-ClarkPP-NS-592PP-NS-445MedgluvPP-NS-595PP-NS-446MedlinePP-NS-593PP-NS-447TronexPP-NS-597NEWHYPERLINK "https://purchasing.premierinc.com/sca/catalog/ViewContent.action?contentId=/Contract_Launch/Surgeon_Gloves_Launch_Effective_05.01.10.xml"Surgeon GlovesAnsellPP-OR-626PP-OR-359May 1, 2010 through April 30, 2013 (36 months)CardinalPP-OR-627PP-OR-360MedlinePP-OR-628PP-OR-361MolnlyckePP-OR-629PP-OR-362 Recall announcement that Baxter Healthcare Corporation is initiating a voluntary recall Renamin (Amino Acid) for injection. This product is available on agreements PP-IV-033 and PP-IV-043. Cardiology announcement that Physio-Control Inc., Medtronic, has improved its quality system and has meant FDA requirements. Therefore, will now resume shipment of its external defibrillator. (PP-CA-110). SEEDS Contract Launches announcement that SEEDS (Sourcing Education and Enrichment for Diverse and Small Suppliers) have been added to OR Accessory Products portfolio, Mectra Labs, Inc. (SD-OR-008) and Room Turnover Products portfolio, Preferred Surgical Products LLC (SD-OR-009). Both agreements are effective March 1, 2010 through July 31, 2012. Product Recall 3M has issued a voluntary recall of Micropore surgical tape, both single rolls and bulk packaged. This recall with effect Avid custom procedure trays used in hemodialysis centers. Lots effected; AVID number3M #Description5107921530-136TAPE, MICROPORE 1 X 365124991530-154TAPE, MICROPORE 1X5453012471530-118TAPE, MICROPORE 1"X18" ROLL9925321530-12YTAPE, MICROPORE, 1 IN X 72 IN Laparoscopic Suction and Irrigation Products announcement of new agreements with incumbents and a new Supplier. Agreements effective May 1, 2010 through April 30, 2013. These instruments are used in Laparoscopic procedures to suction and remove fluid, remove smoke from the surgical field, cauterize tissue and irrigate the surgical field. SupplierNew contract number Previous contract numberCardinalPP-OR-635 PP-OR-356 ConMedPP-OR-634NewGeniconPP-OR-637 PP-OR-358StrykerPP-OR-636PP-OR-357 Arthroscopy Supplies announcement of new agreements with incumbent suppliers. Agreements effective May 1, 2010 through April 30, 2013. Product category includes arthroscopes, instrumentation, power equipment, implants and disposable supplies. SupplierNew contract number  Previous contract number ConMedPP-OR-630PP-OR-370Smith & NephewPP-OR-632PP-OR-372StrykerPP-OR-631PP-OR-371 Orthopedic Power Tools and Accessories announcement of new agreements with incumbent suppliers. Agreements effective May 1, 2010 through April 30, 2013. This products category includes battery, electric or nitrogen-driven equipment that assist Surgeons during orthopedic, neurological and spine procedures. Awarded supplierNew Contract NumberCurrent Contract NumberBrasseler USAPP-OR-638PP-OR-373ConMedPP-OR-639PP-OR-374MicroAire SurgicalPP-OR-640PP-OR-375Stryker InstrumentsPP-OR-641PP-OR-376 Backorder announcement that Teleflex Medical has issued a backorder for item numbers A-6020-08LF and A-6002-08L, Pleur-evac chest drainage products (PP-OR-514). Both items affected represent infant units. Backorder may exist until mid-March. Polysomnography, Neurological Equipment and Accessories announcement of new agreements with incumbents Cadwell Laboratories Inc. (PP-MM-097), CareFusion 209 Inc. (PP-MM-099) and Nihon Kohden America Inc. (PP-MM-098) and new Supplier Embla Systems Inc. (PP-MM-100). Agreement effective May 1, 2010 through April 30, 2013. Urgent Medical Device Correction Lifescan (PP-LA-196, PP-LA-260) has notified the FDA of customer complaints concerning their blood glucose products; SureStepPro, SureStepFlexx or OneTouch SureStep. The complaint is that the meter may provide a false low instead of High reading. Reach out to your local LifeScan Representative for details. Cardiac Rhythm Management announcement that effective February 1, 2010 through January 31, 2012. Deadlines for Participating Member Designation Forms (PMDFs) are below; Biotronik (PP-CA-159) Members who wish to take advantage of the DRG Rebate Program have until February 19, 2010 (extended from January 22) to submit a PMDF. Medtronic (PP-CA-160 - Members on current tiers have until March 31 to submit a PMDF designating a tier. St. Jude (PP-CA-161) - Members on current tiers have until March 1 to submit a PMDF designating a tier PMDFs for all suppliers are available in Supply Chain Advisor. Contact your Client Services Executive or Clinical Services for any questions or assistance. Sterrad Technology announcement that J & J is offering several equipment promotions (PP-OR-526). Products include; STERRAD NX"! System, EVOTECH ECR, STERRAD 100NX"! System, STERRAD 100S System, or STERRAD 200 System. Promotion dates are February 8, 2010 through June 30, 2010. For complete offer details and program guidelines, please contact your Premier corporate accounts director, Kit Schumaker, via e-mail at HYPERLINK "mailto:KSchumak@its.jnj.com"KSchumak@its.jnj.com For specific assistance, each member hospital should contact their ASP account executive or GNYHA Client Services Executive. Surgical Incontinence Products announcement that C. R. Bard has added an Adjustable Single-Incision Sling to PP-OR-538. Surgical Endoscopy and Video Equipment announcement that Olympus America Inc. with implement an annual price increase effective April 1, 2010 (PP-OR-505). The impact is 2.91% increase on all tiers. Nursing announcement that Hospira has developed a website, HYPERLINK "http://www.HospiraAdvanceWithUs.com"www.HospiraAdvanceWithUs.com, to inform their customers of product retirement and migration for products such as specialty injectables and medication management systems and technologies. Imaging announcement that Covidien has a new sourcing agreement with the Institute of Atomic Energy in Poland to gain access to medical isotopes. This is an additional source for Molybdenum 99 (PP-IM-075). Group Buy announcement for Infant Care Capital Equipment with Draeger Medical Inc. Products include incubators, warmers, transport systems and jaundice management. Group buy begins February 15, 2010 through May 15, 2010. More information can be found at HYPERLINK "http://www.premierinc.com/groupbuy"www.premierinc.com/groupbuy (GB-WC-036A). Price Increase announcement that Olympus America Inc. will implement an annual price increase for their Surgical Endoscopy products on agreement PP-OR-508, effective April 1, 2010. Voluntary Recall announcement that on February 8, 2010 United States Surgical (Covidien) issued a recall on their ProTrak fixation device (PP-OR-341). The impacted lot numbers for product number 174006, include batch numbers P9M0113, P9M0312, P9M0515, P9M0516, P9M0647, P9M0696, P9M0771 and P9M0816. Urgent Recall announcement that Becton, Dickinson and Company has initiated a recall for products on agreement PP-NS-472, Nexiva Closed IV Catheter System which includes the Q-Syte devices. Devices may not function properly due to a manufacturing deviation Trade-In Program announcement that Medrad Interventional/Possis, (PP-CSA-155) is offering a trade-in allowance for any member that owns an AngioJet drive unit, #101973-001. You will receive a credit towards the purchase of an AngioJet Ultra Console, # 105650-001. All purchase orders must be received by end of business on Monday, March 29, 2010, to qualify. Cardiology Recall announcement that Bard Electrophysiology (PP-CA-135) has issued a recall for their Channel FX Transseptal Sheath Kit, lots XD25200, XD252501, XD252502, XD252503, XD252504, XD252505, XD252506, XD252507, XD252508, XD252509. The transseptal introducer sheath radiopaque/soft tip may fracture or detach in vivo use, resulting in a device fragment that can pass into the systemic arterial circulation and lead to an embolic event. Tracheostomy Tubes and Related Products announcement that because the Premier Surgical Services Sourcing Committee has determined that this product category is classified as physician preference. Therefore, a sole source contract cannot be awarded. Nellcor Puritan Bennett has been added to the portfolio with incumbent Smiths Medical. Effective January 1, 2010 through December 31, 2012. SupplierNew contract number  Previous contract number NellcorPP-OR-633PP-OR-306Smiths MedicalPP-OR-585PP-OR-307The category includes the following tracheostomy tubes; cuffed fenestrated, cuffed non-fenestrated, uncuffed fenestrated, uncuffed non-fenestrated and foam cuffed. Gas Plasma Sterilization announcement that the Johnson & Johnson Health Care Systems Inc., (PP-OR-526) has been extended until February 28, 2011. Contract was to expire February 28, 2010. Sterilization of Packaging Systems announcement that Kimberly-Clark Health Care received an updated 510(k) clearance to market the KC300 KimGuard One-Step for pre-vacuum steam sterilization (K091685). The FDA now required directions for use to be included each case of KimGuard product. (PP-OR-471) The new language in the directions for use is in the sterility maintenance section and reads as follows: Healthcare facilities may use established protocols to monitor sterility maintenance of packages wrapped with the KimGuard* and KimGuard One-Step* Sterilization Wraps in accordance with acceptable standards of practice.Real-time testing simulating clinical use supports maintenance of package sterility for at least 30 days; however, this time-point does not prevent facilities from continuing to use established healthcare facility protocols. FDA Grants 18-month extension to facilities transitioning from STERIS System 1 to an alternative device. Imaging announcement that Afga Healthcare has reduced list price of its CR 85-X, CR 35-X and CR 30-X computed radiography system packages on PP-IM-131. Reposable Surgical Instruments announcement of new agreements with incumbents Suppliers, ConMed, Genicon and Microline and a new Supplier Surgical Innovation. Effective April 1, 2010 through March 31, 2012. These agreements will be co-terminus with Endomechanical Products. SupplierNew contract number  Previous contract number ConMedPP-OR-622PP-OR-345GeniconPP-OR-623PP-OR-346MicrolinePP-OR-624PP-OR-347Surgical InnovationsPP-OR-625New OR Equipment Drapes announcement of new agreement with incumbent Microtek Medical PP-OR-586, Old PP-OR-354. Effective April 1, 2010 through March 31, 2013. Surgical Patient Prep Products announcement of new agreements with incumbents 3M Industries Inc. and CareFusion 2200 Inc. Effective April 1, 2010 through March 31, 2013. SupplierNew contract number  Previous contract number 3MPP-OR-620PP-OR-308CareFusionPP-OR-621PP-OR-309 Price Increase announcement that Baxa Corporation will exercise its right to implement an annual price increase. (PP-IV-041). Effective February 1, 2010. IV Pump Promotion announcement from Baxa Corporation (PP-IV-041) 099 Repeater Pumps. Promotion February 1, 2010 through April 30, 2010. For details contact April Hixson at 301.617.2101 or april.hixson@baxa.com. Support Services Outsourcing Facilities Operations announcement of new agreements with incumbents Crothall Services Group and Hospital Housekeeping Systems (HHS) and a new Supplier, HHA Services. Effective April 1, 2010 through March 31, 2013. SupplierNew contract number  Previous contract number Crothall Services Group, d/b/a Crothall Healthcare Inc., Crothall Facilities Management Inc., and Crothall Laundry ServicesPP-MM-094PP-MM-021HHA ServicesPP-MM-095NEWHospital Housekeeping SystemsPP-MM-096PP-MM-022 Group Buy announcement a group buy opportunity for Patient Lifts with EZ Way Inc. from November 15, 2009 through February 14 2010. Product and pricing information is also available in Supply Chain Advisor; contract number GB-NS-557A. Cribs, Bassinets, and Youth Beds announcement of new agreements have been awarded to Homewood Health Care Products Inc. (PP-WC-045) and NK Medical Products (PP-WC-046) effective April 1, 2010 through March 31, 2013. Surgical Mesh announcement that Davol Inc. (PP-OR-365) is discontinuing Composix Mesh products effective March 31, 2010. Recall announcement that Bard Access Systems, Inc. (PP-OR-426) has issued a recall on their 19 g, 1 inch HuberPlus Non-Coring Needle Safety Infusion sets. Specific lot numbers; RETK0229 Huber Plus"!, 19g, 1 inch, Needless Y-site, product code 011901NY RETJ0655 Huber Plus"!, 19g, 1 inch, Needless Y-site, product code 011901NY RETJ0656 Huber Plus"!, 19g, 1 inch, product code 011901 The reason for the recall is because after activation of the safety mechanism, the tip of the needle protrudes from the safety sheath creating the potential for needlestick injury, which can result in the transmission of blood borne pathogens. Endomechanical, Suture and Topical Wound Sealant announcement that these agreements were set to expire March 31, 2010, Sourcing Committee, Premier and Suppliers have decided to extend all agreements for an additional two-year term, effective April 1, 2010 through March 31, 2012. Applied Medical, Ethicon and U.S. Surgical are the only suppliers to have pricing tiers and terms and conditions changes for the two-year extension. Pricing tiers and terms and conditions have not changed in the extended agreements for Aesculap, ConMed, Genicon, Patton and Teleflex. All extended agreements are effective April 1, 2010 through March 31, 2012. Notify your Client Services Executive or Clinical Services if you have questions. IV Therapy Price Increase announcement that Baxter Healthcare Corporation will exercise their contractual right to increase prices effective February 1, 2010. Baxter is capping its increase at 3 percent. Tiers 1 through 5 will have a 3 percent increase and pricing will increase by 1.5 percent in Tiers 6-8. Hospira Empty Evacuation Containers announcement that Hospira requested a price increase in September on their empty evacuation containers available through Premier agreement PP-IV-045 (TPN compounders, filling devices, elastomeric pumps, and admixture products). While there was a price increase in the market, Premier denied the requested price change. The price increase imposed through other group purchasing organizations contracts does not apply to the Premier contract. Women and Children Recall announcement that Encompass Group is voluntarily recalling the Thermoflect product line for relabeling. Product is available on PP-WC-042. Recall announcement that Baxter Healthcare Corporation is initiating a voluntary recall on Y Type Blood Solution Sets, product code 2C8750. These sets are available on PP-IV-023. Imaging announcement of price increase on Covidien Radiopharmaceutical Distribution agreement PP-IM-075. As provided in the agreement, Covidien will soon begin implementing two pricing initiatives for select radiopharmaceutical products. The price increase for radiopharmaceuticals involves third party manufactured products and Covidien manufactured products. These increases will become effective March 1, 2010 instead of January 1, 2010. IV Therapy Group Buy announcement of a group buy with CareFusion for Alaris IV pumps, December 15, 2009 through March 31, 2010. This is an opportunity to purchase Alaris PC Unit hardware and Guardrails software for the PC unit for $2900. The $2,900 price represents the following additional discount compared with Premier national agreement pricing: Group Buy Additional Discounts over National Agreement PricingTier 1Tier 2ATier 2B Tier 3ATier 3BTier 4ATier 4BTier 518.2% additional discount13.9% additional discount12.8% additional discount12.8% additional discount11.0% additional discount11.0% additional discount6.3% additional discount3.4% additional discount DePuy Spinal Implants announcement that DePuy (PP-OR-544) has agreed not to increase prices on January 1, 2010 for members that have sign PMDF. Recall Encompass Group has announced a voluntary recall of their Thermoflect product line (PP-WC-042). They are in the process of sending labels to customers to be attached to blankets to customers that this product line should not be used in the MR environment. Endotracheal Tubes announcement of new agreements with incumbents Nellcor Puritan Bennett and Smiths Medical and new Supplier Teleflex Medical. Effective with firm pricing January 1, 2010 through December 31, 2012. SupplierNew contract number  Previous contract number Nellcor PuritanPP-OR-582PP-OR-305Smiths MedicalPP-OR-583PP-OR-304TeleflexPP-OR-584New Blood Glucose Meters, Reagents, Consumables and Services announcement of new agreements with Johnson & Johnson Systems Inc. (LifeScan), Nova Biomedical Corporation and Roche Diagnostics Corporation. Effective March 1, 2010 through February 28, 2013. SupplierNew contract number  Previous contract numberJohnson & Johnson Healthcare Systems, Inc. (LifeScan)PP-LA-260PP-LA-196Nova Biomedical CorporationPP-LA- 261NewRoche Diagnostics CorporationPP-LA-262PP-LA-195 Cardiac Rhythm Management Deadlines new agreements are effective February 1, 2010 through January 31, 2012. Deadlines for Participating Member Designation Forms (PMDFs) are below; Biotronik Members who wish to take advantage of the DRG Rebate Program have until February 19, 2010 (extended from January 22) to submit a PMDF. Medtronic - Members on current tiers have until March 31 to submit a PMDF designating a tier. St. Jude - Members on current tiers have until March 1 to submit a PMDF designating a tier PMDFs for all suppliers are available in Supply Chain Advisor. Contact your Client Services Executive or Clinical Services for any questions or assistance. Imaging Group Buy announcement that Toshiba America Medical Systems beginning January 1, 2010 through March 31, 2010 is offering an opportunity that provides additional value above the Premier contracted price; ModalitiesContract NumberGroup Buy Value-add*Computed TomographyGB-IM-107CDiscount dollars and softwareGeneral RadiographyGB-IM-108CDiscount dollarsCardiovascular ImagingGB-IM-109CDiscount dollarsUltrasound RadiologyGB-IM-110CDiscount dollars and probeMagnetic Resonance ImagingGB-IM-111CDiscount dollars, table and software General Urologicals announcement of new agreements with incumbents C.R. Bard, Covidien and Rochester Medical Corporation. Effective March 1, 2010 through February 28, 2013. SupplierNew contract number  Previous contract number C.R. Bard Inc. Bard Medical DivisionPP-NS-584PP-NS-409Rochester Medical CorporationPP-NS-585 PP-NS-411CovidienPP-NS-583PP-NS-412 NOTE: Field Guide will be available on request. Cardiac Rhythm Management announcement of new agreement was made on December 1, 2009. Please note deadlines for Participating Member Designation Forms (PMDFs) are below; Biotronik Members who wish to take advantage of the DRG Rebate Program have until January 22 to submit a PMDF. Medtronic - Members on current tiers have until March 31 to submit a PMDF designating a tier. St. Jude - Members on current tiers have until March 1 to submit a PMDF designating a tier. Instrument Containers announcement that agreements with Aesculap Inc, (PP-OR-314), CareFusion (PP-OR-315), Case Medical (PP-OR-316) and Medline Industries Inc. (PP-OR-317) have been extended to July 31, 2010. Surgical Patient Preps announcement that CareFusion is consolidating codes on agreement PP-OR-309. The prep tray offering is now consolidated into six standard configurations. Contact your CareFusion Representative for details. Surgical Instruments announcement of new agreements with incumbent and a new Supplier. Effective February 1, 2010 through January 31, 2013. Current agreement with Teleflex/Pilling-Weck (PP-OR-332) expires January 31, 2010. SupplierNew contract number  Previous contract number AesculapPP-OR-614PP-OR-329CareFusionPP-OR-615PP-OR-330JaritPP-OR-616PP-OR-331SpectrumPP-OR-617New Laparoscopic Surgical Instruments announcement of new agreements with incumbents and new Suppliers. Effective February 1, 2010 and January 31, 2013. Current agreement with Teleflex/Pilling-Weck (PP-OR-321) expires January 31, 2010. SupplierNew contract number  Previous contract number AesculapPP-OR-608PP-OR-318CareFusion PP-OR-609PP-OR-319GeniconPP-OR-610NewJarit InstrumentsPP-OR-611PP-OR-320National Advance EndoscopyPP-OR--613NewSurgical InnovationsPP-OR-612New Recall announcement that B. Braun has issued a voluntary recall of its Horizon/Outlook IV Pump Sets due to reports of System Error 9 alarms. A system Error 9 alarm indicates a potential pressure loss in the pump cassette delivery chamber. This alarm is generated during the pump initiation sequence and will not allow the set to be utilized. This requires a new set to be obtained, thus creating a potential for delay in therapy. Labels, Identification bands announcement of updated financial information for the new agreement with St. John (PP-MM-092), effective February 1, 2010. Savings on all tiers. Patient Beds and Stretchers announcement that of new agreements in three categories: Patient Beds, Mattresses and Therapeutic Surfaces Purchase, Patient Beds, Mattresses and Therapeutic Surfaces Rental, Stretchers. Agreements effective March 1, 2010, through February 29, 2010. Note: The following agreements expire on February 28, 2010: SIZEwise Rentals LLC (PP-NS-359) for specialty beds, SpanAmerica (PP-NS-431) and EHOB (PP-NS-432) for mattress overlay products and replacement mattresses. CategorySupplierNew Contract Expiring Contract Patient Beds, Mattresses and Therapeutic Surfaces Purchase ArjoHuntleighPP-MM-079 frames and surfacesNewEncompassPP-MM-080 surfaces onlyPP-NS-433 mattress overlay / replacementGaymar*PP-MM-081 surfaces onlyPP-NS-434 mattress overlay / replacementHill-Rom CompanyPP-MM-082 frames and surfacesPP-NS-354 patient bedsKCI USA Inc.PP-MM-083 Surfaces onlyPP-NS-358 specialty bedsStryker MedicalPP-MM-084 frames and surfacesPP-NS-355 Patient Beds, Mattresses and Therapeutic Surfaces Rental ArjoHuntleighPP-MM-085NewHill-Rom CompanyPP-MM-086PP-NS-357 specialty bedsKCI USA Inc.PP-MM-087PP-NS-358 specialty bedsUniversal Hospital Services Inc. (UHS)PP-MM-088NewStretchersHill-Rom CompanyPP-MM-089NewStryker MedicalPP-MM-090PP-NS-351TransMotion Medical*PP-MM-091New Reprocessing announcement that Stryker Corporation announced it has a definitive agreement to acquire privately held Ascent Healthcare Solutions Inc. (PP-OR-434) before the close of 2009. Ascent will keep its name and become the reprocessing and remanufacturing division of Stryker. Price Increase announcement that Olympus America Inc. (PP-OR-492) will increase pricing 5% on products IS72025 and IS72010 and a pending 3.73 percent increase in pricing on IS72009. The prices of products IS72037 and IS72015 will be decreased by 14 percent and 24 percent, respectively. FDA Notification and Recommendations announcement that in a notice dated December 3, 2009, the FDA notified healthcare facility administrators and infection control healthcare professionals of important information regarding the regulatory status of the STERIS System 1 processor (SS1) used in surgical and endoscopy suites for reprocessing, i.e., sterilizing or disinfecting, medical devices. STERIS has significantly modified the SS1, and the FDA has not approved or cleared this modified product. Thus, the FDA has not determined whether the SS1 is safe or effective for its labeled claims, including claims that it sterilizes medical devices. Use of a device that is promoted to sterilize or disinfect a medical or surgical device, but that does not properly perform these functions, poses risks to patients and users. Improperly disinfected or sterilized instruments may transmit pathogens to patients and healthcare staff, or expose them to hazardous chemicals. Improper sterilization or disinfection may also adversely affect the quality and functionality of reprocessed instruments. The FDA recommends that if a facility has an acceptable alternative to the SS1 to meet sterilization and disinfection needs, the facility should transition to that alternative as soon as possible to ensure continued patient safety. If an acceptable alternative to the SS1 is not available, the facility should promptly assess its patient care needs and sterilization and disinfection requirements, and take steps to obtain legally marketed substitutes for the SS1. Recall announcement that BD has initiated a recall on 30 mil Luer-Lok syringes, lot number 9175046, found on PP-NS-460. A small number of unit packages may have open seals. Sterling Nitrile Exam Gloves Kimberly-Clark in a letter dated Dec 8, 2009 announced a backorder and revised allocations of their Sterling silver Nitrile products (PP-NS-445). This will affect the timing of order fulfillment and shipment. Skin Breakdown Prevention Products announcement of new agreements awarded to DeRoyal Industries Inc., Gaymar Industries Inc., Joerns Healthcare Inc., Medline Industries Inc. and Sage Products Inc. Effective March 1, 2010, through February 28, 2013. SupplierNew contract number Previous contract numberDeRoyal IndustriesPP-NS-578PP-NS-429Gaymar Industries Inc.PP-NS-579PP-NS-434 mattress overlay productsJoerns Healthcare Inc.PP-NS-580NewMedline IndustriesPP-NS-581PP-NS-430Sage ProductsPP-NS-582New Annual Price Increases announcement that the following companies have announced price increases; Intregra LifeSciences (PP-OR-478) neurological products effective January 1, 2010. Increase impacts all tiers at an aggregate of 3%. DePuy Spine (PP-OR-544) effective January 1, 2010. Increase impacts all tiers at an aggregate of 6%. Olympus America, Inc. for surgical endoscopy and video equipment (PP-OR-505) effective January 1, 2010. Increase impacts all tiers at an aggregate of 5%. Product Notice CareFusion (PP-OR-303 and PP-OR-533) has announced that they are experiencing production delays that affect its iodine-based prep trays, bulk bottle solutions and surgical scrub brush product lines. Production will be suspended until maintenance activities are completed. OR Lights and Booms announcement of new agreements with incumbent suppliers Berchtold Corporation, Maquet Inc., Skytron, Steris Corporation and Stryker Instruments and new suppliers Amico Clinical Solutions, Nuvo Inc. and Trumpf Medical Systems Inc. Effective February 1, 2010, through January 31, 2013. SupplierNew contract number  Previous contract number AmicoPP-OR-599NewBerchtoldPP-OR-594PP-OR-322MaquetPP-OR-593PP-OR-233Nuvo*PP-OR-597NewSkytronPP-OR-598PP-OR-323SterisPP-OR-595PP-OR-324StrykerPP-OR-596PP-OR-325TrumpfPP-OR-600New OR Tables announcement of new agreements to incumbent Suppliers Maquet Inc., Skytron and Steris Corporation and new suppliers Berchtold Corporation, Nuvo Inc. and Trumpf Medical Systems Inc. Pricing will remain firm for duration of contract. Effective February 1, 2010, through January 31, 2013. SupplierNew contract number  Previous contract number BerchtoldPP-OR-590NewMaquetPP-OR-587PP-OR-326NuvoPP-OR-591NewSkytronPP-OR-588PP-OR-327SterisPP-OR-589PP-OR-328TrumpfPP-OR-592New Patient Prep Clippers and Blades announcement of new agreements with incumbents, CareFusion 2200, Inc. and Medline Industries and new Supplier 3M industries. Effective February 1, 2010 through January 31, 2013. SupplierNew contract number  Previous contract number 3MPP-OR-602NEWCareFusionPP-OR-603 PP-OR-310 MedlinePP-OR-604PP-OR-311 Regional Anesthesia Trays and Related Products announcement of new agreements have been awarded to incumbent Supplier, Smiths Medical and two new Suppliers, Arrow International, Inc. and Becton Dickinson. Effective February 1, 2010 through January 31, 2013. Note B. Braun agreement PP-OR-312 expires January 31, 2010. SupplierNew contract number  Previous contract number Arrow PP-OR-607NewBDPP-OR-605NewSmiths PP-OR-606PP-OR-313 Recall announcement that Smiths Medical ASD Inc. has initiated a voluntary recall on a limited number of Medfusion syringe infusion pumps, models 3010A and 3500 manufactured between August 1, 2008 and June 10, 2009 (PP-IV-018). There has been an increased trend in reports of Motor Not Running (MNR) and Motor Rate Error (MRE) alarm message events with certain Medfusion syringe infusion pumps. When a MNR/MRE alarm message event occurs, the pump is prevented from delivering fluids. Product Stockout - announcement that Baxter Healthcare Corporation has extended the stockout of Heparin Sodium in 5% Dextrose Injection liquid premix products (PP-IV-033). Effected products codes are 2B0807, 2B0802 and 2B0808. Baxter does not know when manufacture of Heparin Sodium in 5% Dextrose will resume. Recall announcement that Baxa Corporation issued recall letters on specific lots of their ExactaMix TPN bags (PP-IV-041). The failure is limited to specific lots of the 500mL (Baxa Item #738), 1000mL (Baxa Item # 739), and 2000mL (Baxa Item # 740). Failure may result in a port becoming loose or disengaging from the bag which may result in a leak. Product Notice Philip/Respironics has issued a voluntary field action on their Respironics V60 ventilator (PP-MM-027). Issue is with a component of the ventilator power management (PM) printed circuit board (PCB). This issue was noted in ventilators shipped before August 5, 2009 Laboratory Reprocessed Disposables announcement that incumbent Supplier Environmental Support Systems Inc. (L.E.S.S). Agreement covers the reprocessing services for disposable cuvettes, sample cups, and other disposable plastic products for medical laboratories. Effective March 1, 2010 through February 28, 2013. Cardiac Rhythm Management Devices announcement of agreements with incumbents for Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy (CRT) devices and Leads. Effective February 1, 2010 through January 31, 2012 with an optional one year extension. These agreement offer firm pricing for the term of the agreements. SupplierNew Contract Numbers  Previous Contract Numbers BiotronikPP-CA-159PP-CA-112MedtronicPP-CA-160PP-CA-115St. JudePP-CA-161PP-CA-114 Syringe Pump Promotion announcement that Smiths Medical (PP-IV-018) is offering a $500 trade-in or trade-up promotions toward Medfusion 3500 syringe pumps with v5 software. Promotion started November 15, 2009 and ends January 25, 2010. Bedside Procedure Trays and Needles announcement that new agreements have been awarded to incumbents CareFusion 2200 Inc. and Covidien as well as Supplier, Busse Hospital Disposables. Agreements effective February 1, 2010 through January 31, 2013. SupplierNew contract number  Previous contract number Busse Hospital Disposables*PP-NS-590NewCareFusion 2200, Inc. PP-NS-588PP-NS-427 (fka Cardinal)Tyco Healthcare Group LP dba CovidienPP-NS-589PP-NS-428 Recall announcement of a voluntary Recall of AMO Tecnis 1-Piece Intraocular Lens. This recall only affects specific lot numbers of unused product. These products on are contract PP-OR-467). Surgical Instrument and Scope Repair announcement of new agreements have been awarded to current incumbents and new a new Supplier. Agreements effective February 1, 2010 through January 31, 2013. SupplierNew contract number  Previous contract number Surgical Instrument Repair  Previous contract number Scope Repair IMSPP-MM- 075PP-MM-007PP-MM-049Mobile InstrumentPP-MM- 076PP-MM-006SpectrumPP-MM- 077PP-MM-004US Medical SystemsPP-MM-078NewNew Imaging Update, because of Covidiens exit from the barium contract media market globally they will discontinue shipments of all barium products to U.S. distributors effective January 15, 2010. Covidien will honor the current Premier contract (PP-IM-073) pricing through June 2010. Contact Covidiens Product Monitoring Group at HYPERLINK "mailto:productmonitoringhazelwood@covidien.com"productmonitoringhazelwood@covidien.com or 1.800.778.7898. For a product cross reference. Nursing/Surgical announcement that Sage Products is offering a limited-time, free trial of Sage 2% Chlorhexidine Gluconate Cloths Preoperative Skin Preparation (PP-NS-440). Promotion starts November 1, 2009 and ends January 30, 2010. Imaging announcement that new agreement are computed radiography with incumbents Agfa HealthCare Corporation and FujiFilm Medical Systems USA Inc. new Supplier, Konica Minolta Medical Imaging USA Inc. Agreements effective January 1, 2010 through December 31, 2012. Agfa HealthCare Corp.PP-IM-131PP-IM-079FujiFilm Medical Systems USA Inc.PP-IM-132PP-IM-078Konica Minolta Medical Imaging USA Inc.PP-IM-133New Ultra Thrombectomy announcement that Medrad Interventional/Possis (PP-CA-155) is offering a trade-in allowance for any member that currently owns an Angio-Jet drive unit, item 101973-001. Contact your Client Services Executive or call the Medrad Hotline at 800.810.7677. Temperature Monitoring announcement that an agreement has been awarded to incumbent Smiths Medical. Effective January 1, 2010 through December 31, 2012. Products in this category included esophageal stethoscopes, myocardial, tympanic and general purpose probes, foley catheters, skin sensors and neonatal products. Current agreement with DeRoyal (PP-OR-301) and Nellcor Puritan Bennett (PP-OR-303) expire December 31, 2009. Tracheostomy Tubes announcement that a new agreement has been awarded to incumbent Smiths Medical (new PP-OR-585, previous PP-OR-307). The category includes cuffed fenestrated, cuffed non-fenestrated, uncuffed fenestrated, uncuffed non-fenestrated and foamed cuffed. Effective January 1, 2010 through December 31, 2012. High Level Disinfection Reprocessing announcement that new agreements with incumbents Hygia Health Services and ReNu Medical Inc. has been awarded. Effective January 1, 2010 through December 21, 2012. Hygia Health Services New, PP-NS-587 Previous, PP-FA-061 ReNu Medical, Inc. New, PP-NS-586 Previous, PP-FA-062 High level disinfection is an environmentally friendly and clinically safe method for reprocessing a wide range of semi-critical and non-critical single use devices. Products that are reprocessed through high level disinfection include: Blood pressure cuffs DVT compression garments Stethoscopes Fetal monitoring belts Pressure infuser bags Pneumatic tourniquet cuffs Air cushion masks Pulse oximeter probes Splints Teleradiology Services announcement of a new category for teleradiology services. Theses services are for reading and/or consultation services offered by remote radiologists who are able to view the radiologic images via electronic transmission. This category is open to acute and continuum of care members. Effective dates November 1, 2009 October 31, 2012. SupplierNew contract numbers  Previous contract numbers NightRays PP-IM-134 New Quality NightHawkPP-IM-135New Templeton Reading, LLC.PP-IM-136 NewUS RadiologyPP-IM-137 New Cardiology announcement that Bard Electrophysiology is offering over 45% off list price for Stringer Ablation catheters (PP-CA-135). This promotion starts November 1, 2009 and ends December 31, 2009. Surgical Gowns announcement that Cardinal Health (PP-OR-481) has extended their promotion for 5 to 10 free cases of SmartGown surgical gowns with conversion after complimentary evaluation of the gown. Offer extended to December 31, 2009. Barium announcement that Covidien has made the announcement to exit barium business globally. Covidien will discontinue shipments of all barium products to U.S. distributors effective January 15, 2010. No orders will be processed after that date. Covidiens entire line of barium sulfate products, accessories and related products is impacted by this discontinuation. Covidien-supplied distributors should continue to place orders through your normal distribution channel. Your specific distributor may have barium products in stock beyond the January 15 date, therefore you should check with them on availability of any given product. Covidien anticipates most distributors will carry approximately 30 days of inventory, with some carrying 60 days. With respect to pricing, Covidien will honor the current contract (PP-IM-073) pricing through June 2010. Premier is currently evaluating what actions to take in response to this announcement and will provide more information in short time. Bone Cement - announcement that Stryker Orthopedics (PP-OR-455) is offering a 50% off bone cement starting October 19, 2009 through December 28, 2009. Buy bone cement at 50 percent off current list price. Minimum of 10 ten-packs must be purchased. Maximum of 100 ten-packs may be purchased. Offer valid at current list price only. Contract prices do not apply. Only one order per hospital Surgical and Isolation Mask Update announcement that the Premier member Surgical Services Committee voted to add new suppliers to the portfolio. Joining Cardinal, Kimberly-Clark and Precept in the portfolio are 3M Company, AMD-Ritmed Inc, Dukal Corporation, Medline Industries, Inc, Prestige Ameritech and Tronex Healthcare Industries. All new agreements will be effective October 1, 2009, except 3M, which will become effective November 1, 2009. All contracts in the portfolio will be effective through December 31, 2010. The new, complete supplier matrix is shown below. SupplierNew contract number  Previous contract number Contract effective dates3M CompanyPP-OR-573NewNovember 1, 2009 through December 31, 2010AMD RitmedPP-OR-574NewOctober 1, 2009 through December 31, 2010Cardinal HealthN/APP-OR-452April 1, 2008 through December 31, 2010DukalPP-OR-576NewOctober 1, 2009 through December 31, 2010Kimberly-ClarkN/APP-OR-453April 1, 2008 through December 31, 2010MedlinePP-OR-575NewOctober 1, 2009 through December 31, 2010Precept MedicalN/APP-OR-454April 1, 2008 through December 31, 2010Prestige AmeritechPP-OR-577NewOctober 1, 2009 through December 31, 2010TronexPP-OR-578NewOctober 1, 2009 through December 31, 2010 Smith Medical Ambulatory Infusion System announcement of savings from 4% to 48% off CADD-Solis Ambulatory Infusion System (PP-IV-018) depending on Tier level from September 21, 2009 through January 15, 2010. There are also financing options from MedOne Capital. BD Safety Hypodermic Products announcement from Becton, Dickinson and Company that they are experiencing supply challenges due to unprecedented demand for safety hypodermic syringes and needles associated with early flu vaccination season and their commitment to the U.S. government for mass H1N1 supplies. Contact your Supply Chain Executive and BD Rep for alternative products. Diagnostic and Interventional announcement that agreements with C. R. Bard, Inc. (PP-CA-140), Boston Scientific Corporation (PP-CA-141) and Cook incorporated (PP-CA-142) have been extended to January 31, 2011. Peripheral and Biliary Stents announcement that agreements with Abbott Vascular (PP-CA-137), Boston Scientific Corporation (PP-CA-138) and ev3 Endovascular, Inc. (PP-CA-139) have been extended to January 31, 2011. Group Buy announcement of a GE Imaging Group Buy. Savings up to 25% from October 1, 2009 through December 31, 2009. Products include diagnostic imaging products across nine modalities and also includes extended warranty and additional discounts for service and maintenance agreements purchased along with specific equipment. Bausch & Lomb announcement that Bausch & Lomb has added the 2 millimeter micro-incision cataract surgery platform to its agreement (PP-OR-466). SureTemp Plus Thermometers announcement that Welch Allyn is offering $40 savings on minimum purchase orders of SureTemp Plus thermometers starting October 1, 2009 through December 31, 2009. Osteotech bone tissue and synthetic implants products announcement, please note that this agreement (PP-OR-541) effective July 1, 2009 is not requiring signature of PMDFs for existing customers. However, note pricing change and load into your data system. Vascular Compression Therapy announcement of new agreements in two categories with pump devices and sleeves found in the category titled Vascular Compression Therapy. Agreements are awarded to Covidien Healthcare (old PP-NS-388, new PP-NS-575) and new Supplier Compression Therapy Concepts (new PP-NS-576). Agreements effective December 1, 2009 through November 30, 2012. Disposable Non-Sterile Personal Protection apparel announcement of new agreements with incumbents Cardinal Health (old PP-NS-383, new PP-NS-571) and Medline Industries (old PP-NS-384, new PP-NS-572) and new Supplier AllCare Inc., (PP-NS-570). This category now includes products previously found in the categories titled Disposable Personal Protection Attire and Caps and Shoe Covers. Agreements effective December 1, 2009 through November 30, 2012. Vascular Compression Therapy Anti-Embolism stockings announcement that of new contract awards in two categories with stockings found in VCT Anti-Embolism Stockings. Awarded suppliers for anti-embolism stocking are C!#$/567UVacgIJ}vfYL;5CJOJQJ\^JhT~5CJOJQJ\^J67hir s c d   h+ 7$8$H$]^gd-gd- & Fgd) & Fgd) & Fgd) & Fgd)$a$gd-[gd gd;9Lgh q r  b c { }   įğpp`O`BOh~+5OJQJ\^J h-5CJOJQJ\^JaJh-h-5OJQJ\^J h 5+5CJOJQJ\^JaJ h-5CJOJQJ\^JaJh-5OJQJ\^Jh 5+h 5+5OJQJ\^J)h-h-5>*CJOJQJ\^JaJ h-5CJOJQJ\^JaJ h-5CJOJQJ\^JaJh 5+5OJQJ\^Jh75OJQJ\^J    * + U V g h q ̰}f}_N:'$hGh-CJOJPJQJ^JaJ'h<h-5CJOJPJQJ^JaJ!h-5CJOJPJQJ^JaJ h<h--h-5B*CJOJPJQJ\^JaJph3h<h-5B*CJOJPJQJ\^JaJph1h-h-CJOJQJ^JaJfHq 7h-h-5>*CJOJQJ^JaJfHq &h-h-5>*CJOJQJ^JaJh-h-5OJQJ\^Jh-h~+5OJQJ\^J   ' < U $If]gd7y]$If]^gd7y] h+ 7$8$H$]gd-U V h r v I8++ $If]gd7y]$If]^gd7y]kd$$IflFjB"    t0<6    44 lapyt-q r u v w I K Z žiR>R>))h~+5B*CJOJQJ\^JaJph&h~+5B*CJOJQJ^JaJph,h~+h~+5B*CJOJQJ^JaJph2h~+h~+5>*B*CJOJQJ\^JaJphh~+h~+5OJQJ\^J h~+5CJOJQJ\^JaJh~+5OJQJ\^Jh~+5OJQJ\^J h\h-'h\h-6CJOJPJQJ^JaJ'h<h-6CJOJPJQJ^JaJ$h<h-CJOJPJQJ^JaJv w x J K z _WOJ::$7$8$H$^a$gd~+gd~+ & Fgd)$a$gd-[kd$$IflFjB"    t 0<6    44 lap yt-    +  & Fgd) & F^gd)^gdO & F^gd)^gdOgdO & Fgd)$a$gd-[p^pgd~+$7$8$H$^a$gd~+    "һq`L:) hOhVCJOJQJ^JaJ#hOhV5CJOJQJ^JaJ&hOhV5CJOJQJ\^JaJ h~+5CJOJQJ\^JaJhOhV5OJQJ\^JhOhV5OJQJ\^JhV5OJQJ\^JhO5OJQJ\^Jh~+h~+5OJQJ\^J,h~+h~+5B*CJOJQJ^JaJph)h0]h~+B*CJOJQJ^JaJph/h0]h~+5B*CJOJQJ\^JaJph +  S}~ͻͻ|hXC1X#hVhV5CJOJQJ^JaJ)hVhV5>*CJOJQJ\^JaJhVhV5OJQJ\^J&hVhV5CJOJQJ\^JaJ hV5CJOJQJ\^JaJ&hVhV5CJOJQJ\^JaJhV5OJQJ\^JhV5OJQJ\^J#hOhV5CJOJQJ^JaJ&hOhV5>*CJOJQJ^JaJ hOhOCJOJQJ^JaJhVCJOJQJ^JaJBswx & Fgd) & Fgd)^gd3 & Fgd) $ & Fa$gd) $^a$gd$+, $a$gd$+, & Fgd)$ & F7$8$H$a$gd)$a$gd-[ïzhVI8' hw>5CJOJQJ\^JaJ hw>5CJOJQJ\^JaJhw>5OJQJ\^J#h$+,h$+,5CJOJQJ^JaJ#h6Qh$+,5CJOJQJ^JaJ h6Qh$+,CJOJQJ^JaJ#h-hO5CJOJQJ^JaJ#h-h$+,5CJOJQJ^JaJ&h-h$+,5CJOJQJ\^JaJh-h$+,5OJQJ\^Jh-h$+,5OJQJ\^Jh-h~+5OJQJ\^Jh$+,5OJQJ\^J `bvwɸޖޖކyeޖUyA&hw>h|5CJOJQJ\^JaJh|h|5OJQJ\^J&hw>hw>5CJOJQJ\^JaJh|5OJQJ\^Jhw>hw>5OJQJ\^J)hw>hw>5>*CJOJQJ\^JaJhw>5OJQJ\^J!h3hw>5>*OJQJ\^J)h3hw>5>*CJOJQJ\^JaJ hw>5CJOJQJ\^JaJ h35CJOJQJ\^JaJ2<QR[\]jn߻{jUjMIM3Mj*hgkh|0J5CJOJQJ\^JaJhk3jhk3U)h|h|5>*CJOJQJ\^JaJ h|5CJOJQJ\^JaJ h-7[5CJOJQJ\^JaJ h-7[5CJOJQJ\^JaJ h|5CJOJQJ\^JaJh-7[5OJQJ\^Jh|h|5OJQJ\^J&hw>hY 5CJOJQJ\^JaJ&hw>h|5CJOJQJ\^JaJh|5OJQJ\^JxRS/0HRf$$&`#$/If^`a$gdP $^a$gd-h^hgdOgdP & Fgd) & Fgd) & Fgd)$a$gd-7[ & Fgd)$a$gd-[ & Fgd)İnZJ=-hPhP5OJQJ\^JhP5OJQJ\^Jh .KhP5OJQJ\^J&h .Kh .K5CJOJQJ\^JaJ&h .Kh .K5CJOJQJ\^JaJh .K5OJQJ\^Jh .Kh .K5OJQJ\^J h-7[5CJOJQJ\^JaJ&h-7[h-7[5CJOJQJ\^JaJh-7[5OJQJ\^Jh-7[CJOJQJ^JaJ h6Qh-7[CJOJQJ^JaJh-7[h-7[5OJQJ\^J ;<"#./0BDصueQ=)&h-hO5CJOJQJ\^JaJ&h-hr5CJOJQJ\^JaJ&h-hr5CJOJQJ\^JaJh-hr5OJQJ\^JhPhP5OJQJ\^JhPhr5OJQJ\^JhP5CJOJQJ^JaJ hPhPCJOJQJ^JaJ#hPhP5CJOJQJ^JaJ hP5CJOJQJ\^JaJ&hPhP5CJOJQJ\^JaJ&hPhP5CJOJQJ\^JaJ H®udPdP:dPdP*hr5B*CJOJPJQJ^JaJph'h-ZXhr5CJOJPJQJ^JaJ!hr5CJOJPJQJ^JaJ0h=hr5B*CJOJPJQJ^JaJph h-ZXhr0h-ZXhr5B*CJOJPJQJ^JaJph&hOhr5CJOJQJ\^JaJ)h-hr5>*CJOJQJ\^JaJ)hOhr5>*CJOJQJ\^JaJ&hOhO5CJOJQJ\^JaJA$$$&`#$/If^`a$gdPkd$$IflFH D 2 ``` t 6`1110    44 lap111yt-B%$$&`#$/If^`a$gdPkd$$IflFH D 2 ` t 6` 10    44 lap 1yt-$$&`#$/Ifa$gdPB%$$&`#$/If^`a$gdPkd$$IflFH D 2 ` t 6` 10    44 lap 1yt-$$&`#$/Ifa$gdP " . f ӺӪuduOu?hjAhr5OJQJ\^J)hrhr5>*CJOJQJ\^JaJ hr5CJOJQJ\^JaJ&hrhr5CJOJQJ\^JaJ&hrhr5CJOJQJ\^JaJhr5OJQJ\^Jhrhr5OJQJ\^J0h-ZXhr5B*CJOJPJQJ^JaJph h-ZXhr'h-ZXhr5CJOJPJQJ^JaJ!hr5CJOJPJQJ^JaJB%$$&`#$/If^`a$gdPkd$$IflFH D 2 ` t 6` 10    44 lap 1yt-$$&`#$/Ifa$gdPB99^gdrkdr$$IflFH D 2 ` t 6` 10    44 lap 1yt-$$&`#$/Ifa$gdP YwkdT$$IfTl0| GG  t 644 lBa]pytT~T $$Ifa$gdP $IfgdP^gdr & Fgd $a$gd-[ ! !!!.!/!?!@!P!Q!a!b!r!s!!!!!!!!!!!!!!!!""K"~""ķp&hQhQ5CJOJQJ\^JaJ)hQhQ5>*CJOJQJ\^JaJ hQ5CJOJQJ\^JaJhQ5OJQJ\^Jhus5OJQJ\^Jhrh;5OJQJ\^J h hrCJOJQJ^JaJ h hr&h hr5CJOJQJ\^JaJ, $hkd$$IfTl0| gg t 644 lBa]pytT~T $IfgdPhkd,$$IfTl0| gg t 644 lBa]pytT~T hkd$$IfTl0| gg t 644 lBa]pytT~T $IfgdP ! ! !$hkdd $$IfTl0| gg t 644 lBa]pytT~T $IfgdPhkd $$IfTl0| gg t 644 lBa]pytT~T !!!!&!.!hkd2 $$IfTl0| gg t 644 lBa]pytT~T $IfgdP.!/!7!?!@!$hkd $$IfTl0| gg t 644 lBa]pytT~T $IfgdPhkd $$IfTl0| gg t 644 lBa]pytT~T@!H!P!Q!Y!a!hkd $$IfTl0| gg t 644 lBa]pytT~T $IfgdPa!b!j!r!s!$hkd8$$IfTl0| gg t 644 lBa]pytT~T $IfgdPhkdj$$IfTl0| gg t 644 lBa]pytT~Ts!}!!!!!hkd$$IfTl0| gg t 644 lBa]pytT~T $IfgdP!!!!!$hkd$$IfTl0| gg t 644 lBa]pytT~T $IfgdPhkd$$IfTl0| gg t 644 lBa]pytT~T!!!!!!hkdp$$IfTl0| gg t 644 lBa]pytT~T $IfgdP!!!!!$hkd $$IfTl0| Gg t 644 lBa]pytT~T $IfgdPhkd>$$IfTl0| gg t 644 lBa]pytT~T!!!!!""""""""{oooooo $$Ifa$gdPgdQ & Fgd gdrhkd$$IfTl0| Gg t 644 lBa]pytT~T $IfgdP """"""""""""#####%#J##$4$ҸvbvP>#hjAhQ5CJOJQJ^JaJ#hQhQ5CJOJQJ^JaJ&hQhr5CJOJQJ\^JaJ&hQhQ5CJOJQJ\^JaJ$hhQCJOJPJQJ^JaJ'hhQ5CJOJPJQJ^JaJ hhQ3hhQ5B*CJOJPJQJ\^JaJphhQ5OJQJ\^JhOhQ5OJQJ\^J hQ5CJOJQJ\^JaJ"""""E999 $$Ifa$gdPkd$$IfTlFp$ ~  t06    44 lapytPT"""""E999 $$Ifa$gdPkd$$IfTlFp$ ~  t06    44 lapytPT""# ##k___ $$Ifa$gdPkd$$IfTlFp$ ~ t06    44 laytPT######E<<11 $ & Fa$gd ^gdQkdc$$IfTlFp$ ~  t06    44 lapytPT###$$5$c%d%%%%h&i&*((())* & Fgd $^a$gdO$a$gdO & Fgd $a$gd-[ $ & Fa$gd) & Fgd)h^hgd- & Fgd  & Fgd $ & Fa$gd 4$5$G$I$}$$b%c%d%%%%%%%xhxTD7h;5OJQJ\^JhOh;5OJQJ\^J&hOhus5CJOJQJ\^JaJhOhO5OJQJ\^J&hOhO5CJOJQJ\^JaJh-h-5OJQJ\^Jh-hO5OJQJ\^J)hQhO5>*CJOJQJ\^JaJ hO5CJOJQJ\^JaJ hO5CJOJQJ\^JaJhO5OJQJ\^JhjAhO5OJQJ\^J%%%%$&g&h&i&)(*((()))))˽raTC2 h4u5CJOJQJ\^JaJ h4u5CJOJQJ\^JaJh4u5OJQJ\^J h5hOCJOJQJ^JaJhjA5CJOJQJ^JaJh,05CJOJQJ^JaJ#hOhO5CJOJQJ^JaJhO5OJQJ^Jh;hO5>*OJQJ^JhOhO5OJQJ^J hO5CJOJQJ\^JaJ&hOhO5CJOJQJ\^JaJhOhO5OJQJ\^J))*********+++)+++Q+,ɼٚuuaM;#hvhv5CJOJQJ^JaJ&hvhv5CJOJQJ\^JaJ&hvhv5CJOJQJ\^JaJhvhv5OJQJ\^J)h4uhv5>*CJOJQJ\^JaJ hv5CJOJQJ\^JaJ hv5CJOJQJ\^JaJhv5OJQJ\^Jh4uh4u5OJQJ\^J h4u5CJOJQJ\^JaJ)h4uh4u5>*CJOJQJ\^JaJ**++P.Q.i.j.k///P1Q1Q2R2h^hgd; & Fgd  & F^gd $ & F7$8$H$a$gd $]a$gdv$@&]^a$gdv $7$8$H$a$gdv$ & F7$8$H$a$gd  & Fgd $a$gd-[,,",$,J,Z,[,,P.Q.i.j.////:0001 1޹ޕq]F>:>hk3jhk3U,h$+,hv5B*CJOJQJ^JaJph'h$+,hv5B*OJQJ\^Jph&h$+,hv5CJOJQJ\^JaJh$+,hv5OJQJ\^Jhv5OJQJ\^J,h<|hv5B*CJOJQJ^JaJph h<|hvCJOJQJ^JaJ&hvhv5>*CJOJQJ^JaJ#hvhv5CJOJQJ^JaJhv5CJOJQJ^JaJ 1:1;1O1P1Q1c11111P2Q2R222̼vvfV<5 h:hh3h:hh5B*CJOJPJQJ\^JaJphhjAh;5OJQJ\^Jh,0h5OJQJ\^J)hjAh5>*CJOJQJ\^JaJ&hjAh5CJOJQJ\^JaJhjAh5OJQJ\^Jh;5OJQJ\^Jh$+,hz5OJQJ\^J,h$+,hv5B*CJOJQJ^JaJphjhk3U'h$+,hv0J5CJOJQJ^JaJR2[2_2p2{222 $$Ifa$gdv22222I=== $$Ifa$gdvkde$$IflF$ 8   t06    44 laXpytjA222222222222222222222333Q3k3l33=4>4ǷǷǰڝǷǰraLaLaLaLa)hzhz5>*CJOJQJ\^JaJ hz5CJOJQJ\^JaJ hz5CJOJQJ\^JaJhz5OJQJ\^JhO5OJQJ\^J$h?hCJOJPJQJ^JaJ h:hhhCJOJPJQJ^JaJ$h:hhCJOJPJQJ^JaJ'h:hh5CJOJPJQJ^JaJ!h5CJOJPJQJ^JaJ22222I=== $$Ifa$gdvkdZ$$IflF$ 8   t06    44 laXpytjA222>4?4445og_gWRI^gdzgdz & Fgd  & Fgd $a$gd-[kdO$$IflF$ 8  t06    44 laXytjA>4?4Q4v444445555555555555555ϺϺ~wa~P*OJQJ\^J)hzhz5>*CJOJQJ\^JaJ&hzhz5CJOJQJ\^JaJhzhz5OJQJ\^Jh5OJQJ\^J55555$kd$$IflF  2  t 6`0    44 lapytz$$&`#$/If^`a$gdv55555%kd$$IflF  2  t 6` 0    44 lap ytz$$&`#$/Ifa$gdv$$&`#$/If^`a$gdv55566%kd$$IflF  2  t 6` 0    44 lap ytz$$&`#$/Ifa$gdv$$&`#$/If^`a$gdv566 6 666666-6.67686A6B6C6D6W6X6e6f666εε䓆uduOu)hh5>*CJOJQJ\^JaJ hC8u5CJOJQJ\^JaJ h5CJOJQJ\^JaJhC8u5OJQJ\^J!hzhz5>*OJQJ\^J!hz5CJOJPJQJ^JaJ0h-ZXhz5B*CJOJPJQJ^JaJph*hz5B*CJOJPJQJ^JaJph h-ZXhz'h-ZXhz5CJOJPJQJ^JaJ6 6666%kd$$IflF  2  t 6` 0    44 lap ytz$$&`#$/Ifa$gdv$$&`#$/If^`a$gdv6.686B6C6%kd$$IflF  2  t 6` 0    44 lap ytz$$&`#$/Ifa$gdv$$&`#$/If^`a$gdvC6D6E677767L7t77778888888$$If^`a$gdv & Fgd ^gd^gdh^hgdjA & Fgd $a$gd-[^gdz677777767K7L7M7s7t7777777888"8#8$8ͼޞޞyl_K>hC8u5OJQJ\^J&hC8uhC8u5CJOJQJ\^JaJhC8u5OJQJ\^Jh'y5OJQJ\^J!hhC8u5>*OJQJ\^J&hh5>*CJOJQJ^JaJhjA5CJOJQJ^JaJhO5CJOJQJ^JaJ!hhjA5>*OJQJ\^J!hjAh5>*OJQJ\^Jh5CJOJQJ^JaJ#hh5CJOJQJ^JaJ$8i8888888888888888888888 9 999#9$9%9&9ɻq`q`q`q`q`q`qO!hC8uhjA5>*OJQJ\^J!hC8u5CJOJPJQJ^JaJ'hUhC8u5CJOJPJQJ^JaJ hUhC8u*hC8u5B*CJOJPJQJ^JaJph0hUhC8u5B*CJOJPJQJ^JaJphhC5>*OJQJ\^J!hC8uh'y5>*OJQJ\^J)hC8uhC8u5>*CJOJQJ\^JaJ hC8u5CJOJQJ\^JaJ88888G3'' $$Ifa$gdv$$If^`a$gdvkd $$IfTlFAf!   tYYYYYYYYY0%    44 lapYYYYYYYYYyt;T88 99$9]I== $$Ifa$gdv$$If^`a$gdvkd!$$IfTlFAf!   t 0%    44 lap yt;T$9%9&99<:>:]XPCC ]^gd'y & Fgd gdC8ukdO"$$IfTlFAf!   t 0%    44 lap yt;T&98999:9]9o9r9999999<:=:>:ssaO?h'yh'y5OJQJ\^J#jhk3hk35UmHnHu#h'yh'y5CJOJQJ^JaJ&h'yh'y5CJOJQJ\^JaJh'yhC5OJQJ\^J)h'yh'y5>*CJOJQJ\^JaJ)hh'y5>*CJOJQJ\^JaJ h'y5CJOJQJ\^JaJh'y5OJQJ\^J&hC8uh'y5CJOJQJ\^JaJhC5OJQJ\^J>:H:]:v:w:$kd#$$IflF d   t 6`YYYYYYYYY0    44 lapYYYYYYYYYyt;$$&`#$/If^`a$gdv>:H:\:f:g:o:p:v:w:::::::::::::::::::::: ;";.;ʹʹʘziTi)hh{H5>*CJOJQJ\^JaJ h{H5CJOJQJ\^JaJ h{H5CJOJQJ\^JaJh{H5OJQJ\^Jh'y5OJQJ\^J'hUh'y5CJOJPJQJ^JaJ!h'y5CJOJPJQJ^JaJ hUh'y*h'y5B*CJOJPJQJ^JaJph0hUh'y5B*CJOJPJQJ^JaJph w:::::%kd$$$IflF d   t 6` 0    44 lap yt;$$&`#$/Ifa$gdv$$&`#$/If^`a$gdv:::::%kd$$$IflF d   t 6` 0    44 lap yt;$$&`#$/Ifa$gdv$$&`#$/If^`a$gdv:::<<<"<D<Z<z<|< $$Ifa$gdvgd{H & Fgd $a$gd-[^gd'y .;a;<<|<~<<<<<<<<== =>=@=R=T=ɯppZF' *h.h{HCJOJPJQJ^JaJ* *h.h{H5CJOJPJQJ^JaJ h.h{HCJOJQJ^JaJ$h.h{HCJOJPJQJ^JaJ'h.h{H5CJOJPJQJ^JaJ h.h{H3h.h{H5B*CJOJPJQJ\^JaJphh{Hh{H5OJQJ\^J h{H5CJOJQJ\^JaJ)h{Hh{H5>*CJOJQJ\^JaJ|<~<<<<E999 $$Ifa$gdvkd%$$IfTlFB(p  t06    44 lapytvT<<<<=VJJJ $$Ifa$gdvkd&$$IfTlFB(p  t 06    44 lapytvT= =@=T=j==QEEEE $$Ifa$gdvkd'$$IfTl-FB(p  t 06    44 lapytvTT=f=v=====>'>3>6>k>>>>>űydydyP?.!h{Hh{H5>*OJQJ\^J!h;=h_ 5>*OJQJ\^J&h;=h{H5CJOJQJ\^JaJ)h;=h285>*CJOJQJ\^JaJ&h;=h285CJOJQJ\^JaJh;=h285OJQJ\^Jh{H5OJQJ\^J h.h{H' *h.h{HCJOJPJQJ^JaJ$h.h{HCJOJPJQJ^JaJ h.h{HCJOJQJ^JaJ,h.h{HB*CJOJQJ\^JaJph===>>>VME@4 $$Ifa$gdvgd{H & Fgd_ ^gd{Hkd($$IfTl^FB(p  t 06    44 lapytvT>>>> ? ? ?9kd)$$IfTlFb  t06    44 lapytvT $$Ifa$gdv> ? ??.?/?:?N?O?S?g?h?v??????????@@-@ʷʷʷʷުwbQ?b#h28h285CJOJQJ^JaJ h285CJOJQJ\^JaJ)h28h285>*CJOJQJ\^JaJ#h285>*CJOJQJ\^JaJh285OJQJ\^J&h28h285CJOJQJ\^JaJh285OJQJ\^J$hRph{HCJOJPJQJ^JaJ'hRph{H5CJOJPJQJ^JaJ hRph{H3hRph{H5B*CJOJPJQJ\^JaJph ??$?.?/?:?D?9kd*$$IfTlFb  t06    44 lapytvT $$Ifa$gdvD?N?O?S?]?g?_kd+$$IfTlFb t06    44 laytvT $$Ifa$gdvg?h?v???E999 $$Ifa$gdvkd(,$$IfTlFb  t06    44 lapytvT???=B>BCCkcVM@c $H$^a$gd28 $H$a$gd28 $ & FH$a$gd $a$gd-[kd-$$IfTlFb t06    44 laytvT-@1@2@8@AeAB BBCCCCCCCCCNDD֯֟p[F)h rh r5>*CJOJQJ\^JaJ)hh r5>*CJOJQJ\^JaJ h r5CJOJQJ\^JaJ h r5CJOJQJ\^JaJh r5OJQJ\^Jh28h285OJQJ\^J)h28h285CJH*OJQJ\^JaJ#h28h285CJOJQJ^JaJ&h28h285CJOJQJ\^JaJ)h28h285>*CJOJQJ\^JaJDDDDD+E,EDENEXEYEmEwEEEEEEEEE˺sYsYsYL8&h rh[5CJOJQJ\^JaJh[5OJQJ\^J3h_h28B*CJOJPJQJ\^JaJhph$h_h28CJOJPJQJ^JaJ'h_h285CJOJPJQJ^JaJ h_h280h_h285B*CJOJPJQJ^JaJph!h rh285>*OJQJ\^J!h28h r5>*OJQJ\^J h r5CJOJQJ\^JaJ#h r5>*CJOJQJ\^JaJCDDDE+E $$Ifa$gdvgd28 & Fgd +E,EDENEXEI888$$7$8$H$Ifa$gdvkd-$$IflF \!bh d      tI}I}I}0.6    44 lapI}I}I}ytjAXEYEmEwEEI888$$7$8$H$Ifa$gdvkd.$$IfliF \!bh d  t0.6    44 lapytjAEEEEEI888$$7$8$H$Ifa$gdvkd/$$IflWF \!bh d  t0.6    44 lapytjAEEEFFIA94gd r & Fgd $a$gd-[kd0$$IfliF \!bh d  t0.6    44 lapytjAEEEF"FHFKFFFFFFFFFκ⥔ibN;'' *hd0-h rCJOJPJQJ^JaJ$hd0-h rCJOJPJQJ^JaJ'hd0-h r5CJOJPJQJ^JaJ hd0-h r3hd0-h r5B*CJOJPJQJ\^JaJph!h[h_ 5>*OJQJ\^J!h rh[5>*OJQJ\^J)h[h[5>*CJOJQJ\^JaJ&h;h r5CJOJQJ\^JaJ&h;h[5CJOJQJ\^JaJ h[5CJOJQJ\^JaJh[5OJQJ\^JFFFFFFF $$Ifa$gdvFFFFFI=== $$Ifa$gdvkd1$$IflFx|%   ``` t33306    44 lap333yt;FFFGGGGGG&GKGfGgG}GGGGGG污xxcOc>0h;=5>*OJQJ\^J!hOh;=5>*OJQJ\^J&hOh[5CJOJQJ\^JaJ)hOh[5>*CJOJQJ\^JaJ)hOh(5>*CJOJQJ\^JaJ&hOh(5CJOJQJ\^JaJhOh(5OJQJ\^Jh(5OJQJ\^J' *hd0-h rCJOJPJQJ^JaJ'hd0-h r5CJOJPJQJ^JaJ hd0-h r$hd0-h rCJOJPJQJ^JaJFFGGG_SSS $$Ifa$gdvkd2$$IflFx|%   ` t 06    44 lap yt;GGGGGGG_WKB66 $$Ifa$gdv^gd[ & F^gd[$a$gd-[kd3$$IflFx|%   ` t 06    44 lap yt;GH HHHH:H=kdf4$$IflFx|6$   ``` t33306    44 lap333ytjA $$Ifa$gdvGHH:HNHOH_HhHiHsHtHHHHHHHHHKILIMIʷʷʷނnaPCh8c5OJQJ\^J h(5CJOJQJ\^JaJh(5OJQJ\^J&h(h(5CJOJQJ\^JaJh(5OJQJ\^J'hh[6CJOJPJQJ^JaJ' *hh[CJOJPJQJ^JaJ$hh[CJOJPJQJ^JaJ'hh[5CJOJPJQJ^JaJ hh[3hh[5B*CJOJPJQJ\^JaJph:HDHNHOH_HiHsHSkdi5$$IflFx|6$   ` t 06    44 lap ytjA $$Ifa$gdvsHtHHHH_SSS $$Ifa$gdvkd@6$$IflFx|6$   ` t 06    44 lap ytjAHHHLIMITJUJ_WOWG>^gd9H & Fgd  & Fgd $a$gd-[kd7$$IflFx|6$   ` t 06    44 lap ytjAMI^I`ISJTJUJ~JJJJJJJJJJK󯨎zziWC+/hNh9H5B*CJOJQJ^JaJhph&hjAh9H5CJOJQJ\^JaJ#hjAh9H5CJOJQJ^JaJ hNh9HCJOJQJ^JaJ&hNh9H5CJOJQJ\^JaJ2hNh9H5B*CJOJQJ\^JaJhph hNh9H#hNh9H5CJOJQJ^JaJh9Hh8c5OJQJ\^J h9H5CJOJQJ\^JaJ h9H5CJOJQJ\^JaJh9H5OJQJ\^JUJ^JnJ~JJ'kd7$$IflF Jr ^   t 6 "06    44 lae4pytjA$$"& #$/Ifa$b$gd9HJJJJ$$"& #$/7$8$H$Ifa$b$gd9H$"& #$/7$8$H$Ifb$gd9HJJJ>&$"& #$/7$8$H$Ifb$gd9Hkd9$$Ifl[F Jr ^  t 6 "06    44 lae4pytjAJJJJ#kd$:$$IflF Jr ^  t 6 "06    44 lae4pytjA$$"& #$/7$8$H$Ifa$b$gd9HJKK3K$$"& #$/Ifa$b$gd9H$$"& #$/7$8$H$Ifa$b$gd9H$"& #$/Ifb$gd9HKK2K3K4KXKYKcKwKxKyKzK{KKKKKKKһҖwgVI8 h8c5CJOJQJ\^JaJh8c5OJQJ\^J h8c5CJOJQJ\^JaJh8ch8c5OJQJ\^J#h9Hh9H5CJOJQJ^JaJh8c5OJQJ\^Jh9H5OJQJ\^J/hNh9H5B*CJOJQJ^JaJhph,hNh9H5B*CJOJQJ^JaJph hNh9H&hjAh9H5CJOJQJ\^JaJ#hjAh9H5CJOJQJ^JaJ3K4KYK>*$"& #$/Ifb$gd9Hkd8;$$IflnF Jr ^  t 6 "06    44 lae4pytjAYKcKxK$$"& #$/Ifa$b$gd9H$$"& #$/7$8$H$Ifa$b$gd9HxKyKzK{K>5-$a$gd-[^gd9HkdL<$$IflnF Jr ^  t 6 "06    44 lae4pytjA{K|K}K~KKKKK4M5MNNrNsNNN!O~OO$a$gd-[$7$8$H$^a$gd8c $7$8$H$a$gd8c$7$8$H$^a$gd;$h7$8$H$^ha$gd;$ & F7$8$H$a$gd $7$8$H$a$gd9HKK3M5MNN}O~OOOOORR%R&RݺݭlZJ=0h8c5OJQJ\^Jh75OJQJ\^JhjAh75OJQJ\^J#hjAh8c5CJOJQJ^JaJ&hjAh8c5CJOJQJ\^JaJhjAh8c5OJQJ\^JhjAh8c5OJQJ\^Jh;=5OJQJ\^JhjA5OJQJ\^J&h8ch8c5>*CJOJQJ^JaJh;5CJOJQJ^JaJ#h8ch8c5CJOJQJ^JaJ hzjh8cCJOJQJ^JaJORRrSsSnUoU,V-VVVVV W WrXsXYY$a$gdJ $^a$gdJ$a$gdJgd9HgdO & Fgd  & Fgd $ & Fa$gd $ & Fa$gd $a$gd-[ $ & Fa$gd &R'R(RqSrSsSSSSSSST,TmUnUUUU Vķ~w~m~eXG2)hJhJ5>*CJOJQJ\^JaJ hJ5CJOJQJ\^JaJhJ5OJQJ\^Jhkhk5hkhk5\ hZF5\hkhJ5\hkhJ5OJQJ\"h7hJ5CJOJQJ\aJh8c5CJOJQJ\aJhJ5OJQJ\^Jh75OJQJ\^J h75CJOJQJ\^JaJh75OJQJ\^J h8c5CJOJQJ\^JaJ V+V,V-V4V6VrVuVVVVVVWŵ{m\K3/hC;hJ56B*CJOJQJ^JaJph!hJh9H5>*OJQJ\^J!h9HhO5>*OJQJ\^JhO5>*OJQJ\^J!hOhS;B5>*OJQJ\^J)hJhS;B5>*CJOJQJ\^JaJ&hJhS;B5CJOJQJ\^JaJhJhS;B5OJQJ\^JhJhS;B5OJQJ\^JhS;B5OJQJ\^JhJ5OJQJ\^J hJ5CJOJQJ\^JaJ W W WqXsXYZZC[[[h]{]^^``ajaaabbһtbTLHLhk3jhk3UhJhJ5OJQJ^J#hkhJ5CJOJQJ^JaJhk5CJOJQJ^JaJ#hJhjA5CJOJQJ^JaJ#hJhJ5CJOJQJ^JaJ&h;5B*CJOJQJ^JaJph,hJhJ5B*CJOJQJ^JaJph/hC;hJ56B*CJOJQJ^JaJph)hJ56B*CJOJQJ^JaJphY[[^M_N_c__``aaajaaabnc4d e ef & Fgd gdJ&^gdJ^gdJh^hgdJ $ & Fa$gd $ & F8^8a$gd $a$gdJ $^a$gdJb_b`babbb$c%clcmcnccccc2d3dJdKddd e e e e$e&eXe†vfR&hJhS;B5CJOJQJ\^JaJhJhS;B5OJQJ\^JhJhS;B5OJQJ\^JhJ5OJQJ\^J,hJhJ5B* CJOJQJ^JaJphI}'hJhJ0J5CJOJQJ^JaJhk3#hJhJ5CJOJQJ^JaJ$hJhJ5B* OJQJ^JphI}jhk3UhJhJ0J5OJQJ^JXeeeeefff fffffgggghhhh4iͳuaO;O;O&h;h75>*CJOJQJ^JaJ#h;h75CJOJQJ^JaJ&h;h75CJOJQJ\^JaJh;h75OJQJ\^Jhh5OJQJ\^J h5CJOJQJ\^JaJh5OJQJ\^JhS;B5OJQJ\^Jh5OJQJ\^JhS;B5OJQJ\^J)hJhS;B5>*CJOJQJ\^JaJ hS;B5CJOJQJ\^JaJffffgg5i6iVkWkkkll#m$m.mBm$$If^`a$gd&^k $If^gd&^kgd$ & Fgd  & Fgd  & Fgd h^hgdjA & Fgd gd & Fgd  & Fgd $a$gd-[4i5i6iKiLiiiiijkUkVkWkbkkklllӿueXGXGX:h$5OJQJ\^J h5CJOJQJ\^JaJh5OJQJ\^JhjAhjA5OJQJ\^JhjAhk5OJQJ\^J&hjAh75>*CJOJQJ^JaJ#hjAh75CJOJQJ^JaJ&hjAh5CJOJQJ\^JaJ&hjAh75CJOJQJ\^JaJhjAh5OJQJ\^JhjA5OJQJ\^Jh;h5OJQJ\^Jll"m#m$m[m\mmmmmmmmmmmmmmmmn;n*OJQJ\^J!h$h$5>*OJQJ\^J)h$h$5>*CJOJQJ\^JaJ h$5CJOJQJ\^JaJBm[m\mhm3"\$If^`\gd0wkd`=$$IfTlFb B.#d   tYYYYYYYYY00    44 lajpYYYYYYYYYytjAT$$If^`a$gd&^khmrm{mmmmmmQD $If^gd&^kkdd>$$IfTlFb B.#d   t 00    44 lajp ytjAT $$Ifa$gd&^kmmmmm]PDD $$Ifa$gd&^k $If^gd&^kkd*OJQJ\^J#h$5>*CJOJQJ\^JaJ)h$h$5>*CJOJQJ\^JaJ nnnnnnn9kdB$$IfTlFx($   t06    44 lapyt&^kT $$Ifa$gd&^knnnnnnnnooooo(o*o+o1o4o9o:oToUoVo\oֿݛs_֭P<'h$^"h$5CJOJPJQJ^JaJh$5CJOJQJ^JaJ'h`6h$5CJOJPJQJ^JaJh$5CJOJQJ^JaJ#h`6h$5CJOJQJ^JaJ hUYh$#hUYh$CJOJQJ\^JaJ#h$^"h$5CJOJQJ^JaJ,h$^"h$5B*CJOJQJ^JaJph h-fh$$h-fh$CJOJPJQJ^JaJh$CJOJPJQJ^JaJnnnnnooJ9$$7$8$H$Ifa$gd&^kkdC$$IfTl^Fx($   t 06    44 lapyt&^kT $$Ifa$gd&^koo+o5o9oQEEE $$Ifa$gd&^kkdD$$IfTl^Fx($  t 06    44 lapyt&^kT9o:oVo`odoQEEE $$Ifa$gd&^kkdE$$IfTl^Fx($  t 06    44 lapyt&^kT\o_odoeofoo p%p'p(p;pOppqwqxqqŵ|o^L8Lo+hH5OJQJ\^J&hOPhOP5>*CJOJQJ^JaJ#hOPhOP5CJOJQJ^JaJ hOP5CJOJQJ\^JaJhOP5OJQJ\^JhjAhk5OJQJ\^J)hjAhOP5>*CJOJQJ\^JaJ&hjAhOP5CJOJQJ\^JaJhjAhOP5OJQJ\^J!h$h$5>*OJQJ\^J h-fh$$h-fh$CJOJPJQJ^JaJh$CJOJPJQJ^JaJdoeofo(p)pxqVME=2 $ & Fa$gd $a$gd-[ & Fgd ^gd$kdF$$IfTl^Fx($   t 06    44 lapyt&^kTxqyqPrQrssss&s-s?sFs $$Ifa$gd&^kgdo.~ & Fgd  & Fgd $a$gd-[ qqrMrOrPrcrrrrsssFsGsbs~ssssOyg`gLHgLhH&h shH5CJOJQJ\^JaJ hQJhH#h shH5CJOJQJ^JaJho.~ho.~5OJQJ\^J)ho.~ho.~5>*CJOJQJ\^JaJ ho.~5CJOJQJ\^JaJho.~5OJQJ\^JhH5OJQJ\^J)hOPhH5>*CJOJQJ\^JaJ hOP5CJOJQJ\^JaJ hH5CJOJQJ\^JaJFsGsbs'$$7$8$H$Ifa$gd&^kkdxG$$IfTl\L z  t(֛֛֛֛0.644 lap(֛֛֛֛yt&^kTbsjsts~s$$7$8$H$Ifa$gd&^k~sss& $7$8$H$Ifgd&^kkdH$$IfTl41\L z  t(0.644 lap(yt&^kTssss$$7$8$H$Ifa$gd&^kssssssssssssssssssstt t ttttt(tktnttѽѽ꽹ѡѡѡ㔃q\)ho.~ho.~5>*CJOJQJ\^JaJ#ho.~5>*CJOJQJ\^JaJ ho.~5CJOJQJ\^JaJho.~5OJQJ\^J/h shH5B*CJOJQJ^JaJhphhH&h shH5CJOJQJ\^JaJ#h shH5CJOJQJ^JaJ hQhH)h shH56CJOJQJ\^JaJsss& $7$8$H$Ifgd&^kkdI$$IfTl4g\L z  t(0.644 lap(yt&^kTssss$$7$8$H$Ifa$gd&^ksss& $7$8$H$Ifgd&^kkdK$$IfTl4^\L z  t(0.644 lap(yt&^kTssss$$7$8$H$Ifa$gd&^ksss&$$7$8$H$Ifa$gd&^kkd@L$$IfTl4U\L z  t(0.644 lap(yt&^kTssss$$7$8$H$Ifa$gd&^k $$Ifa$gd&^ksss& $7$8$H$Ifgd&^kkd{M$$IfTl4C\L z  t(0.644 lap(yt&^kTsstt$$7$8$H$Ifa$gd&^k $$Ifa$gd&^kt t t& $7$8$H$Ifgd&^kkdN$$IfTl4U\L z  t(0.644 lap(yt&^kT tttt$$7$8$H$Ifa$gd&^k $$Ifa$gd&^ktt t&$a$gd-[kdO$$IfTl4C\L z  t(0.644 lap(yt&^kT tttttt$$If^`a$gd&^k $If^gd&^kgdo.~ & Fgd tttttttttu#u:u;uWuZuaurusuuuuuuuuuuupp_pKp'hmho.~CJOJPJQJ\^JaJ hmho.~CJOJQJ^JaJ#hmho.~5CJOJQJ^JaJ'hmho.~5CJOJPJQJ^JaJ'hmho.~6CJOJPJQJ^JaJ*hmho.~5CJOJPJQJ\^JaJ hmho.~0hmho.~5B*CJOJPJQJ^JaJphho.~5>*OJQJ\^J!ho.~ho.~5>*OJQJ\^JtttttG:.. $$Ifa$gd&^k V$If^Vgd&^kkdQ$$IfTlFu(#  ``` t1110@    44 lap111yt;=Tttu$u/u:uZMMAA $$Ifa$gd&^k V$If^Vgd&^kkdR$$IfTlFu(#   t 0@    44 lap yt;=T:u;ubumuruZMAA $$Ifa$gd&^k V$If^Vgd&^kkdR$$IfTlFu(#   t 0@    44 lap yt;=TrusuuuuZMAA $$Ifa$gd&^k V$If^Vgd&^kkdS$$IfTlFu(#   t 0@    44 lap yt;=TuuuuuZMAA $$Ifa$gd&^k V$If^Vgd&^kkdT$$IfTlFu(#   t 0@    44 lap yt;=TuuuvvvZUMD4$$If`a$gd&^k^gdJ{ & Fgd gdkdzU$$IfTlCFu(#   t 0@    44 lap yt;=Tuuuuivvvvvvvv%wBwKwLwįğ拄kO9*hho.~5CJOJPJQJ\^JaJ6hho.~5B*CJOJPJQJ\^JaJhph0hho.~5B*CJOJPJQJ^JaJph hho.~'hho.~5CJOJPJQJ^JaJhJ{hw5OJQJ\^J)hJ{hJ{5>*CJOJQJ\^JaJ hJ{5CJOJQJ\^JaJ hJ{5CJOJQJ\^JaJhJ{5OJQJ\^Jh5OJQJ\^Jvvvvvvv$$If`a$gd&^kvv kdWV$$Ifl&rK D% j  t20t"644 la<p2yto.~vvv%wBwLwVw_wawiwjwvw$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^k LwVwvwwwxwwwwwwwwwwwwwwwwxxxxxxAxBxLxMxNxxxyxxxxxκκκՇΞs`κs`κ$hho.~CJOJPJQJ^JaJ&hho.~5CJOJQJ\^JaJ-hho.~56CJOJPJQJ\^JaJ6hho.~5B*CJOJPJQJ\^JaJhph'hho.~5CJOJPJQJ^JaJ hho.~*hho.~5CJOJPJQJ\^JaJ'hho.~CJOJPJQJ\^JaJ$vwww kdW$$Ifl41rK D% j  t20t"644 la<p2yto.~wwxwwwww$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kww kdY$$Ifl4 rK D% j  t20t"644 la<p2yto.~wwwwwww$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kww kdZ$$Ifl4rK D% j  t20t"644 la<p2yto.~wwwxxx$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kxx kd[$$Ifl4rK D% j  t20t"644 la<p2yto.~xx8xBxLxMx$$7$8$H$If`a$gd&^k$$7$8$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kMxNx kdR]$$Ifl4rK D% j  t20t"644 la<p2yto.~NxOxoxyxxx$$7$8$H$If`a$gd&^k$$7$8$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kxx kd^$$Ifl4rK D% j  t20t"644 la<p2yto.~xxxxxx$$7$8$H$If`a$gd&^k$$7$8$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kxxxxxxxxxxxxxxxyy"yzsWC-sWC*hho.~5CJOJPJQJ\^JaJ'hho.~CJOJPJQJ\^JaJ6hho.~5B*CJOJPJQJ\^JaJhph hho.~9hho.~56B*CJOJPJQJ\^JaJhph- *hho.~56CJOJPJQJ^JaJ$hho.~CJOJPJQJ^JaJ) *hho.~5CJOJQJ\^JaJ'hho.~5CJOJPJQJ^JaJ* *hho.~5CJOJPJQJ^JaJxx kd"`$$Ifl4*rK D% j  t20t"644 la<p2yto.~xxxxxx$$7$8$If`a$gd&^k$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^kxx kda$$Ifl4irK D% j  t20t"644 la<p2yto.~xxyy"y#y$$7$8$If`a$gd&^k$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^k $7$8$H$Ifgd&^k"y#y$y%yByLyVyWyXyYyxyyyyyyyyyyyyyzzϳϟϳψϳϟ{kWB)h;=h9S5>*CJOJQJ\^JaJ&h;=h9S5CJOJQJ\^JaJh;=h9S5OJQJ\^Jh5OJQJ\^J-hho.~56CJOJPJQJ\^JaJ'hho.~CJOJPJQJ\^JaJ6hho.~5B*CJOJPJQJ\^JaJhph'hho.~5CJOJPJQJ^JaJ hho.~*hho.~5CJOJPJQJ\^JaJ#y$y kdc$$Ifl4*rK D% j  t20t"644 la<p2yto.~$y%yByLyVyWy$$7$8$If`a$gd&^k$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^kWyXy kdd$$Ifl4WrK D% j  t20t"644 la<p2yto.~XyYyxyyyy$$7$8$If`a$gd&^k$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^kyy kde$$Ifl4rK D% j  t20t"644 la<p2yto.~yyyyyy$$7$8$If`a$gd&^k$$7$8$H$If`a$gd&^k$7$8$H$If`gd&^kyy kdpg$$Ifl4rK D% j  t20t"644 la<p2yto.~yyzzzzz $$Ifa$gd&^k^gd9S & Fgd9S^gdJ{zzzzz{{{2{G{H{I{L{S{T{|5|6|ƿwgwS>-!hOh;=5>*OJQJ\^J)hOh9S5>*CJOJQJ\^JaJ&hOhGud5CJOJQJ\^JaJhOh9S5OJQJ\^JhOhGud5OJQJ\^J!h9Sh9S5>*OJQJ\^J$h<h9SCJOJPJQJ^JaJ'h<h9S5CJOJPJQJ^JaJ h<h9S3h<h9S5B*CJOJPJQJ\^JaJphh;5>*OJQJ\^J!h;=h;5>*OJQJ\^Jzz{ {{I=== $$Ifa$gd&^kkdh$$Ifl$Fx|(#    t06    44 la<pyt{{2{<{G{_SSS $$Ifa$gd&^kkdi$$IflFx|(#   @ t 06    44 la<p ytG{H{I{6|7||r}_VNIA8^gd9H & Fgd gdAV & FgdAV^gd9Skdj$$IflFx|(#   @ t 06    44 la<p yt6|7|G|V|||,}q}r}s}}}}͹n^F./h;hW5B*CJOJQJ\^JaJph/h;h/5B*CJOJQJ\^JaJphh9Sh9S5OJQJ\^J!h9Sh9S5>*OJQJ\^J)h9Sh/5>*CJOJQJ\^JaJ h/5CJOJQJ\^JaJ&hjAh/5CJOJQJ\^JaJ&hjAh/5CJOJQJ\^JaJ&hjAh5CJOJQJ\^JaJhjAh5OJQJ\^Jh;=5>*OJQJ\^J r}s}}}}}}~$ h+ $7$8$H$Ifa$gd&^k$ h+ G$7$8$H$If^Ga$gdWgdW^gd9Sgd9S}}}}~~`~t~u~v~~~~~~~~~~./0NX\]^pqz{ϻwc' *hRhWCJOJPJQJ^JaJ* *hRhW5CJOJPJQJ^JaJ'hRhW6CJOJPJQJ^JaJ$hRhWCJOJPJQJ^JaJ hRhW'hRhW5CJOJPJQJ^JaJhWhW5OJQJ\^JhWh5OJQJ\^J hW5CJOJQJ\^JaJ!~~%kdk$$IfTlh\ 6n$5 ;8 ```` t(33330<644 la p(3333yt;=T~-~`~j~t~u~2kdl$$IfTl4\ $G 1 t0<644 la yt;=T $$Ifa$gd&^k$ h+ $7$8$H$Ifa$gd&^ku~v~~~~~2kdm$$IfTl4\ $ G 1 t0<644 la yt;=T $$Ifa$gd&^k$ h+ $7$8$H$Ifa$gd&^k~~~~~~2kdn$$IfTl4\ $ G 1 t0<644 la yt;=T $$Ifa$gd&^k$ h+ $7$8$H$Ifa$gd&^k~~$. $$Ifa$gd&^k$$7$8$H$Ifa$gd&^k./&kdpo$$IfTl4\ $G 1  t(0<644 la p(yt;=T/0NX\ $$Ifa$gd&^k$ h+ $7$8$H$Ifa$gd&^k\]&kdp$$IfTl4\ $ G 1  t(0<644 la p(yt;=T]^q{ $$Ifa$gd&^k$ h+ $7$8$H$Ifa$gd&^k&$$7$8$H$Ifa$gd&^kkdq$$IfTl4\ $ G 1  t(0<644 la p(yt;=T(),-.`ijstuǀȀɀʀڿګګګkګګګW&hRhW5CJOJQJ\^JaJ* *hRhW5CJOJPJQJ^JaJ* *hRhW6CJOJPJQJ^JaJ'hRhW6CJOJPJQJ^JaJ' *hRhWCJOJPJQJ^JaJ hRhW'hRhW5CJOJPJQJ^JaJ$hRhWCJOJPJQJ^JaJ#hRhW5CJOJQJ^JaJJ9$$7$8$H$Ifa$gd&^kkd!s$$IfTl4\ $G 1 t0<644 la yt;=T $$Ifa$gd&^k)-./`jJ9$$7$8$H$Ifa$gd&^kkds$$IfTl4\ $ G 1 t0<644 la yt;=T $$Ifa$gd&^kjtuvJ9$$7$8$H$Ifa$gd&^kkdt$$IfTl4\ $ G 1 t0<644 la yt;=T $$Ifa$gd&^kȀVE999 $$Ifa$gd&^k$$7$8$H$Ifa$gd&^kkdu$$IfTl4\ $ G 1 t0<644 la yt;=TȀɀʀlmVG?7$a$gd-[ & Fgd $[$\$a$gdWkdv$$IfTl4\ $ G 1 t0<644 la yt;=TʀԀjlmtс܂ كڃۃFξr[L:#hjAh)tN5CJOJQJ^JaJhjA5CJOJQJ^JaJ,hOh)tN5B*CJOJQJ^JaJph&hOh)tN5>*CJOJQJ^JaJ#hOhjA5CJOJQJ^JaJ#hOh)tN5CJOJQJ^JaJ&hOh)tN5CJOJQJ\^JaJhOh)tN5OJQJ\^J&h/hi5CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^JmڃۃGuvog$a$gd-[$ & F 8h]a$gd $ & F]a$gd $]a$gd)tN$@&]^a$gdND $7$8$H$a$gd)tN$7$8$H$^a$gdND$7$8$H$^a$gdjA$h7$8$H$^ha$gdjA$ & Fh7$8$H$^ha$gdjA FGtu+_`aĴq`F?.!hi5CJOJPJQJ^JaJ h:hhi3h:hhi5B*CJOJPJQJ\^JaJph!hihi5>*OJQJ\^J)hihi5>*CJOJQJ\^JaJ hi5CJOJQJ\^JaJhZFhi5OJQJ\^Jhi5OJQJ\^Jh)tNhi5OJQJ\^J,h)tNh)tN5B*CJOJQJ^JaJph#h)tNh)tN5CJOJQJ^JaJ#hjAhAV5CJOJQJ^JaJ v`ajn $$Ifa$gdJW^gdi & Fgd E999 $$Ifa$gdJWkdcw$$IfTlFp$ ~  t06    44 lapytJWTLJȇ·ч҇Շևׇ߇͈Έψl\hOh D5OJQJ\^J)hih D5>*CJOJQJ\^JaJ h D5CJOJQJ\^JaJh D5OJQJ\^J!hih D5>*OJQJ\^J!hi5CJOJPJQJ^JaJ h:hhihiCJOJPJQJ^JaJ$h:hhiCJOJPJQJ^JaJ'h:hhi5CJOJPJQJ^JaJȇ҇ևE999 $$Ifa$gdJWkdex$$IfTlFp$ ~  t06    44 lapytJWTևׇk___ $$Ifa$gdJWkdgy$$IfTlFp$ ~ t06    44 laytJWTΈψE=5=- & Fgd & Fgd $a$gd-[kdz$$IfTlFp$ ~  t06    44 lapytJWT9ˌьҌތ>PQRZ !4ŵraaM@h5OJQJ\^J&h/h=5CJOJQJ\^JaJ h D5CJOJQJ\^JaJ)h=h=5>*CJOJQJ\^JaJ h=5CJOJQJ\^JaJh=5OJQJ\^Jh Dh=5OJQJ\^JhOh D5OJQJ\^J#hOh D5CJOJQJ^JaJ)hOh D5>*CJOJQJ\^JaJ&hOh D5CJOJQJ\^JaJQR!"ߏnoy$$&`#$/If^`a$gd[,Agd" & Fgd  & Fgd  & Fgd  & Fgd $a$gd-[ & Fgd $^a$gd D4ޏߏ8lmnoǐȐɼ|l\C<(<'hIzh"5CJOJPJQJ^JaJ hIzh"0hIzh"5B*CJOJPJQJ^JaJphh"h"5OJQJ\^Jh"hxt5OJQJ\^J)h"h"5>*CJOJQJ\^JaJ h"5CJOJQJ\^JaJh5OJQJ\^Jh"5OJQJ\^Jhxt5OJQJ\^J!hh5>*OJQJ\^J)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJA$$$&`#$/If^`a$gd[,Akd {$$IflF vN   t 6`YYYYYYYYY0    44 lapYYYYYYYYYyt"ǐȐܐB%$$&`#$/If^`a$gd[,Akd |$$IflF vN   t 6` 0    44 lap yt"$$&`#$/Ifa$gd[,AܐB::$a$gd"kd|$$IflF vN   t 6` 0    44 lap yt"$$&`#$/Ifa$gd[,AȐ pőcdyǒӒՒŸydyydyWFyF h<5CJOJQJ\^JaJh<5OJQJ\^J)h]yh]y5>*CJOJQJ\^JaJ h]y5CJOJQJ\^JaJh]y5OJQJ\^J&h/hk5CJOJQJ\^JaJh5OJQJ\^Jhxt5OJQJ\^Jh"5OJQJ\^J#hIzh"5CJOJQJ^JaJ hIzh"'hIzh"5CJOJPJQJ^JaJders*X & FgdO & F8^8gd ^gdCu  & Fgd  & Fgd  & Fgd  & Fgd h^hgd/gd$a$gd-[^gd"ՒTs)*WXYab̻t`L<(&hhwS5CJOJQJ\^JaJhh5OJQJ\^J&h/h s5CJOJQJ\^JaJ&hOh s5CJOJQJ\^JaJ&hOhO5CJOJQJ\^JaJ#hOhCu 5CJOJQJ^JaJhCu 5CJOJQJ^JaJ#hCu hCu 5CJOJQJ^JaJ hCu 5CJOJQJ\^JaJhCu 5OJQJ\^J!h]yhCu 5>*OJQJ\^J)h]yh<5>*CJOJQJ\^JaJXY;tu˜$ h+ $7$8$H$Ifa$gd 3^gdAV $^a$gd s^gdq & Fgd gdAV & Fgd gd & Fgd $a$gd-[ & F7$8$H$gd $^a$gdCu bcoq "#wȖ֖IJo_RE4 h9{o5CJOJQJ\^JaJhq5OJQJ\^Jhk5OJQJ\^Jhhq5OJQJ\^J2hhCu 5>*CJOJPJQJ^JaJnHtH/hhCu 5CJOJPJQJ^JaJnHtH hhCu CJOJQJ^JaJ#hhCu 5CJOJQJ^JaJ&hhCu 5CJOJQJ\^JaJ&hhwS5CJOJQJ\^JaJ&hh5CJOJQJ\^JaJ֖ؖJuͽp_J8#hq5>*CJOJQJ\^JaJ)hqh65>*CJOJQJ\^JaJ!hqhAV5>*OJQJ\^J!hAVhq5>*OJQJ\^J hq5CJOJQJ\^JaJ h65CJOJQJ\^JaJh65OJQJ\^Jh5OJQJ\^Jhhl{5OJQJ\^J h5CJOJQJ\^JaJ h9{o5CJOJQJ\^JaJ hCu 5CJOJQJ\^JaJMabcx>RSTl˚Ԛ՚ߚ#ڣӂuh65OJQJ\^Jh5OJQJ\^J' *hsPhqCJOJPJQJ^JaJ8hsPhq5CJOJPJQJ^JaJfHq $hsPhqCJOJPJQJ^JaJ hsPhq'hsPhq5CJOJPJQJ^JaJ!hqh5>*OJQJ\^J)˜֘$ h+ $7$8$H$Ifa$gd 34+ h+ $7$8$H$Ifgd 3kd}$$Iflh\ .D%@  ```` t(33330644 la<p(3333ytq4MWabcxN9 h+ $7$8$H$Ifgd 3kd~$$Ifl4\ .D%@  t0644 la<ytq $$Ifa$gd 3xN9 h+ $7$8$H$Ifgd 3kd$$Ifl4\ .D% @  t0644 la<ytq $$Ifa$gd 3N@ $7$8$H$Ifgd 3kdy$$Ifl4\ .D% @  t0644 la<ytq $$Ifa$gd 3* h+ $7$8$H$Ifgd 3kdA$$Ifl4\ .D%@   t(0644 la<p(ytq>HR $$Ifa$gd 3RST* h+ $7$8$H$Ifgd 3kdj$$Ifl4\ .D% @   t(0644 la<p(ytqTlv $$Ifa$gd 3* $7$8$H$Ifgd 3kd$$Ifl4\ .D% @   t(0644 la<p(ytq˚՚ߚN@ $7$8$H$Ifgd 3kd$$Ifl4\ .D%@  t0644 la<ytq $$Ifa$gd 3ѝNF>F6 & Fgd  & Fgd $a$gd-[kd$$Ifl4\ .D% @  t0644 la<ytq $$Ifa$gd 3#\(НѝҝκuaQ?/hh4>5OJQJ\^J#hBEhBE5CJOJQJ^JaJhau@hk5OJQJ\^J&hau@h5!l5CJOJQJ\^JaJ&hau@h4>5CJOJQJ\^JaJhau@h4>5OJQJ\^Jh6h15OJQJ\^J!h6h0L5>*OJQJ\^J&h6h65>*CJOJQJ^JaJh65CJOJQJ^JaJ#h6h65CJOJQJ^JaJ h65CJOJQJ\^JaJ ѝҝx$!>`m}$$&`#$/Ifa$gd1 ]^gd4>$7$8$H$^a$gdau@$7$8$H$^a$gd  & F7$8$H$gd $7$8$H$a$gdBE Nwx#$ ƴvbSD5h15CJOJQJ^JaJh15CJOJQJ^JaJhau@5CJOJQJ^JaJ'h4>h4>5CJOJPJQJ^JaJ&h4>h4>5CJOJQJ\^JaJ.h4>h4>5CJOJQJ\^JaJmH sH #h4>h4>5CJOJQJ^JaJ#hhjA5CJOJQJ^JaJ#hh4>5CJOJQJ^JaJ&hh15CJOJQJ\^JaJ&hh4>5CJOJQJ\^JaJ !>}~ΠϠ :;N]es̶̯̯̯̯̯̯̯̯k^NhjAhwH5OJQJ\^Jh5OJQJ\^J)h4>h4>5>*CJOJQJ\^JaJ h4>5CJOJQJ\^JaJ hwH5CJOJQJ\^JaJhwH5OJQJ\^J h4>h1+h4>h15CJOJQJ^JaJmHsH#h4>h15CJOJQJ^JaJ#h4>h4>5CJOJQJ^JaJh5CJOJQJ^JaJ}~|gggg$$&`#$/Ifa$gd1kdL$$Ifl\L <''8 'D 't 6`644 layt1|gggg$$&`#$/Ifa$gd1kd$$Ifl\L <''8 'D 't 6`644 layt1 ȠΠ|gggg$$&`#$/Ifa$gd1kd$$Ifl\L <''8 'D 't 6`644 layt1ΠϠ֠ݠ|gggg$$&`#$/Ifa$gd1kd$$Ifl\L <''8 'D 't 6`644 layt1|gggg$$&`#$/Ifa$gd1kd‰$$Ifl\L <''8 'D 't 6`644 layt1 |gggg$$&`#$/Ifa$gd1kd$$Ifl\L <''8 'D 't 6`644 layt1 '.4:|gggg$$&`#$/Ifa$gd1kd$$Ifl\L <''8 'D 't 6`644 layt1:;<pq89|tlg_SKt & Fgd $h^ha$gd. & Fgd gd & Fgd $a$gd-[kde$$Ifl\L <''8 'D 't 6`644 layt1opq{ 7A %9O*̿ziTiz@zi&h/h5CJOJQJ\^JaJ)hl{h5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^J#hwH5>*CJOJQJ\^JaJ)hwHhwH5>*CJOJQJ\^JaJ hwH5CJOJQJ\^JaJhwH5OJQJ\^JhjAh.5OJQJ\^Jh.hwH5OJQJ\^J&hjAhwH5CJOJQJ\^JaJ9 &Ϧ˧̧gh%&gdK( & Fgd  & Fgd gd/^gd $ & Fa$gd $ & Fa$gd sgd & Fgd  & Fgd $a$gd-[ & Fgd *.B\%&z{ΦϦɷ|jXI:Xh15CJOJQJ^JaJh5CJOJQJ^JaJ#hh5CJOJQJ^JaJ#hau@h/5CJOJQJ^JaJ,hau@h5B*CJOJQJ^JaJph#hau@h5CJOJQJ^JaJ#hOh s5CJOJQJ^JaJ#hOh5CJOJQJ^JaJhh5OJQJ\^J h5CJOJQJ\^JaJ)hh5>*CJOJQJ\^JaJɧʧ˧̧ާefgp"$&s^sIs8!hK(hK(5>*OJQJ\^J)hehe5>*CJOJQJ\^JaJ)hK(he5>*CJOJQJ\^JaJ he5CJOJQJ\^JaJhe5OJQJ\^J h5CJOJQJ\^JaJ hK(5CJOJQJ\^JaJhK(5OJQJ\^Jh'5OJQJ\^Jh5OJQJ\^J#hh5CJOJQJ^JaJ&hh5CJOJQJ\^JaJ&CDH=>GHK°zkzkzdkzVE6hK(6CJOJQJ^JaJ hohK(CJOJQJ^JaJhK(CJOJQJ^JaJ hohK(hK(5CJOJQJ^JaJ#hohK(5CJOJQJ^JaJ)h/h5>*CJOJQJ\^JaJhe5CJOJQJ^JaJ#hK(he5CJOJQJ^JaJ&hOhe56CJOJQJ^JaJ&hOhe6>*CJOJQJ^JaJ)hOhe56>*CJOJQJ^JaJ&  $$Ifa$gd~'?^gdK(>HLI;**$$7$8$H$Ifa$gd~'? $7$8$H$Ifgd~'?kdF$$IflF\  ! ~ 2  t0<6    44 la<pytK(KLMajktuvw@AB߫ƵƵ|j|XD7he5OJQJ\^J&h,\'hK(5>*CJOJQJ^JaJ#hOhO5CJOJQJ^JaJ#hK(h,\'5CJOJQJ^JaJhK(5CJOJQJ^JaJ#hK(hK(5CJOJQJ^JaJ!hehe5>*OJQJ\^J hohK( hohK(CJOJQJ^JaJhK(CJOJQJ^JaJ#hohK(5CJOJQJ^JaJ h#]hK(#h#]hK(6CJOJQJ^JaJLMaku_Q@@$$7$8$H$Ifa$gd~'? $7$8$H$Ifgd~'?kdW$$IflF\  ! ~ 2 ` t 0<6    44 la<p ytK(uvwAB_VF6$h7$8$H$^ha$gd,\'$ & F7$8$H$a$gd ^gdK(kd.$$IflF\  ! ~ 2 ` t 0<6    44 la<p ytK(BZ[ݬެ  $$Ifa$gdO & Fgd $a$gd-[ & Fgd $^a$gdK(>p7$8$H$]>^pgdau@$>7$8$H$]>a$gdOgdO$ & F>7$8$H$]>a$gd YZlmoܬݬެ'(23ȷ|k^JCJ.JC) *hgSh=5CJOJQJ\^JaJ hgSh=&hgSh=5CJOJQJ\^JaJh_5OJQJ\^J!hBEhd5>*OJQJ\^J)h=hd5>*CJOJQJ\^JaJ)h=h=5>*CJOJQJ\^JaJ hd5CJOJQJ\^JaJ h=5CJOJQJ\^JaJh=5OJQJ\^Jhd5OJQJ\^Jhe5OJQJ\^J he5CJOJQJ\^JaJ(2j^OO$$7$8$Ifa$gdO $7$8$IfgdOkd$$IfTF9 a%n  tM6    22 l4apyt=T23>HRj^OO$$7$8$Ifa$gdO $7$8$IfgdOkd$$IfTF9 a%n  tM6    22 l4apyt=T3RStu)ͮήöwj]L<hSrh5OJQJ\^J hSr5CJOJQJ\^JaJhSr5OJQJ\^Jh"Z5OJQJ\^Jh"ZhSr5OJQJ\^J hd5CJOJQJ\^JaJ hd5CJOJQJ\^JaJhd5OJQJ\^Jh5OJQJ\^Jhd5OJQJ\^J) *hgSh=5CJOJQJ\^JaJ hgSh=&hgSh=5CJOJQJ\^JaJRS`jtsdd$$7$8$Ifa$gdO $7$8$IfgdOkd=$$IfTF9 a%n tM6    22 l4apyt=Ttu}j^OO$$7$8$Ifa$gdO $7$8$IfgdOkd6$$IfTF9 a%n  tM6    22 l4apyt=Tsdd$$7$8$Ifa$gdO $7$8$IfgdOkdY$$IfTF9 a%n tM6    22 l4apyt=TήjbZUMB $ & Fa$gd  & Fgd gd"Z & Fgd $a$gd-[kd`$$IfTF9 a%n  tM6    22 l4apyt=Tήٮh¯ү ˰Ͱܰٷ}l_RA0 h5CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jh@w5OJQJ\^J hd5CJOJQJ\^JaJhSr5OJQJ\^Jh"Z5OJQJ\^J hhSrCJOJQJ^JaJh5CJOJQJ^JaJ h5>*CJOJQJ^JaJ hSrhSrCJOJQJ^JaJ hSr5CJOJQJ\^JaJ)hhSr5>*CJOJQJ\^JaJh¯̰Ͱɱѱٱ $IfgdD$a$gd & Fgd $a$gd-[ & Fgd gd"Z $ & Fa$gd $^a$gdSr -./E>?@NPϽzi\L8&h_hyB5CJOJQJ\^JaJh_hyB5OJQJ\^JhyB5OJQJ\^J h5CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jhl{5OJQJ\^J hX[h hX[hCJOJQJ^JaJ#hX[h5CJOJQJ^JaJh5CJOJQJ^JaJh5CJOJQJ^JaJ#hX[h5CJOJQJ^JaJ^UUUU $IfgdDkd$$Ifl\F? n t0644 layt.  -^UUUU $IfgdDkd9$$Ifl\F? n t0644 layt.-./?@w޴^VNVF>> & Fgd  & Fgd & Fgd $a$gd-[kd$$Ifl\F? n t0644 layt.P/6vwݴ޴ߴ8N[ĴucS?*)h_hyB5>*CJOJQJ\^JaJ&h_h&/5CJOJQJ\^JaJh_h&/5OJQJ\^J#h,\'h,\'5CJOJQJ^JaJh5OJQJ\^Jhh5OJQJ\^J hAf5CJOJQJ\^JaJ h5CJOJQJ\^JaJh_hBE5OJQJ\^J&h_h5CJOJQJ\^JaJ&h_hAf5CJOJQJ\^JaJ&h_hyB5CJOJQJ\^JaJ޴ߴCD·ӷ$$| &`#$/Ifa$gd_$| &`#$/Ifgd_gd}f & Fgd $a$gd-[$7$8$H$^a$gd_$ & F7$8$H$a$gd/ $7$8$H$a$gd,\' [׵صٵCDVڮvbvNvA4h}f5OJQJ\^JhAf5OJQJ\^J'hyBhyB5CJOJPJQJ^JaJ&hyBhyB5CJOJQJ\^JaJ#hyBhyB5CJOJQJ^JaJ&hyBhyB5>*CJOJQJ^JaJ#h_h'5CJOJQJ^JaJ&h_hyB5>*CJOJQJ^JaJ.h_hyB5CJOJQJ\^JaJmH sH #h_hyB5CJOJQJ^JaJ&h_hyB5CJOJQJ\^JaJV{·ӷطﺩq`N9)hBbh}fB*CJOJQJ^JaJph#h}fB*CJOJQJ^JaJph hBbh}fCJOJQJ^JaJh}fCJOJQJ^JaJ hBbh}fh}f5B*CJOJQJph$hBbh}f5B*CJOJQJph!h}fh}f5>*OJQJ\^Jh@w5>*OJQJ\^J#h}f5>*CJOJQJ\^JaJ)h}fh}f5>*CJOJQJ\^JaJ h}f5CJOJQJ\^JaJ@.$| &`#$/Ifgd_kd$$IflJFO   t 6`| 06    44 lapyt_&'>RkPG;; $$Ifa$gdD $IfgdDkd$$IflFO  t 6`| 06    44 layt_$$| &`#$/Ifa$gd_&'.>CRjklʸ˸"%sbM)h}fh}f5>*CJOJQJ\^JaJ h}f5CJOJQJ\^JaJh}f5OJQJ\^J hxh}fCJOJQJ^JaJ&h}fB*CJOJQJ\^JaJph,hxh}fB*CJOJQJ\^JaJphh}f$hBbh}f5B*CJOJQJphh}f5B*CJOJQJph hoh}f)h3M@h}fB*CJOJQJ^JaJphklpg[[ $$Ifa$gdD $IfgdDkd|$$IflCFFj X     tPPP6    44 lapPPPyt.Ƹʸpg[[ $$Ifa$gdD $IfgdDkdv$$Ifl,FFj X     t6    44 lapyt.ʸ˸pg[[ $$Ifa$gdD $IfgdDkdp$$IflFFj X     t6    44 lapyt.Ϲй"#ph`hXhPh & Fgd[ & Fgd  & Fgd $a$gd-[kdx$$IflFFj X     t6    44 lapyt.%&-.6ιϹйyκdzآsDŽfVB0#hOh;5CJOJQJ^JaJ&hOh;5CJOJQJ\^JaJhOh;5OJQJ\^Jh1Oq5OJQJ\^J h.5CJOJQJ\^JaJh;5OJQJ\^J!h}fh;5>*OJQJ\^J!h}fh}f5>*OJQJ\^J&h}fh}f5CJOJQJ\^JaJ h}f5CJOJQJ\^JaJ)h}fh}f5>*CJOJQJ\^JaJ#h}f5>*CJOJQJ\^JaJ !"5akzͼμ޼߼˻xgVD5D.D h9ih1Oqh1Oq5CJOJQJ^JaJ#h`h1Oq5CJOJQJ^JaJ h15>*CJOJQJ^JaJ h1Oq5>*CJOJQJ^JaJ&h1Oqh1Oq5>*CJOJQJ^JaJ hAf5CJOJQJ\^JaJ h1Oq5CJOJQJ\^JaJh1Oq5OJQJ\^JhOh1Oq5OJQJ\^JhOh;5OJQJ\^J#hOh;5CJOJQJ^JaJ#hOh_5CJOJQJ^JaJ#ż޼ $$Ifa$gdDgd1 & F L^`gd ޼߼I888$$7$8$H$Ifa$gdDkd$$IflF\  !  $   t0<6    44 la<pyt1<FJKW234Bʾ˾!:m跦{k{Z{I<hrnD5OJQJ\^J h5CJOJQJ\^JaJ h-#5CJOJQJ\^JaJh"Zh"Z5OJQJ\^J hy5CJOJQJ\^JaJhy5OJQJ\^Jh5OJQJ\^J h1Oq5CJOJQJ\^JaJh1Oq5OJQJ\^J#h`h1Oq6CJOJQJ^JaJ#h`h1Oq5CJOJQJ^JaJ h9ih1Oq h`h1OqCJOJQJ^JaJ<FJI888$$7$8$H$Ifa$gdDkd$$IflF\  !  $  t0<6    44 la<pyt1JKL34˾IA9A1 & Fgd  & Fgd $a$gd-[kdx$$IflF\  !  $  t0<6    44 la<pyt1˾;<~$%$ & F}87$8$H$^8a$gd ^gdrnDgdO & F|gd $ & F7$8$H$a$gd gdiW & Fgd  & Fgd $a$gd-[^gd"ZB{}~#$,ɷ|gV|g|gA4h5OJQJ\^J)hiWhiW5>*CJOJQJ\^JaJ hhiWCJOJQJ^JaJ)hhiW5CJOJQJ\]^JaJ&hhiW5CJOJQJ\^JaJ#hiW5>*CJOJQJ\^JaJ)hiWhrnD5>*CJOJQJ\^JaJ#hiW5>*CJOJQJ\^JaJ)hiWhiW5>*CJOJQJ\^JaJ hiW5CJOJQJ\^JaJ hrnD5CJOJQJ\^JaJ,s2ƵsaR>&hrnDhrnD5CJOJQJ\^JaJhBE5CJOJQJ^JaJ#hOh_ 5CJOJQJ^JaJ#hOhrnD5CJOJQJ^JaJhl{5CJOJQJ^JaJhrnD5CJOJQJ^JaJ#hrnDhrnD5CJOJQJ^JaJ hO5CJOJQJ\^JaJ&hOh5CJOJQJ\^JaJ)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJ39:KL^gdq & Fzgd $a$gd-[ & F{gd gdQ y & F{gd gdFe$ & F~87$8$H$^8a$gd $ & F}87$8$H$^8a$gd $ & F}87$8$H$^8a$gd[]8ȴziUiAi&hh5CJOJQJ\^JaJ&hhQ y5CJOJQJ\^JaJ h5CJOJQJ\^JaJ hau@5CJOJQJ\^JaJ&h[hQ y5CJOJQJ\^JaJ)h[hQ y5>*CJOJQJ\^JaJ&h[hQ y5CJOJQJ\^JaJ&h[hQ y5CJOJQJ\^JaJh[hQ y5OJQJ\^J&hFehFe5CJOJQJ\^JaJ89:BDLKLxxxxxdVGh0CJOJQJ\^JaJh0h0OJQJ\^J&hqhq5CJOJQJ\^JaJhq5CJOJQJ^JaJ#hqhq5CJOJQJ^JaJ&hyhq5>*CJOJQJ^JaJ&hqhq5CJOJQJ\^JaJ hq5CJOJQJ\^JaJhq5OJQJ\^Jh05OJQJ\^J&hqh5CJOJQJ\^JaJ5cstuﮗkZA: hdzh01hdzh0B*CJKHOJPJQJ^JaJph hdzh0CJOJQJ^JaJ'h-fh05CJOJPJQJ^JaJ!h05CJOJPJQJ^JaJ h-fh0-h05B*CJOJPJQJ\^JaJph3h-fh05B*CJOJPJQJ\^JaJph#h0h0CJOJQJ\^JaJ)hqh05>*CJOJQJ\^JaJ h05CJOJQJ\^JaJtu~$$J&`#$/Ifa$gdgd0 & Fygd @++$$J&`#$/Ifa$gdkdm$$IflF&   t 6`J06    44 lapyt3kd$$IfllF&  t 6`J 06    44 lapyt$C$J&`#$/9DIf[$\$a$gd<kd{$$IfllF&  t 6`J 06    44 lapyt$$J&`#$/Ifa$gd mֳss_K;h(hAV5OJQJ\^J&h0h05CJOJQJ\^JaJ&h0hD5CJOJQJ\^JaJ)hDhD5>*CJOJQJ\^JaJ hD5CJOJQJ\^JaJhD5OJQJ\^Jh@w5OJQJ\^J#h0h0CJOJQJ\^JaJ!h05CJOJPJQJ^JaJ hdzh0h0CJOJPJQJ^JaJ$hdzh0CJOJPJQJ^JaJ <3*h^hgd@w^gd0kdj$$IfllF&  t 6`J 06    44 lapyt$$J&`#$/Ifa$gdij67@DU`pq $$Ifa$gd3f^gd & Fugd $a$gd-[ & Fvgd gd1 & Fwgd gd,\' & Fxgd gd( & Fgd h^hgd@w*64AVկnYI5n&h/h15CJOJQJ\^JaJh1h"Z5OJQJ\^J)hDhD5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^J)h/h,\'5>*CJOJQJ\^JaJh,\'5>*OJQJ\^J)hFehD5>*CJOJQJ\^JaJ hd5CJOJQJ\^JaJ hD5CJOJQJ\^JaJhD5OJQJ\^Jh(5OJQJ\^J4h 4567qrٷ٧̍nVnVFB1!h5CJOJPJQJ^JaJhhCJOJPJQJ^JaJ/h Bh5CJOJPJQJ^JaJmHsH/hhh5CJOJPJQJ^JaJmHsH h-fh3h-fh5B*CJOJPJQJ\^JaJphhh5OJQJ\^J)hh5>*CJOJQJ\^JaJh5OJQJ\^J h5CJOJQJ\^JaJ)hDh5>*CJOJQJ\^JaJqrI==== $$Ifa$gd3fkdY$$IflFA(#U    t06    44 laXpyt,\'_SSS $$Ifa$gd3fkd\$$IflFA(#U    t 06    44 laXp yt,\''ȴۉuduW=6 h\hm|3h\hm|5B*CJOJPJQJ\^JaJphh5OJQJ\^J hm|5CJOJQJ\^JaJhm|5OJQJ\^J hEh$hEhCJOJPJQJ^JaJ!h5CJOJPJQJ^JaJ h*h'h*h6CJOJPJQJ^JaJ$hUhCJOJPJQJ^JaJhCJOJPJQJ^JaJ'hUh5CJOJPJQJ^JaJ_SSS $$Ifa$gd3fkd3$$IflFA(#U    t 06    44 laXp yt,\'_WOJ>>> $$Ifa$gdhgdm| & Ftgd $a$gd-[kd $$IflFA(#U    t 06    44 laXp yt,\'9kd$$IfTl$F_#V# H   t06    44 la pyt"ZT $$Ifa$gdh 234DEMNOSTUVǷǤǤǷunaTDhOh5OJQJ\^JhO5OJQJ\^Jhl{5OJQJ\^J h\hm|'h\hm|6CJOJPJQJ^JaJ'hg@hm|6CJOJPJQJ^JaJ hg@hm|$hg@hm|CJOJPJQJ^JaJhm|CJOJPJQJ^JaJ$h\hm|CJOJPJQJ^JaJ'h\hm|5CJOJPJQJ^JaJ!hm|5CJOJPJQJ^JaJ 3Ikd$$IfTl4F_#V# H  t 06    44 la pyt"ZT $$Ifa$gdh34EOSUIII $$Ifa$gdhkd$$IfTl4F_#V# H  t 06    44 la pyt"ZTSTUVVNF7$ & Fsh^ha$gd_ $a$gdO$a$gd-[kdګ$$IfTl~F_#V# H  t 06    44 la pyt"ZTHIR^_ȸȨqqbUH;hz'5OJQJ\^Jh[5OJQJ\^JhFe5OJQJ\^Jh5CJOJQJ^JaJ&hh5>*CJOJQJ^JaJ#hh5CJOJQJ^JaJ h5CJOJQJ\^JaJhOh_ 5OJQJ\^JhOhO5OJQJ\^J&hOh5CJOJQJ\^JaJhOh5OJQJ\^J&hOhm|5CJOJQJ\^JaJZr"f$ & Fp7$8$H$a$gd gdUu & Fpgd ^gd & Fqgd  & Fqgd $a$gd-[ & Frgd h^hgd[ $^a$gd_ $ ^ a$gdOYZqrĴďzfVD4hh15OJQJ\^J#h55>*CJOJQJ\^JaJhZFh/5OJQJ\^J&hZFh55CJOJQJ\^JaJ)hZFh55>*CJOJQJ\^JaJhh55OJQJ\^J)h5h55>*CJOJQJ\^JaJh"Zh@w5OJQJ\^J h55CJOJQJ\^JaJh55OJQJ\^Jhz'5OJQJ\^J hz'5CJOJQJ\^JaJ !"ճnYE4 hh[sCJOJQJ^JaJ&h%h[s5CJOJQJ\^JaJ)h%h[s5>*CJOJQJ\^JaJ&hh[s5CJOJQJ\^JaJh|hUu5OJQJ\^JhUuh[s5OJQJ\^J h|5CJOJQJ\^JaJ h[s5CJOJQJ\^JaJ hX!5CJOJQJ\^JaJ h0e5CJOJQJ\^JaJhX!5OJQJ\^Jh(5OJQJ\^J "]^`nJKLXYijo_R@9@9@9@9@9 hX!hX!#hX!hX!5CJOJQJ^JaJh15OJQJ\^Jh1hX!5OJQJ\^J hX!5CJOJQJ\^JaJhX!5OJQJ\^J!hZFh5>*OJQJ\^J#hZFh[s>*CJOJQJ^JaJ&hZFh[s5>*CJOJQJ^JaJ)h,\'h[s5>*CJOJQJ\^JaJ&h,\'h[s5CJOJQJ\^JaJ#h,\'h[s5CJOJQJ^JaJ_`KLTX $$Ifa$gd^gd1 & Fogd gd$87$8$H$^8a$gdC$87$8$H$^8a$gd[sXYzzqq $Ifgd^kd$$IfT-0P 6 t0634-abyt^Tzqq $Ifgd^kd$$IfT-0P 6 t0634-abyt^Tizqq $Ifgd^kdw$$IfT-0P 6 t0634-abyt^Tijzqq $Ifgd^kdP$$IfT-0P 6 t0634-abyt^Tzqq $Ifgd^kd)$$IfT-0P 6 t0634-abyt^T!Wn]M@3nh=5OJQJ\^JhN25OJQJ\^JhUuh=5OJQJ\^J h-[5CJOJQJ\^JaJ h=5CJOJQJ\^JaJ&hX!h=5CJOJQJ\^JaJhX!h=5OJQJ\^Jh,\'5OJQJ\^J h,\'5CJOJQJ\^JaJ&hX!hX!5CJOJQJ\^JaJ h"Z5CJOJQJ\^JaJ hX!hX!#hX!hX!5CJOJQJ^JaJzqhc[SK & Fmgd $a$gdd' & Fngd gd[s^gdl{^gdUukd$$IfT-0P 6 t0634-abyt^TWd%'2;yz{ɺnnYI5&h/h-[5CJOJQJ\^JaJh-[h*CJOJQJ\^JaJ hN25CJOJQJ\^JaJhN25OJQJ\^Jh5OJQJ\^Jh=5CJOJQJ^JaJ#h=h=5CJOJQJ^JaJhZF5CJOJQJ^JaJh,\'h15OJQJ\^J h=5CJOJQJ\^JaJ)hFeh=5>*CJOJQJ\^JaJ&'z{F:8^8gdO & Fjgd gd*CJOJQJ\^JaJ)hh*CJOJQJ\^JaJh*CJOJQJ\^JaJ h;^A5CJOJQJ\^JaJ h;^A5CJOJQJ\^JaJh;^A5OJQJ\^Jhau@5OJQJ\^J h*OJQJ\^J)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jh(5OJQJ\^Jh(h[s5OJQJ\^J hUu5CJOJQJ\^JaJ hd'5CJOJQJ\^JaJ h#5CJOJQJ\^JaJh1.5OJQJ\^J ()?@AGHPQefgnowx´un ho3h"hCJOJQJ^JaJmHsH(ho3hCJOJQJ^JaJmHsH hb9h hb9hCJOJQJ^JaJhCJOJQJ^JaJh(5OJQJ\^Jh(hC5OJQJ\^J hr5CJOJQJ\^JaJh[hau@5OJQJ\^J$ )@jaaa $Ifgd#xkd($$IfT<Fj   t6    22 l4apyt/T@AHQf $Ifgd#xokd=$$IfTFj ''' t6    22 l4ayt/Tfgox $Ifgd#xokd$$IfTFj ''' t6    22 l4ayt/T $Ifgd#xokd$$IfTFj ''' t6    22 l4ayt/T!"+/@JZznnnnn $$Ifa$gd#xgd1 & Fcgd $a$gdNwokd$$IfTFj ''' t6    22 l4ayt/T 8XYo !"Z[cdνz`YH4'h~+h()5CJOJPJQJ^JaJ!h()5CJOJPJQJ^JaJ h\h()3h\h()5B*CJOJPJQJ\^JaJphh15OJQJ\^Jh1h[S5OJQJ\^J h()5CJOJQJ\^JaJ)h()h()5>*CJOJQJ\^JaJ h[S5CJOJQJ\^JaJ h[S5CJOJQJ\^JaJh[S5OJQJ\^J&h1h5OJQJ\^JmHsHZ[dozI=== $$Ifa$gd#xkd$$Ifl$F6! 2   t06    44 laXpytdmz{VWY[ֵp_N!h"Zhl{5>*OJQJ\^J!h_ h_ 5>*OJQJ\^J#h[S5>*CJOJQJ\^JaJ)h[Sh[S5>*CJOJQJ\^JaJ h[S5CJOJQJ\^JaJh[S5OJQJ\^Jh()5OJQJ\^J'h~+h()5CJOJPJQJ^JaJ h~+h()$h~+h()CJOJPJQJ^JaJh()CJOJPJQJ^JaJz{_SSS $$Ifa$gd#xkd$$IflF6! 2   t 06    44 laXp yt_SSS $$Ifa$gd#xkd$$IflF6! 2   t 06    44 laXp yt_SSS $$Ifa$gd#xkdf$$Ifl^F6! 2   t 06    44 laXp ytZ[_VNE<7gd[S^gd_ h^hgd_  & Fbgd ^gd()kd=$$IflF6! 2   t 06    44 laXp yt  !/069@CDEMSV]`abcͼͼͼuaM&h_ h[S5CJOJQJ\^JaJ&h_ h5CJOJQJ\^JaJh_ h5OJQJ\^J'h-fh[S5CJOJPJQJ^JaJ$h-fh[SCJOJPJQJ^JaJh[SCJOJPJQJ^JaJ!h[S5CJOJPJQJ^JaJ h-fh[S3h-fh[S5B*CJOJPJQJ\^JaJph!h[Sh[S5>*OJQJ\^J $$Ifa$gd#x  E999 $$Ifa$gd#xkd$$IfTlFx(p  t06    44 lapyt[ST !0:DVJJJ $$Ifa$gd#xkd$$$IfTlFx(p  t 06    44 lapyt#xTDEMWaVJJJ $$Ifa$gd#xkd$$IfTlFx(p  t 06    44 lapyt#xTabcVM@;gd[S & Fa hgd ^gd[Skd$$IfTlFx(p  t 06    44 lapyt#xT²xjXC*CJOJQJ\^JaJ$$ &`#$/Ifa$gd#x$ &`#$/Ifgd#x@.$ &`#$/Ifgd#xkd$$IflbFd\  p  t 6` 06    44 lapyt,\'P>$ &`#$/Ifgd#xkd$$IflyFd\  p t 6` 06    44 layt,\'$$ &`#$/Ifa$gd#x.8BeS>>$$ &`#$/Ifa$gd#x$ &`#$/Ifgd#xkd$$IflyFd\  p t 6` 06    44 layt,\'.ABCVW`ajklmwcqđsfU@3h15OJQJ\^J)hOc[hOc[5>*CJOJQJ\^JaJ hOc[5CJOJQJ\^JaJhOc[5OJQJ\^J h5CJOJQJ\^JaJh5OJQJ\^Jh[S5OJQJ\^J)hBbh[SB*CJOJQJ^JaJph hBbh[SCJOJQJ^JaJ h3M@h[S)h3M@h[SB*CJOJQJ^JaJph#h[SB*CJOJQJ^JaJphh[SCJOJQJ^JaJBCWakeS>>$$ &`#$/Ifa$gd#x$ &`#$/Ifgd#xkd$$IflyFd\  p t 6` 06    44 layt,\'klmdee\TLD?gd1 & F_gd $a$gdNw & F`gd ^gd[SkdW$$IflyFd\  p t 6` 06    44 layt,\'@BDy *>tu̽|o^J^2/hvR~h`5B*CJOJQJ\^JaJph333&h|}&h`5CJOJQJ\^JaJ h`5CJOJQJ\^JaJh`5OJQJ\^J)h"Zh"ZB*CJOJQJ^JaJph333h_ 5OJQJ\^Jh_ hw 5OJQJ\^JhOc[5CJOJQJ^JaJh15CJOJQJ^JaJ#h1h15CJOJQJ^JaJ hOc[5CJOJQJ\^JaJ h15CJOJQJ\^JaJ^0123yq$a$gd[s$-DM ]^a$gdUu$ & F6-DM ]a$gd $-DM ]a$gd`$ & F9-DM ]a$gd $-DM ]a$gd"Z 7$8$H$gd_ & F^7$8$H$gd 2J]^gսw`wHw1,h.h"Z5B*CJOJQJ^JaJph333/h.h`56B*CJOJQJ^JaJph333,h.hRq5B*CJOJQJ^JaJph333,h.h`5B*CJOJQJ^JaJph3332h.h`5>*B*CJOJQJ\^JaJph333)hvR~h`B*CJOJQJ^JaJph333/hvR~h`5B*CJOJQJ\^JaJph333)hA?h`B*CJOJQJ^JaJph333)h`5B*CJOJQJ\^JaJph333 gr0123qжТw_K:-h5OJQJ\^J h[sh[sCJOJQJ^JaJ&h5B*CJOJQJ^JaJph333/h.h`5>*B*CJOJQJ^JaJph333,h.h[5B*CJ OJQJ^JaJ ph333&h[5B*CJ OJQJ^JaJ ph333&h`5B*CJ OJQJ^JaJ ph3332h.h`5>*B*CJOJQJ\^JaJph333,h.h`5B*CJOJQJ^JaJph333/h.hRq5B*CJOJQJ\^JaJph333 2JLNP12YZnop ̽~vrv^vL̽?h5OJQJ\^J#h[h;r5CJOJQJ^JaJ'h[h;r0J5CJOJQJ^JaJhk3jhk3U#h[h}5CJOJQJ^JaJh,\'CJOJQJ^JaJhCCJOJQJ^JaJ h}h}CJOJQJ^JaJh}5CJOJQJ^JaJ#h}h}5CJOJQJ^JaJ h}5CJOJQJ\^JaJ h5CJOJQJ\^JaJNPpij56`a34LM $7$8$H$a$gdl{ & FWgd  & FXgd gd1 & FYgd  & FZgd  & F[gd  & F\gd $a$gdNw $ & F]a$gd $a$gd} $ & F]a$gd  hij456>@^grstķęĈwfwUMIM3*hmeMhF0J5CJOJQJ\^JaJhk3jhk3U hw 5CJOJQJ\^JaJ h@(U5CJOJQJ\^JaJ hF5CJOJQJ\^JaJ hF5CJOJQJ\^JaJh15OJQJ\^J h5CJOJQJ\^JaJh5OJQJ\^JhF5OJQJ\^Jh5OJQJ\^J h5CJOJQJ\^JaJ h5CJOJQJ\^JaJ_i234>Qn9:hiȸxgcMg@h&5OJQJ\^J*hmeMhL60J5CJOJQJ\^JaJhk3 hL65CJOJQJ\^JaJ)hL6h@(5>*CJOJQJ\^JaJ h@(5CJOJQJ\^JaJh@(5OJQJ\^Jh15OJQJ\^Jh1h"Z5OJQJ\^J hN_85CJOJQJ\^JaJhN_85OJQJ\^J hF5CJOJQJ\^JaJjhk3U3JKLM^`z{=ʵʡ~lXK9)h&h&5OJQJ\^J#h&h&5CJOJQJ^JaJh&5OJQJ\^J&h_ h[5CJOJQJ\^JaJ#h_ h&5CJOJQJ^JaJh&h_ h&OJQJ&hl{hl{5CJOJQJ\^JaJ&h&h&5CJOJQJ\^JaJ)h&h&5>*CJOJQJ\^JaJ h&5CJOJQJ\^JaJ&h&h&5CJOJQJ\^JaJ h&5CJOJQJ\^JaJM{|  = > G K \ g w x  $$Ifa$gd~9egdj] & FRgd gdd'$ & FS7$8$H$a$gd h^hgd[ & FTgd $a$gdNw & FUgd gd&$ & FV7$8$H$a$gd    ϻxfUFf9,hT5OJQJ\^Jhd'5OJQJ\^Jh&5CJOJQJ^JaJ hU^wh&CJOJQJ^JaJ#h&h&5CJOJQJ^JaJ h&5CJOJQJ\^JaJh[h[5OJQJ\^Jh[h(5OJQJ\^J#h[h&>*CJOJQJ^JaJ&h[h&5>*CJOJQJ^JaJ&h[h&5CJOJQJ\^JaJh[h&5OJQJ\^Jh&5OJQJ\^J a u y      ) < = > x y        ︨ziYFYFzi$h-fhj]CJOJPJQJ^JaJhj]CJOJPJQJ^JaJ!hj]5CJOJPJQJ^JaJ h-fhj]3h-fhj]5B*CJOJPJQJ\^JaJphh"Z5OJQJ\^Jh&hT5OJQJ\^J hj]5CJOJQJ\^JaJ h <5CJOJQJ\^JaJ)h[shT5>*CJOJQJ\^JaJ hT5CJOJQJ\^JaJx y    E999 $$Ifa$gd~9ekd"$$IfTlFx(p  t06    44 lapyt~9eT     VJJJ $$Ifa$gd~9ekd2$$IfTlFx(p  t 06    44 lapyt~9eT          ^ x      C  @vi\K9#h@$Ch@$C5CJOJQJ^JaJ h@$C5CJOJQJ\^JaJh@$C5OJQJ\^Jhl{5OJQJ\^J)hThT5>*CJOJQJ\^JaJ hT5CJOJQJ\^JaJhT5OJQJ\^Jhj]CJOJQJhj]hj]5CJOJQJ h-fhj]hj]CJOJPJQJ^JaJ$h-fhj]CJOJPJQJ^JaJ'h-fhj]5CJOJPJQJ^JaJ  _   VC;3$a$gdNw & FQgd $dd[$\$^a$gdj]kd $$IfTlFx(p  t 06    44 lapyt~9eT@CPEFz|ϻzjz]M@/ h*CJOJQJ\^JaJ h-#5CJOJQJ\^JaJ h_J+5CJOJQJ\^JaJh_J+5OJQJ\^Jh15OJQJ\^Jh1h_J+5OJQJ\^J9kd$$IfTlFx(p  t06    44 lapytOxT $$Ifa$gdOxJkd$$IfTl^Fx(p  t 06    44 lapytOxT $$Ifa$gdOx./DRSThs|n]P;)h Sh S5>*CJOJQJ\^JaJh\5OJQJ\^J!h_J+h <5>*OJQJ\^Jh5>*OJQJ\^J)h_J+h_J+5>*CJOJQJ\^JaJ h_J+5CJOJQJ\^JaJ h S5CJOJQJ\^JaJh S5OJQJ\^J!h_J+h S5>*OJQJ\^J hryh_J+$hryh_J+CJOJPJQJ^JaJ'hryh_J+5CJOJPJQJ^JaJ$.QEEE $$Ifa$gdOxkd $$IfTl^Fx(p  t 06    44 lapytOxT./DNRQEEE $$Ifa$gdOxkd$$IfTl^Fx(p  t 06    44 lapytOxTRSTVNFA9 & FKgd gd < & FLgd $a$gdNwkd$$IfTl^Fx(p  t 06    44 lapytOxT *ּ}m}m}}m}m}`SB` h\5CJOJQJ\^JaJh\5OJQJ\^Jh5OJQJ\^Jh SCJOJPJQJ^JaJ$h-fh SCJOJPJQJ^JaJ'h-fh S5CJOJPJQJ^JaJ!h S5CJOJPJQJ^JaJ h-fh S3h-fh S5B*CJOJPJQJ\^JaJphh_ 5OJQJ\^Jh{B5OJQJ\^Jh{Bhl{5OJQJ\^J $$Ifa$gdOxgd{B E999 $$Ifa$gdOxkd$$IfTlF@x|p  t06    44 lapytl{TVJJJ $$Ifa$gdOxkd$$IfTl^F@x|p  t 06    44 lapytl{TQIAI9 & FJgd  & FJgd $a$gdNwkd$$IfTl^F@x|p  t 06    44 lapytl{T H`ϻϦϕwfQ@2h5>*OJQJ\^J!h"ZhQ5>*OJQJ\^J)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^J!h.h.5>*OJQJ\^J!h[h.5>*OJQJ\^J)h[h5>*CJOJQJ\^JaJ&h[h[5CJOJQJ\^JaJ&h[h5CJOJQJ\^JaJh[h5OJQJ\^JhC5OJQJ\^J $$Ifa$gdOx$F$If^Fa$gdgd & FIgd h^hgd. GHQR[\]ijstwxy͹͹~j͹WJh5OJQJ\^J$h-fhCJOJPJQJ^JaJ'hUh6CJOJPJQJ^JaJ!h6CJOJPJQJ^JaJ hUh$hUhCJOJPJQJ^JaJhCJOJPJQJ^JaJ'hUh5CJOJPJQJ^JaJ!h5CJOJPJQJ^JaJ h-fh3h-fh5B*CJOJPJQJ\^JaJphHR\E5)) $$Ifa$gdOx$F$If^Fa$gdkd$$IfTlFdP# ` P  t06    44 lapytBT\]jtx[K?? $$Ifa$gdOx$F$If^Fa$gdkd$$IfTl^FdP# ` P  t 06    44 lap ytBTxy[K?? $$Ifa$gdOx$F$If^Fa$gdkd$$IfTlFdP# ` P  t 06    44 lap ytBTwx[SKSC>gdl{ & FGgd  & FHgd $a$gdNwkd$$IfTl^FdP# ` P  t 06    44 lap ytBT3u}Fvwxݾzm`O:O:O-hZT5OJQJ\^J)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jhl{5OJQJ\^J!h#h#5>*OJQJ\^J)h#h#5>*CJOJQJ\^JaJ h#5CJOJQJ\^JaJh#5OJQJ\^Jh5OJQJ\^J#hhZT5CJOJQJ^JaJ#hh5CJOJQJ^JaJ h5CJOJQJ\^JaJxk l !! $<a$gda2 $<^a$gdd' $ & FD<a$gd $<a$gdQ$7$8$H$^a$gd@w$7$8$H$^a$gda$7$8$H$^a$gd.gdZT & FEgd $a$gdNw & FFgd ,8Ubsp(vрn\J#hQhQ5CJOJQJ^JaJ#hQh"Z5CJOJQJ^JaJ#haha5CJOJQJ^JaJh[s5CJOJQJ^JaJ h]IhaCJOJQJ^JaJ&h]Iha5CJOJQJ\^JaJh[5OJQJ\^JhZTha5OJQJ\^J ha5CJOJQJ\^JaJ ha25CJOJQJ\^JaJha25OJQJ\^Jj k l  >!?!g!|!!!!!!ʸrcTcrG6 ha5CJOJQJ\^JaJha5OJQJ\^Jh#5CJOJQJ^JaJha25CJOJQJ^JaJ ha25>*CJOJQJ^JaJ&ha2ha25>*CJOJQJ^JaJ#ha2ha25CJOJQJ^JaJh6e85CJOJQJ^JaJ#h;rhL0 5CJOJQJ^JaJ#h;rha25CJOJQJ^JaJ&h;rha25CJOJQJ\^JaJh;rha25OJQJ\^J!"3"6""""""###$$2$óxgS=&=-h#~h#~5>*@CJOJQJ]^JaJ*h#~h#~5@CJOJQJ]^JaJ&h#~h#~5CJOJQJ]^JaJ h#~5CJOJQJ\^JaJ&h#~h#~5CJOJQJ\^JaJh#~5OJQJ\^Jh_e75OJQJ\^JhZT5OJQJ\^JhZTh#5OJQJ\^J,haha5B*CJOJQJ^JaJph)haha5>*CJOJQJ\^JaJ ha5CJOJQJ\^JaJ!""$$Z%[%&&''((:);)z) $$Ifa$gdL]gd6e8^gd[h^hgd# $ & F>a$gd gd"Z $ & F?a$gd  & F@gd $a$gdNw $ & FAa$gd $a$gdN & FBgd gdZT & FCgd 2$3$$$$$$Y%Z%b%&&&&t&}&&ʺ|k|b]I4I)hl{hWz5>*CJOJQJ\^JaJ&hl{hWz5CJOJQJ\^JaJ hWz\hWzOJQJ\ hWz5CJOJQJ\^JaJhWz5OJQJ\^Jh#~h#~5OJQJ\^Jhw 5@OJQJ]^J"h#~h#~5@OJQJ]^JhNhN5OJQJ\^JhN5OJQJ\^J*h#~h#~5@CJOJQJ]^JaJ$h#~5@CJOJQJ]^JaJ&'''''o(z(((((9):);)z){)ǺykZLE2+ h h'3$h h'3CJOJPJQJ^JaJ h6e8h6e8h'3CJOJQJ^JaJ h#h'3CJOJQJ^JaJhQCJOJQJ^JaJ hNhw CJOJQJ^JaJ h{Bh{Bh[h#~CJOJQJ^Jh[h'3CJOJQJ^Jh[h'3OJQJh[h'3CJOJQJ#hl{h15CJOJQJ^JaJ&hl{hWz5>*CJOJQJ^JaJ#hl{hWz5CJOJQJ^JaJz){)))))))))))))yyyyyyyytyyyFf $$Ifa$gdL]ykd]$$IflyX$!  t 0!644 la<p yt1 {)))))))) **'*-*A*H*\*b*v*|*********&+/++++1,2,3,F,Ŵţyyl_lh#e5OJQJ\^JhA?5OJQJ\^J)hQhQ5>*CJOJQJ\^JaJ)hbEhbE5>*CJOJQJ\^JaJ hQ5CJOJQJ\^JaJ hbE5CJOJQJ\^JaJhQ5OJQJ\^J'h h'35CJOJPJQJ^JaJ h h'3$h h'3CJOJPJQJ^JaJ")))))* ***'*-*9*B*H*T*]*b*n*w*|*** $$Ifa$gdL]**kd+$$Iflִ2 c' X$11 t0!6    44 la<yt1**'+(+2,3,----.-9-I-J- $$Ifa$gdgd!_ & F;gd gd#e & F<gd  & F=gd $a$gdNw F,H, ----J-K-[-o-p----------ͽ{h{h{hTC6hl{5OJQJ\^J!hl{hl{5>*OJQJ\^J'h h!_6CJOJPJQJ^JaJ$h h!_CJOJPJQJ^JaJ'h h!_5CJOJPJQJ^JaJ h h!_3h h!_5B*CJOJPJQJ\^JaJphh!_5OJQJ\^Jh!_hA?5OJQJ\^J h!_5CJOJQJ\^JaJ hA?5CJOJQJ\^JaJ hA?5CJOJQJ\^JaJJ-K-[-e-o-I=== $$Ifa$gdkd$$IflF$ 8p   t06    44 laXpyt!_o-p----ZNNN $$Ifa$gdkd $$Ifl^F$ 8p   t 06    44 laXpyt!_-----ZNNN $$Ifa$gdkd$$Ifl^F$ 8p  t 06    44 laXpyt!_---....ZUMHH< $$Ifa$gdgd,\' & F:gd gdl{kd$$Ifl^F$ 8p   t 06    44 laXpyt!_--w.......///2/3/O/Z/^/ͻ~jYjF?jF+'hUhA?6CJOJPJQJ^JaJ hUhA?$hUhA?CJOJPJQJ^JaJ!hA?5CJOJPJQJ^JaJ'hUhA?5CJOJPJQJ^JaJhA?3h-fhA?5B*CJOJPJQJ\^JaJph!h <h_ 5>*OJQJ\^Jh,\'5>*OJQJ\^J#hA?5>*CJOJQJ\^JaJ)hA?hA?5>*CJOJQJ\^JaJ hA?5CJOJQJ\^JaJhA?5OJQJ\^J....../=kd$$Ifl~F ! 2  t06    44 laXpyt)8[ $$Ifa$gd/(/2/3/O/Z/^/Skd$$Ifl^F ! 2  t 06    44 laXp yt)8[ $$Ifa$gd^/_/}///_SSS $$Ifa$gdkd$$Ifl^F ! 2  t 06    44 laXp yt)8[^/_/}//////00*0I0J0K0ҿx`K6`)hA?hA?B*CJOJQJ^JaJph333)hA?5B*CJOJQJ\^JaJph333/hvR~h|}&5B*CJOJQJ\^JaJph333 h@w5CJOJQJ\^JaJ&h|}&h|}&5CJOJQJ\^JaJ h|}&5CJOJQJ\^JaJh|}&5OJQJ\^JhA?$h-fhA?CJOJPJQJ^JaJ$hUhA?CJOJPJQJ^JaJ'hUhA?5CJOJPJQJ^JaJ hUhA? ///J0L0_W?+$-DM ]a$gdA?$ & F9-DM ]a$gd $a$gdNwkd|$$Ifl^F ! 2  t 06    44 laXp yt)8[K0L0U0X0000000=1>1?1G1111192깡vйvй_G//hA?h|}&5>*B*CJOJQJ^JaJph333/hA?hI|L5>*B*CJOJQJ^JaJph333,hA?h|}&5B*CJ OJQJ^JaJ ph333,hA?hF5B*CJOJQJ^JaJph333&h|}&5B*CJOJQJ^JaJph333/hA?h|}&56B*CJOJQJ^JaJph333,hA?h|}&5B*CJOJQJ^JaJph3332hA?h|}&5>*B*CJOJQJ\^JaJph333)hvR~h|}&B*CJOJQJ^JaJph333L000>1?111:2;2333,3A3 $$Ifa$gdgd|}& & F8gd $-DM ]^a$gdF$-DM ]a$gd|}&$h-DM ]^ha$gdF$ & F6-DM ]a$gd 92:2;2M222333A3B3V3`3333333333334 4!4<4F4l4m4n44ҝmmmmm`hIr5OJQJ\^J*hfh|}&5CJOJPJQJ\^JaJ$hfh|}&CJOJPJQJ^JaJ hfh|}&'hfh|}&5CJOJPJQJ^JaJhNh|}&5OJQJ\^J h|}&5CJOJQJ\^JaJh|}&5OJQJ\^JhF5OJQJ\^J&h|}&5B*CJOJQJ^JaJph333 A3B3V3a33K??? $$Ifa$gdkdS$$IflF x! +   t06    44 la<pyt"Z33333qeee $$Ifa$gdkdL$$IflF x! +  t06    44 la<yt"Z33333qeee $$Ifa$gdkd$$IflF x! +  t06    44 la<yt"Z3334 4qeee $$Ifa$gdkd$$IflF x! +  t06    44 la<yt"Z 4!4<4G4l4qeee $$Ifa$gdkdV$$IflF x! +  t06    44 la<yt"Zl4m4n455 5!5"5#5qiaTTTTT ^`gdIr & F7gd $a$gdNwkd$$IflF x! +  t06    44 la<yt"Z44555#5]5^5555555555555ɻxexeUeDxe!h&B5CJOJPJQJ^JaJhFCJOJPJQJ^JaJ$hoEhIrCJOJPJQJ^JaJ'hoEhIr5CJOJPJQJ^JaJ hoEhIr3hoEhIr5B*CJOJPJQJ\^JaJphh_ 5>*OJQJ\^JhIr5>*OJQJ\^J!hCh"Z5>*OJQJ\^J)hIrhIr5>*CJOJQJ\^JaJ hIr5CJOJQJ\^JaJ#5,505A5L5\5]5 $$Ifa$gda$\$If^\a$gdIr]5^5555E5)) $$Ifa$gda$\$If^\a$gdIrkd$$IfTlF =;#T   t06    44 laU pyt1T5555555VF:::: $$Ifa$gda$\$If^\a$gdIrkd$$IfTlpF =;#T   t 06    44 laU pyt1T5555555J:$\$If^\a$gdIrkd$$IfTlyF O;#f   t 06    44 laU pyt1T $$Ifa$gda555!6"6VMD<$a$gdNw^gd&B^gdIrkd$$IfTlF O;#f   t 06    44 laU pyt1T55 6!6"6<6=6>6{66666ķpY?*)hIr5B*CJOJQJ\^JaJph3332hIrhIr5>*B*CJOJQJ\^JaJph333,hIr5>*B*CJOJQJ\^JaJph333)hIrhIr5>*CJOJQJ\^JaJ hIr5CJOJQJ\^JaJ&hIrhIr5CJOJQJ\^JaJhIr5OJQJ\^JhCH5OJQJ\^J)h&BhIr5>*CJOJQJ\^JaJ)h&Bh&B5>*CJOJQJ\^JaJ!hIrhIr5>*OJQJ\^J "666C7D777788899zr$a$gdNw & F3gd gd&B & F4gd $-DM ]a$gdL0 $-DM ]^a$gdOB$ & F5-DM ]a$gd $-DM ]a$gdIr$ & F5-DM ]a$gd 666666B7C7D7M777777ҽҽ{cOc7/hIrhI|L5B*CJOJQJ\^JaJph333&hOB5B*CJOJQJ^JaJph333/hIrhIr5B*CJOJQJ\^JaJph333,hIrhOB5B*CJOJQJ^JaJph333&hIr5B*CJOJQJ^JaJph333,hIrhIr5B*CJOJQJ^JaJph333)hvR~hIrB*CJOJQJ^JaJph333/hvR~hIr5B*CJOJQJ\^JaJph333)hIrhIrB*CJOJQJ^JaJph3337777788S888888899Ҿr]rPC66h#5OJQJ\^JhN5OJQJ\^Jh&B5OJQJ\^J)h5hAt5>*CJOJQJ\^JaJ hAt5CJOJQJ\^JaJ h05CJOJQJ\^JaJh05OJQJ\^JhL0 5OJQJ\^JhL0 h05OJQJ\^J&hIr5B*CJOJQJ^JaJph333,hIrhIr5B*CJOJQJ^JaJph333,hIrhI|L5B*CJOJQJ^JaJph33399:K:M:N:::::::::;;;#;$;*;=;⫚ohTAhTAhTA$h~}hgt#CJOJPJQJ^JaJ'h~}hgt#5CJOJPJQJ^JaJ h~}hgt#3h~}hgt#5B*CJOJPJQJ\^JaJph h15CJOJQJ\^JaJ h_5CJOJQJ\^JaJ h5CJOJQJ\^JaJ hF5CJOJQJ\^JaJ)hgt#hgt#5>*CJOJQJ\^JaJ hgt#5CJOJQJ\^JaJhgt#5OJQJ\^J9::::::::::::::::: $$Ifa$gd ^gdgt#gd1gd_ & F2gd ::::;I=== $$Ifa$gd kdv$$IflF %  t06    44 laXpytgt#;;;;#;_SSS $$Ifa$gd kdy$$Ifl^F %  t 06    44 laXp ytgt##;$;*;4;>;_SSS $$Ifa$gd kdP$$Ifl^F %  t 06    44 laXp ytgt#=;>;?;H;R;V;W;X;z;;;;B<E<G<<н䰣}l[D*3hZhgt#5B*CJOJPJQJ\^JaJph-h{B5B*CJOJPJQJ\^JaJph h{B5CJOJQJ\^JaJ hgt#5CJOJQJ\^JaJ)hpShpS5>*CJOJQJ\^JaJ hpS5CJOJQJ\^JaJhpS5OJQJ\^JhF5OJQJ\^J$h~}hgt#CJOJPJQJ^JaJ'h~}hgt#5CJOJPJQJ^JaJ h~}hgt#'h~}hgt#6CJOJPJQJ^JaJ>;?;H;R;V;_SSS $$Ifa$gd kd'$$Ifl^F %  t 06    44 laXp ytgt#V;W;X;;C<D<E<_ZRIII^gdpS & F1gd gdFkd$$Ifl^F %  t 06    44 laXp ytgt#E<N<R<c<n<~<< $$Ifa$gd <<<<<I=== $$Ifa$gd kd$$IflF= Qp  t06    44 laXpytgt#<<<<<<<<<<<<<<<<<<<<<<<<<Խ{hXEhXh>XEXh> h-fhgt#$hZhgt#CJOJPJQJ^JaJhgt#CJOJPJQJ^JaJ$h-fhgt#CJOJPJQJ^JaJ h\hgt#$h\hgt#CJOJPJQJ^JaJ$h\hgt#CJOJPJQJ^JaJ)h^Thgt#B*CJOJQJ^JaJph-h^Thgt#B*CJOJPJQJ^JaJph'h-fhgt#5CJOJPJQJ^JaJ!hgt#5CJOJPJQJ^JaJ hZhgt#<<<<<_SSS $$Ifa$gd kd$$Ifl{F= Qp  t 06    44 laXp ytgt#<<<<<_SSS $$Ifa$gd kd$$Ifl{F= Qp  t 06    44 laXp ytgt#<<<<<_SSS $$Ifa$gd kd$$Ifl{F= Qp  t 06    44 laXp ytgt#<<<<<<<==="=#='=(===F=G=K=L=M=T====>>>??dzo^Qh725OJQJ\^J h_q<hRsgCJOJQJ^JaJ#hpShRsg5CJOJQJ^JaJ&hRsghRsg5CJOJQJ\^JaJ hRsg5CJOJQJ\^JaJhRsg5OJQJ\^J&hgt#hgt#5CJOJQJ\^JaJhgt#hgt#CJOJPJQJ^JaJ$h-fhgt#CJOJPJQJ^JaJ!hgt#5CJOJPJQJ^JaJ<<=#='=_SSS $$Ifa$gd kd]$$Ifl{F= Qp  t 06    44 laXp ytgt#'=(===G=K=_SSS $$Ifa$gd kd4$$Ifl{F= Qp  t 06    44 laXp ytgt#K=L=M=>>??_VNF>F & F/gd $a$gdNw & F0gd ^gdpSkd $$Ifl{F= Qp  t 06    44 laXp ytgt#????????=@E@{@@@@@ĻraO@1h,5CJOJQJ^JaJhu5CJOJQJ^JaJ#huh55CJOJQJ^JaJ huh5CJOJQJ^JaJ huhuCJOJQJ^JaJ#huhu5CJOJQJ^JaJ&huhu5CJOJQJ\^JaJ#h72huCJOJQJ\^JaJhuOJQJ\hQ5OJQJ\^Jh725OJQJ\^J hRsg5CJOJQJ\^JaJ h725CJOJQJ\^JaJ@@@@@@@@AAAAAABBB,BJB˼{g`P=g=g=$hibh\CJOJPJQJ^JaJh[sCJOJPJQJ^JaJ hibh\'hibh\5CJOJPJQJ^JaJhL0 5CJOJQJ^JaJ h,huCJOJQJ^JaJ#huhu5CJOJQJ^JaJh,5CJOJQJ^JaJh15CJOJQJ^JaJhC5CJOJQJ^JaJ#hFh,5CJOJQJ^JaJ&h,h,5>*CJOJQJ^JaJ?@@@AAAAAA $$Ifa$gd $]^a$gdu$]^a$gd\$ & F.]a$gd AAAB+ $If]gd kd$$Ifl\(# 9     t(0X 644 la<p(yt"ZBB,B6BJBNB$$7$8$H$Ifa$gd $7$8$H$Ifgd JBNBOBPBZBrB|BBBBBBBBBBBBBBBBBC&C2C3C4CBCZCdCrCsCtCCѽѪѽѪs`YѪѪ hW h[s$hW h[sCJOJPJQJ^JaJ'hibh[s5CJOJPJQJ^JaJ$hibh[sCJOJPJQJ^JaJh\CJOJPJQJ^JaJ$hW h\CJOJPJQJ^JaJ'hibh\5CJOJPJQJ^JaJ$hibh\CJOJPJQJ^JaJ hW h\'hW h\6CJOJPJQJ^JaJ"NBOBPBZB@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd $$Ifl4\(#  9     `` t0X 644 la<pyt"ZZBdBrB|BBB/kdT $$Ifl4^\(# 9   `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd BBBBBBB$$7$8$H$Ifa$gd $7$8$H$Ifgd BBBB@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd $$Ifl4^\(# 9   `` t0X 644 la<pyt"ZBBBB/kd $$Ifl4^\(# 9   `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd BBBCC&C3C$$7$8$H$Ifa$gd $7$8$H$Ifgd 3C4C5CBC@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd$$Ifl4.\(# 9   `` t0X 644 la<pyt"ZBCLCZCdCsCtC/kd($$Ifl4\(# 9   `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd tCuCCCCC$$7$8$H$Ifa$gd $7$8$H$Ifgd CCCCCCCDDDDDDD$D.DDLDVD`DnDoDpDDDDDDDDDDDDDDDDEEEEEӿӿڊӿڊӿӿӿӿx#huhu5CJOJQJ^JaJh\CJOJPJQJ^JaJ!h\5CJOJPJQJ^JaJ'hW h\6CJOJPJQJ^JaJ'hibh\5CJOJPJQJ^JaJ hW h\$hW h\CJOJPJQJ^JaJ$hibh\CJOJPJQJ^JaJ,CCCC@2% $If]gd $7$8$H$Ifgd kdk$$Ifl4L\(#  9     `` t0X 644 la<pyt"ZCCCDD$$If]a$gd $$7$8$H$Ifa$gd $Ifgd DD DD@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd$$Ifl4\(#  9     `` t0X 644 la<pyt"ZD$D.D=D>D/kd$$Ifl4\(# 9   `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd >D?DLDVD`DoD$$7$8$H$Ifa$gd $7$8$H$Ifgd oDpDqDD@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd$$Ifl4p\(# 9   `` t0X 644 la<pyt"ZDDDD/kd[$$Ifl4\(#  9     `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd DDDDD$$7$8$H$Ifa$gd $7$8$H$Ifgd DDDD@2!$$7$8$H$Ifa$gd $7$8$H$Ifgd kd$$Ifl4\(#  9     `` t0X 644 la<pyt"ZDDDD/kd$$Ifl4\(# 9   `` t0X 644 la<pyt"Z$$7$8$H$Ifa$gd DDEEE$$7$8$H$Ifa$gd $7$8$H$Ifgd EEE=F@0  & F- ^gd $]^a$gdukd$$Ifl4\(#  9     `` t0X 644 la<pyt"ZE+E?EEE*CJOJQJ^JaJ#hqhq5CJOJQJ^JaJhq5CJOJQJ^JaJ hq5CJOJQJ\^JaJhq5OJQJ\^Jh(hq5OJQJ\^JhAJ5CJOJQJ^JaJ#hAJhAJ5CJOJQJ^JaJh"ZhQ5OJQJ\^JhAJ5CJOJQJ^JhAJhAJ5CJOJQJ^J hAJ5CJOJQJ\^JaJhAJ5OJQJ\^J=F^GHHHKKwMxM(N)NOO~v$a$gdNw & F)gd gd6e8 & F*gd gdq$[$\$^a$gd5$[$\$^a$gdq$[$\$a$gdq$[$\$a$gdC$ & F+[$\$a$gd $ & F,ddH$a$gd G^H|HHHHI3IKKKuMvMwMxMMMMʸ}m`SH7 hZ65CJOJQJ\^JaJhZ65CJ\aJhZ65OJQJ\^Jhq5OJQJ\^Jh5hAJ5OJQJ\^Jh5hq5#h5hq5CJOJQJ^JaJ#hqhq5CJOJQJ^JaJh@w5CJOJQJ^JaJ#hqh_5CJOJQJ^JaJhC5CJOJQJ^JaJ&hqhq5>*CJOJQJ^JaJ#hqhq5CJOJQJ^JaJMMM'N)N4NFNOO?OQOOOPPPķęvgSB1!hh5>*OJQJ\^J!h"Zh_5>*OJQJ\^J&hfhf5>*CJOJQJ^JaJhf5CJOJQJ^JaJ#hfhf5CJOJQJ^JaJ hf5CJOJQJ\^JaJhf5OJQJ\^J hJ'5CJOJQJ\^JaJhJ'5OJQJ\^Jh5OJQJ\^Jh6e85OJQJ\^J hZ65CJOJQJ\^JaJ h5CJOJQJ\^JaJOPP"P7PPP$$If]a$gd#gd & F(gd P%P&PPPQPdPmPnPxPyPPPPPPPPPPPPPPPQQ Q Q QQ%QǶ{ǶjVO{Ƕ h9h'h9h6CJOJPJQJ^JaJ!h6CJOJPJQJ^JaJ'h-fh5CJOJPJQJ^JaJh$h-fhCJOJPJQJ^JaJhCJOJPJQJ^JaJ!h5CJOJPJQJ^JaJ h-fh-h5B*CJOJPJQJ\^JaJph3h-fh5B*CJOJPJQJ\^JaJphPPQPdPnPxPF666$$If]a$gd#kdK$$Ifl4F8$ d@   t06    44 laf4pytl{xPyPPPPP_OOOO$$If]a$gd#kdT$$IflF8$ d@   t 06    44 lap ytl{PPPPP_OOO$$If]a$gd#kd+$$Ifl^F8$ d@   t 06    44 lap ytl{PPPQ Q_OOO$$If]a$gd#kd$$IflF8$ d@   t 06    44 lap ytl{ Q QQ%Q)Q_OOO$$If]a$gd#kd$$IflF8$ d@   t 06    44 lap ytl{%Q)Q*Q+QBQQQYQQQQQRRRR"R|R}RRRʹvfYIv9vhGhG5OJQJ\^JhGhO5OJQJ\^JhO5OJQJ\^JhOhL0 5OJQJ\^J)h"hG5>*CJOJQJ\^JaJhGhF5OJQJ\^Jh"5OJQJ\^J h[z5CJOJQJ\^JaJ hG5CJOJQJ\^JaJhG5OJQJ\^Jh,\'5OJQJ\^J h9h'h9h6CJOJPJQJ^JaJ)Q*Q+QQQR_SH<1 $ & F'a$gd $^a$gd" $ & F'a$gd $^a$gdkd$$IflF8$ d@   t 06    44 lap ytl{RRR}RSS;T*CJOJQJ\^JaJ h/5CJOJQJ\^JaJh/5OJQJ\^JhF5OJQJ\^Jh@w5OJQJ\^J h"5CJOJQJ\^JaJ8U9UnUoUpUqUUUUUUUUUUUUUUUUUUU˺wgTgPw*CJOJQJ^JaJ h(5>*CJOJQJ^JaJ h6e85>*CJOJQJ^JaJ&hH 9hH 95>*CJOJQJ^JaJhH 95CJOJQJ^JaJUUUUUI=== $$Ifa$gdkd $$IflF d(p  t06    44 lapytUUUUU_SSS $$Ifa$gdkd!$$Ifl^F d(p  t 06    44 lap ytUUUUU_SSS $$Ifa$gdkda"$$Ifl^F d(p  t 06    44 lap ytUUUUUUVVV V VVVVVVV"V#V,V-V.V4V5V;V>V?VHVIVJVRV[V\VfVgVmVnVtVwVxV{V|V}V~VVVűűűű֜~ he5CJOJQJ\^JaJhe5OJQJ\^J hH 95>*CJOJQJ^JaJhH 9'h-fhH 95CJOJPJQJ^JaJ!hH 95CJOJPJQJ^JaJ h-fhH 9$h-fhH 9CJOJPJQJ^JaJhH 9CJOJPJQJ^JaJ-UUV VV_SSS $$Ifa$gdkd8#$$Ifl^F d(p  t 06    44 lap ytVVV#V-V_SSS $$Ifa$gdkd$$$Ifl^F d(p  t 06    44 lap yt-V.V5V?VIV_SSS $$Ifa$gdkd$$$Ifl^F d(p  t 06    44 lap ytIVJVRV\VfV_SSS $$Ifa$gdkd%$$Ifl^F d(p  t 06    44 lap ytfVgVnVxV|V_SSS $$Ifa$gdkd&$$Ifl^F d(p  t 06    44 lap yt|V}V~VWW_O8%$ h+ 7$8$H$a$gd1$ & F$ h+ 7$8$H$a$gd $7$8$H$^a$gd[zkdk'$$Ifl^F d(p  t 06    44 lap ytVVVV?WWWsWWWWWWWǵw_EA0!he5CJOJPJQJ^JaJhe3hZhe5B*CJOJPJQJ\^JaJph.h15CJOJQJ^JaJfHq 4h1hgQ5CJOJQJ^JaJfHq &hehe5>*CJOJQJ^JaJhe5CJOJQJ^JaJ#hehe5CJOJQJ^JaJ,hehe5B*CJOJQJ^JaJphhe5CJOJQJ^JaJ#hehe5CJOJQJ^JaJ WWWWWWWW $$Ifa$gd$ h+ 7$8$H$a$gd1WWWWWI=== $$Ifa$gdkdB($$IflF p  t06    44 lapytOWWWWWWXXXXXXXXX X"X)X*X-X.X/X6X7X9X@XAXJXKXLXRXSXUX\X]XfXgXhXnXoXqXxXyX|X}X~XXXȵȵ۵۵۵۵۵hkG5OJQJ\^Jh&B5OJQJ\^J!he5CJOJPJQJ^JaJhe$h-fheCJOJPJQJ^JaJ$hZheCJOJPJQJ^JaJheCJOJPJQJ^JaJ'h-fhe5CJOJPJQJ^JaJ/WWXXX_SSS $$Ifa$gdkdE)$$Ifl{F p  t 06    44 lap ytOXX X*X.X_SSS $$Ifa$gdkd*$$Ifl{F p  t 06    44 lap ytO.X/X7XAXKX_SSS $$Ifa$gdkd*$$Ifl{F p  t 06    44 lap ytOKXLXSX]XgX_SSS $$Ifa$gdkd+$$Ifl{F p  t 06    44 lap ytOgXhXoXyX}X_SSS $$Ifa$gdkd,$$Ifl{F p  t 06    44 lap ytO}X~XXWYXYaYeYvY_ZRMAAA $$Ifa$gdgd{B & F#gd gd&Bkdx-$$Ifl{F p  t 06    44 lap ytOX YTYVYWYXYYYYYYYYYYYYYYYYYYYYYYYʽ{h{dP{h{hPh{h{h'h-fhe5CJOJPJQJ^JaJhe$h-fheCJOJPJQJ^JaJheCJOJPJQJ^JaJ!he5CJOJPJQJ^JaJ h-fhe3h-fhe5B*CJOJPJQJ\^JaJphhA@5OJQJ\^Jh(he5OJQJ\^J)hAJhkG5>*CJOJQJ\^JaJ hkG5CJOJQJ\^JaJvYYYYYYY=kdO.$$IflF$ H F$    t06    44 laJpytA@ $$Ifa$gdYYYYYYYNkd`/$$IflF$ H F$    t 06    44 laJpytA@ $$Ifa$gdYYYYYUIII $$Ifa$gdkdO0$$IflF$ H F$   t 06    44 laJpytA@YYY)[*[3[ZRJE5$$If^a$gdkGgdOB & F"gd $a$gdNwkd:1$$IflrF$ H F$   t 06    44 laJpytA@YYZZZZZZZ#[([)[*[d[ʵzhXE+3hkrhkG5B*CJOJPJQJ\^JaJph$hkGh156>*OJQJ\^JhQ56>*OJQJ\^J#hOB56CJOJQJ\^JaJ#hkG56CJOJQJ\^JaJ)hkGhkG56CJOJQJ\^JaJ&hkGhkG5CJOJQJ\^JaJ)hkGhkG5>*CJOJQJ\^JaJ hkG5CJOJQJ\^JaJhkG5CJ\aJhkG5OJQJ\^Jh"Z5OJQJ\^J 3[7[H[S[c[d[e[=kd2$$IflF hu  t06    44 laJpytA@ $$Ifa$gdd[e[l[u[v[z[{[~[[[[[[[[\\\\]]ι{jXHX9hOB5CJOJQJ^JaJh1h15OJQJ\^J#hYYhYY5CJOJQJ^JaJ hYY5CJOJQJ\^JaJ hw15CJOJQJ\^JaJhw15OJQJ\^Jh15OJQJ\^J$hkrhkGCJOJPJQJ^JaJ)hkrhkGB*CJOJQJ^JaJph-hkrhkGB*CJOJPJQJ^JaJph'hkrhkG5CJOJPJQJ^JaJ hkrhkGe[l[v[z[{[~[[9kd,3$$Ifl{F hu  t 06    44 laJpytA@ $$Ifa$gd$$If^a$gdkG[[[[[[N>$$If^a$gdkGkd4$$Ifl{F hu  t 06    44 laJpytA@ $$Ifa$gd[[[\]]ZUMD<$a$gdNw^gd1 & F!gd gdw kd4$$Ifl{F hu  t 06    44 laJpytA@]]]] ^a^z^}^~^^^^^Q_ijteVF2&h_ haY5CJOJQJ\^JaJh_ haY5OJQJ\^Jh_ 5CJOJQJ^JaJh[5CJOJQJ^JaJhq;5CJOJQJ^JaJh@wh@w5OJQJ\^Jhq;CJOJQJ^JaJ#hq;hq;5CJOJQJ^JaJ hF5CJOJQJ\^JaJ h[5CJOJQJ\^JaJ h[z5CJOJQJ\^JaJh[5OJQJ\^JhF5OJQJ\^J ]~^^^^5`6`RaSaaabbccd $$Ifa$gdgdhg & Fgd$+$a$gdCl^gd6e8gdOY & Fgdhg$a$gdNw & Fgdw gd_ $ & F a$gdO^gd@w & F gd Q_4`5`6`E`````PaQaRaSavaaazm`SB1 h6e85CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jhhg5OJQJ\^Jhw 5OJQJ\^Jh5CJOJQJ^JaJ#hh5CJOJQJ^JaJ&hh5CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jh_ h_ 5OJQJ\^Jh_ hT~5OJQJ\^J#h_ haY5CJOJQJ^JaJaaa`bbbbb_cccccccd̷{f{f{VF1)hhg5B*CJOJQJ\^JaJphh$+hhg5OJQJ\^JhhghCl5OJQJ\^J)h$+h$+5>*CJOJQJ\^JaJ h$+5CJOJQJ\^JaJh$+5OJQJ\^JhQ5OJQJ\^J!hhhg5>*OJQJ\^J)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJ!h6e8hOY5>*OJQJ\^J!hOYh6e85>*OJQJ\^Jdd d ddd&d'd8d9d:dCdDdMdNdWdXdYdbdcdldmdvdwdxdddddddddGeeϾϾϾπoZ)hx!bhx!b5>*CJOJQJ\^JaJ hx!b5CJOJQJ\^JaJhx!b5OJQJ\^JhhgCJOJPJQJ^JaJhhgCJOJQJ^JaJ$hhg5CJOJPJQJ\^JaJ hhg5CJOJQJ\^JaJhhg)hhg5B*CJOJQJ\^JaJph-hhg5B*CJOJPJQJ\^JaJph"d dd'd8d9d:dDdNdXd^R $$Ifa$gdkd5$$IfF d    t6    22 l4aJpytA@$$If^a$gd XdYdcdmdwdxhh$$If^a$gd $$Ifa$gd{kd6$$If-F d    t 6    22 l4aJp ytA@wdxddddxhh$$If^a$gd $$Ifa$gd{kd7$$If-F d    t 6    22 l4aJp ytA@dddeefffff|t|lgggbgd~Ugd( & FgdFv & Fgd"Z$a$gdNw{kd8$$If-F d    t 6    22 l4aJp ytA@ eeefBffffffffffįrXQ@0h~UCJOJPJQJ^JaJ!h~U5CJOJPJQJ^JaJ h-fh~U3h-fh~U5B*CJOJPJQJ\^JaJphh~U5OJQJ\^J!hL0 h(5>*OJQJ\^Jh(5>*OJQJ\^J!h(hFv5>*OJQJ\^J)h~Uh~U5>*CJOJQJ\^JaJ h~U5CJOJQJ\^JaJ hFv5CJOJQJ\^JaJhFv5OJQJ\^Jh@w5OJQJ\^J fffffff $$Ifa$gd"qfffffI=== $$Ifa$gd"qkd9$$IflFt'  t0<6    44 lapytqfffffgggg'g(g)gNgOgXgYgbgcgdgeglggg텰uhWE#h0h05CJOJQJ^JaJ h05CJOJQJ\^JaJh05OJQJ\^Jh~Uh~U5OJQJ\^J h-fh~Uh~UCJOJPJQJ^JaJ'h-fh~U5CJOJPJQJ^JaJ!h~U5CJOJPJQJ^JaJ h^d`h~U'h^d`h~U6CJOJPJQJ^JaJ!h~U6CJOJPJQJ^JaJ$h-fh~UCJOJPJQJ^JaJffggg(gZNNNN $$Ifa$gd"qkd:$$Ifl^Ft'  t 0<6    44 lapytq(g)gBgOgYgcgUIIII $$Ifa$gd"qkd;$$Ifl^Ft'  t 0<6    44 lapytqcgdgeg'h(hhZQIA9 & Fgd$a$gdNw & Fgd0^gd~Ukdv<$$Ifl^Ft'  t 0<6    44 lapytqgg&h'hMhOhhhhhh(iCi_ilinioiĹqW@W@W<h-h5B*CJOJPJQJ\^JaJph3h-fh5B*CJOJPJQJ\^JaJph!h3^h5>*OJQJ\^J)h0h05>*CJOJQJ\^JaJ h05CJOJQJ\^JaJ h5CJOJQJ\^JaJh5CJ\aJh5OJQJ\^Jh0h05OJQJ\^Jh'5CJOJQJ^JaJh05CJOJQJ^JaJhhhhii)iDiEiPi`imini $$Ifa$gd$gd nioisi~i+ $$Ifa$gd$kdW=$$Ifl\ (# +  t(0X 644 la<p(yt"Zoirisi~iiiiiiiiiiiiiiiiiiiijjjjj jVjǴǴǴǑsfU h5CJOJQJ\^JaJh5OJQJ\^JhN5OJQJ\^Jh15OJQJ\^JhhCJOJPJQJ^JaJ$h-fhCJOJPJQJ^JaJ$hKA%hCJOJPJQJ^JaJ$hhCJOJPJQJ^JaJ'h-fh5CJOJPJQJ^JaJ!h5CJOJPJQJ^JaJ~iiiiiii;kd>$$Ifl1\ (# +  t 0X 644 la<pyt"Z $$Ifa$gd$iiiikd?$$Ifl\ (# +  t(0X 644 la<p(yt"Z $$Ifa$gd$iiii $$Ifa$gd$iiii+ $$Ifa$gd$kd@$$Ifl\ (# +  t(0X 644 la<p(yt"ZiijjjWj;6. & FgdgdNkdA$$Ifl\ (# +  t 0X 644 la<pyt"Z $$Ifa$gd$VjWjjjjQkRkkkkkkkkkkkkk ll¾¨ߗ߇zm`mO> h 5CJOJQJ\^JaJ hO(5CJOJQJ\^JaJh 5OJQJ\^JhO(5OJQJ\^Jh5OJQJ\^JhhO(5OJQJ\^J h?5CJOJQJ\^JaJ*hh h0J5CJOJQJ\^JaJhk3jhk3U)hh5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJhNhN5OJQJ\^JWjkkllmmmnn $$Ifa$gd; ^gdO( & FgdO($a$gdNw & FgdL0 gd^gdN lllllmmmmmmmmmmmmm̻̻n]I6$hnhO(CJOJPJQJ^JaJ'hnhO(5CJOJPJQJ^JaJ!hO(5CJOJPJQJ^JaJ!hO(hO(5>*OJQJ\^J)hO(h55>*CJOJQJ\^JaJ#h55>*CJOJQJ\^JaJ)hO(hO(5>*CJOJQJ\^JaJ hO(5CJOJQJ\^JaJhO(5OJQJ\^J!h hL0 5>*OJQJ\^J)h h 5>*CJOJQJ\^JaJmnnnnn2n3n*OJQJ\^Jh&5>*OJQJ\^J)hh5>*CJOJQJ\^JaJ&h/h&W 5CJOJQJ\^JaJ h$e;5CJOJQJ\^JaJ)h$e;h$e;5>*CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jh{B5OJQJ\^Jh5OJQJ\^J hO(5CJOJQJ\^JaJ h 5CJOJQJ\^JaJAqrrTsUssssxtyttttuu9uTu & F7$8$H$gd_ & F7$8$H$gd} 7$8$H$^gd}$7$8$H$^a$gd}^gd} & FgdIR & Fgd}gd} & Fgd!$a$gdNw & Fgd&rrrr s ssPsSsTsUsssssswtxt⛋{k^L=h@5CJOJQJ^JaJ#h}h}5CJOJQJ^JaJh}5OJQJ\^Jh}hIR5OJQJ\^Jh}h}5OJQJ\^Jh}h15OJQJ\^JhOBh!5OJQJ\^J)h}h}5>*CJOJQJ\^JaJ h9H5CJOJQJ\^JaJ h!5CJOJQJ\^JaJ h}5CJOJQJ\^JaJh!5OJQJ\^Jxtttttuu8u9uSuTuhuiuuuuuuvvvvdz쒅t_N=!h[zh,5>*OJQJ\^J!hOYh,5>*OJQJ\^J)h!h!5>*CJOJQJ\^JaJ h!5CJOJQJ\^JaJh!5OJQJ\^Jh$e;h}5OJQJ\^J h&W 5CJOJQJ\^JaJ&h_h(5CJOJQJ\^JaJ&h_h}5CJOJQJ\^JaJ h}5CJOJQJ\^JaJ&h}h}5CJOJQJ\^JaJTuiuuuuvvw ww(w9w:w$$If^a$gd? gd6e8 & Fgd6e8$a$gdNw & F7$8$H$gd&W & F7$8$H$gd} v:w;wDwEwFwGwLwPwVwWwXwiwjwswxwywzwwwwwwwwwwwwwwwwwsxмммммyyl[ hp#5CJOJQJ\^JaJhp#5OJQJ\^Jh8p6h!B*ph333)h8p6h!B*CJOJQJ^JaJph333h!CJOJPJQJ^JaJ$hh!CJOJPJQJ^JaJ'hh!5CJOJPJQJ^JaJ!h!5CJOJPJQJ^JaJh!3hh!5B*CJOJPJQJ\^JaJph":w;wGwRwVwI=--$$If^a$gd? $$Ifa$gd? kdGE$$IflF ,"    t06    44 lapytVwWwjwtwxw_SCC$$If^a$gd? $$Ifa$gd? kdJF$$Ifl-F ,"    t 06    44 lap ytxwywwww_SCC$$If^a$gd? $$Ifa$gd? kdG$$Ifl-F ,"    t 06    44 lap ytwwwww_SCC$$If^a$gd? $$Ifa$gd? kdG$$Ifl-F ,"    t 06    44 lap ytwwwxxx_NFA9 & FgdOBgd! & Fgd&-DM ]gd!kdH$$Ifl-F ,"    t 06    44 lap ytsxxxxxxxxxxxxySy_yyyyyŻ~oo[J=0hTB5OJQJ\^Jh"Z5OJQJ\^J h5>*CJOJQJ^JaJ&hZxh5>*CJOJQJ^JaJh5CJOJQJ^JaJh-O5CJOJQJ^JaJh&h&5OJQJ\^JhO5CJOJQJ^JaJhk5CJOJQJ^JaJhkOJQJ^Jhk5OJQJ\^Jh!5OJQJ\^Jh!h&5OJQJ\^J h!5CJOJQJ\^JaJxyy||||k}l}~~=~i~~~~ & FgdZx$ & F7$8$H$a$gd)$ & F7$8$H$a$gd?O $7$8$H$a$gd,\'$ & F7$8$H$a$gd, $^a$gd $a$gdTB $^a$gdTB $ & Fa$gdTB^gd"Zyyyy6zPzzzz||||||j}k}ȴȝu]I5&hF!5B*CJOJQJ^JaJph&hTB5B*CJOJQJ^JaJph/hTBhTB5>*B*CJOJQJ^JaJph&h@5B*CJOJQJ^JaJph&hD5B*CJOJQJ^JaJph,hTBhTB5B*CJOJQJ^JaJph&hTBhTB5>*CJOJQJ^JaJ#hTBhTB5CJOJQJ^JaJ)hTBhTB5>*CJOJQJ\^JaJ hTB5CJOJQJ\^JaJk}l}x}y}z}}~~~~~~~~~νtbtRE8h|5OJQJ\^Jh{B5OJQJ\^Jh$e;hZx5OJQJ\^J#h?Oh)5CJOJQJ^JaJ#h?Oh?O5CJOJQJ^JaJ h3^5CJOJQJ\^JaJ h,5CJOJQJ\^JaJ)hZxhF!5>*CJOJQJ\^JaJ hF!5CJOJQJ\^JaJhF!5OJQJ\^JhTB5CJ\aJhTB5OJQJ\^Jh 5OJQJ\^J~~;<EIZeuv $$Ifa$gdy4 $^a$gd| $ & F a$gd3^^gd$e; +0g:;<dzǛuaOaO@1h|5CJOJQJ^JaJh15CJOJQJ^JaJ#h|h|5CJOJQJ^JaJ&hClh|5>*CJOJQJ^JaJ hCl5>*CJOJQJ^JaJ)h|5>*B*CJOJQJ^JaJph333/hZxh|5>*B*CJOJQJ^JaJph333&h|5B*CJOJQJ^JaJph333,h|h|5B*CJOJQJ^JaJph333 hZx5CJOJQJ\^JaJ h|5CJOJQJ\^JaJ<ԁՁ*`ag&'7mnÃ&̈́ νννννννννటyi\h]5OJQJ\^Jh.zh,5OJQJ\^J)hZxh|5>*CJOJQJ\^JaJ h|5CJOJQJ\^JaJ hQ45CJOJQJ\^JaJhQ45OJQJ\^J hhFh|CJOJQJ^JaJ#hhFh|5CJOJQJ^JaJ hhFh|/hhFh|5B*CJOJQJ\^JaJph$+ $$Ifa$gdy4kdnI$$Ifl\Ac(#p@   t(0J644 laJp(ytA@ԁՁ1kdJ$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4*.1kdK$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4.8`agq1kdL$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4qu1kdM$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy41kdO$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4&'7;1kd P$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4;Emn1kdQ$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4Ã̓1kd"R$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4̓у1)$a$gdNwkd-S$$Ifl^\Ac(#p@  t 0J644 laJp(ytA@ $$Ifa$gdy4 _`89يڊދ & FgdOBgdu & Fgd.z & Fgd & Fgd#>{ & F gd6e8 & F gd[sgdIR^gdY h^hgdY  & F gdIR$a$gdNw & F gd, '?A]^_`~6789CqaqTG:h#>{5OJQJ\^JhCl5OJQJ\^Jh6e85OJQJ\^Jh3^h[s5OJQJ\^J)hZxh]5>*CJOJQJ\^JaJ h]5CJOJQJ\^JaJh]5OJQJ\^JhIR5OJQJ\^JhIRh)5OJQJ\^J hQ45CJOJQJ\^JaJhY hY 5OJQJ\^J hB+5CJOJQJ\^JaJhB+5OJQJ\^JC46׊؊يڊO﯍ydySF9hkE5OJQJ\^Jhu5OJQJ\^J hkE5CJOJQJ\^JaJ)hZxh5>*CJOJQJ\^JaJ&hh5CJOJQJ\^JaJ h5CJOJQJ\^JaJ h5CJOJQJ\^JaJh5OJQJ\^Jh#>{5OJQJ\^J h]5CJOJQJ\^JaJ)hZxh#>{5>*CJOJQJ\^JaJ h#>{5CJOJQJ\^JaJ݋ߋVWXݎ!Vĥu`OB5Bh(5OJQJ\^Jh[(5OJQJ\^J!hkEh)5>*OJQJ\^J)hkEhkE5>*CJOJQJ\^JaJ#hkE56CJOJQJ\^JaJ h(b5CJOJQJ\^JaJh(b5OJQJ\^Jh@5OJQJ\^J#hkE5>*CJOJQJ\^JaJhkE5OJQJ\^JhOB5OJQJ\^J h5CJOJQJ\^JaJ hkE5CJOJQJ\^JaJދߋWX !Ͻнҽӽսֽؽٽ۽ & F@&gd}@&gd( & F@&gd} & Fgd[s $ & Fa$gd,$a$gdNw & FgdkEgdOBVXȏߏUYn͸|gVI8 h.5CJOJQJ\^JaJh.5OJQJ\^J!h8Mh[s5>*OJQJ\^J)hkEh]65>*CJOJQJ\^JaJ)hkEh(b5>*CJOJQJ\^JaJ h(b5CJOJQJ\^JaJU&h(bh]65CJOJQJ\^JaJ)h(bh]65>*CJOJQJ\^JaJ h]65CJOJQJ\^JaJ h[(5CJOJQJ\^JaJ h[(5CJOJQJ\^JaJ ovidien Healthcare (old PP-NS-396, new PP-NS-573) and Carolon Company (new PP-NS-574). Agreements effective December 1, 2009 through November 30, 2012. Invasive Cardiology Equipment announcement that Philips Medical Systems has been added to this portfolio, PP-CA-147. Agreement effective September 1, 2009 through February 29, 2012. Product line includes two subcategories: Cath lab hemodynamic monitoring systems Electrophysiology monitoring systems     Clinical Services For further Clinical Services support: Contact us directly or through your client service executive to arrange for further assistance: Timothy Glennon, RN, MSN, MBA, CMRP Vice President, Clinical Services, HYPERLINK "mailto:glennon@gnyha.org"glennon@gnyha.org or (212) 506-5445, or Sandee Schoby, LVN, BA, JD, CMRP Director, Clinical Services, HYPERLINK "file:///C:\\Documents%20and%20Settings\\schoby\\Local%20Settings\\Temporary%20Internet%20Files\\Content.Outlook\\74EW74NV\\schoby@gnyha.org"schoby@gnyha.org or (212) 506-5521.   nνϽнѽӽԽֽ׽ٽڽܽݽ߽ʹtaSEh~+B*CJ$OJQJph33h~+B*CJOJQJph33$jhk3hk3CJUmHnHu/jhrB*CJOJQJUmHnHph33uh7y]jh7y]Uh~5OJQJ\^J&h}h}5CJOJQJ\^JaJ h}5CJOJQJ\^JaJ h(5CJOJQJ\^JaJ h{B5CJOJQJ\^JaJ&h}h.5CJOJQJ\^JaJ۽ܽ $a$gdNw <]<^gdUL<]<gdUL$a$gd'ygd'ygdUL$a$gdgd¾þOP ǷǨϤÒä}lä_h~5OJQJ\^J jqhl\NhrUmHnHu j8Thl\NhrUmHnHuh~+h>h~+CJaJ h'yh~+h7y]hj h~+0JCJOJQJh~+0JCJOJQJhk3jhk3Uh~+CJOJQJh~+5CJOJQJ\2jhk3hk35CJOJQJU\mHnHu6&P1h:p9S/ =!"#$% FHܔ_>DXYuJFIFHHC       C  O  !1AQ"2aBq#R$3CbSr%'Tcs&457D*!1A"Qa2qRB ?DmTk- H܋K#ل;vbEJsȬ[k dsA\6Y eTrԗGI8`H]eH4U킢@VՆZ/8E|O !˶339+RE-fߔ_:a$,%OM)~YyPD&z{>bC?V3xT8J⶙s1>> J^,/x}֕.>#NvB%Of?y@H8 #m$%@y g-}[*-}.ۏ~1QV^i .{N52BESҽSr*pEIt1f44z-lZJy gLkheHhUe8mEMN +.|G; 𧗴aĚ+ep\7r] 8X0,rFlE> %ϖ64Ƴuтt&#XqXcF48v3ғzlNqu^4BH4Ugdlln%?늏#T,X^j;ڷORҟg? 5 =F{-C;47CO2E&9R$Ĩ'@20m!n 3݀O@Rq-uE@%ISԩk뫝V>/69MЭYa|0" : v+R>~8?Rf55rjΙ37^uy_ѷ?I)2^t%msN9l*J5[EYG!1\*f < ,="\'X%#A:.L}竑99H\=_kF |(}lTx1\XGsɬ-gՋs$;.|k`huHsO k8v-#iI Hb䳪#i %'4AOs5&s<1fD>}~;YC<$/v;V( !}#]Yhdi fT6 [M?f8FlUv&rJgiAd0s0T'g68۫Z;7.%ŏ(:L>)Dt GדO9 OW*;.t\?ADZtJx[}4 cIf━n%Iu&JoFQfq_nS~춋*O,@sͷ&Yh dsr>mODl!/ qg9I_Vn|@M~=g'Akg ~ߏO4>,NO?g37m , /+D}{%b}f!OUKZREWf7vg/)]~P ๝oP7(z.˖fXK]U@Edrs 6ZNN%Mji/.>&p\SNj h1(yf3Ly"m~V@G<|ȜxyAߔm 6Ly0 Ỡ#|!VW:W\a3Pqo"{\+ 7p-.EJXb)庽2:V8(zZ醡9ʏy0=DG*~,`Y喔g3</3Oޝ|Mkdxmt5X loC~HC[uy|cW]ϳ#t=e/FGJlzHp6h J 0kBgʎͱ]a|lMr^ذ94"i:X%4Q^SWq݂Ko-ޙ?,dv @i) @53ΩHH=}H@c0 d.l.A7$ b&x^^\@@]&꜅ x[`~$/w{kSz{k}oOdd襠7n cuH%$QrD4& L7d~eD[h)*uD=I?ag)%8!l^f0)~+yB0fw=J6eugq;4AN:ZDMI+E6+PJuDI=d{<"iɒڪz*Yj v%`-O\}$ H+[v3H467VZi_eØLjBw?#e5^ {OQh"8!ыq&^Ə!cєhHJ4ep Su 4>gWtH\.*gM0dr2b#uĥ`\h1NqU5qN8his  f||.7j|stw e}9dg 983f HvtN:##q oZ>ţȿ[Һ :-!,vH%nߪa.#JFj&&qD/tE3=-,->Cw<'8LiSY!9gv;$ijh` 4&d5X4u偤t U4 mЫgZHRdcw6ZVO{_tma&MbI>,_h 9G}? ӍYɻg{5,\ R3qK{3z'hK q|?6'TfQIHU/ծ S{iv ]Yb5"melce:ƗficV+{ήtF)uZİz rFKwJS*o+)e/? 8$JfV9ї h# /+p7UEv2,~x}1-ʣ, (I6WR*:șߴ. $y_u3 Z湭g0L' `h845 Hv{#_^o3cZ&<_Y x*O>o5 |*LK[Dh'}G&7ھeKAl׺GL餷 uȻuL5Ly":e: |mFty3+"mZx 6{ 7dfxڀ*1,> ҵ 4 ,;0:,_6t}l:Ji{)̒ eLzL'Rg2vaRR*刴jIE6a7% x˨:64cؾ(Zk^a<ޖ3#bt2T#fKfxh&J6 'clꨚMDE`|C5rCL<+GǠF!Ϊ&};u!3vm ;Ce6v>C#Bzm9O.3tΟ1)!!ؑvOfW>K^ k,=viwp/Qˑ2cpuɏzmxs]4bـ=oe⢕fV 2dZ|atc c]Y>QN.+;k031=]霋(+sof?[l־7d. |h#_EvrMO[+2hSCXG(Hzf=RSx`޹<7JZn߹lKe x}'qe9_9[.g:oKbc̴μ/'O zv>\J\K7XVg5&l mO!%7 w=4f({Whl R1$Ø _^o+Yz\|lt:M\īX;g%u?˵T9#Y&k XΛΏ/5DvgeQCqIFGWXw㯠pi[YWS EߠYN=Ⱦ[sr($W{ `7oⰟ"gCnFF%߀KIf{5n g$nZW$X)5bcw~pL<*͇}ǘ=CMY_tW;>aK+3HJѝt٭n{"$ Uph +mirw]~Vce1uS:ha3Gay,nlGԿG8L ݽ݆\G;gJ@KH]ho2+:˞6fU(zW,tԚ;DYAs pDX+NzNY?vboGa5욗1"Yǿ̭ C ~/1Ua3{s!H%ww>`{چV4jfh谿YG ;P3UE;j0Bb#-? Q삎FchoF_Z֨ıj2^+ ecuw'tLDk~k\Xa2y#}T%ފ8# m xDlð歨l~MܩH\VUGpl9fFhGUTd]䉯ۢoENß 9}l_u%tUր/'5~OUinm hH59-,G>F?#) i:uYj79If%עU<K5Dm䫾;2ϕhTlĔ=D9DE,?6A4" Q4N3]iDa5>'tn8` -]<\&\Yk42*o),7;8?^G#YgëD~˂ `4ѷ3?M8 +)yǏRTq|Dh!5@2V;(kZmseۣp3˞nOROUŴˎU[՜Sat5l*45Kfd\]Ƞs&]Cl%v*_rhYOOmnPƀF쀊tgk)mI-%g46#v+P*^߅rqK 﫜/δߏH VOP${id$roH,N fnG_OL$EHZģUSwI;BN`Nl8OY*Pq7aW.p>&O{>I'&=!z|x+`ϰ @lK\:D\% 5osw|sbbVwQ=t+mj ZzzMv>PaOnU7QK4RO|а ctIKdH-p؋n1#%^;)^Y֖h[0Jeæ!q@SU{y.h|]y\]lxwVcMbZj,ߚ.1 !3QfTH:i0 U#4GQS>IVO7pW1G!`p lVsQ%G+O,Hor3fh( ^95@kd95$d'e7ǎ}Jr|Q'U3It!v譎nV.Qb퐛Cb>ˣl7hn75-$W8.w?9qsl_/]yy|OW߭+ l%ew e2L.]YA ;E܏~AmUt ߔ~Ǣ\qw<>)2OSnc}I GV֊<9'j;HjX\m3C@GVw'IٰJʈN$в5Crދ/Bze[+By]Zi 1Ve?c&gfbcZG{_rUltDi+o[:ɜ5UtTpQ %$~i$==s \XҜbE7PςR fb\~#}>v]ơ佲[sKkce ɓ1H_|x#QR}LFɥ|~iљ V\o⊬!n 0''+59 AEun1xVpG Fv>Ɵx5+Mi7G\C5q cTI@.Oc޸iTcsIm'Դ7U\%2c8ln[KuCҢvalx`#$O]2߈BOL=9MvYKQE,΂?/j::g8, ߉^;ׄ5s3]\D'9{GK䶨sbt?yFQe#ss!}Ξ(E+> ҁ+ CddAajd4i*3 ;굎?L|UIȚ۪4nM' 33 u@VxɌ䝚({EՃ/S EWᒚ2 kO~Մsά1_ \"V-c M`&IZ|⵴aZ٫0'wBElAUrBR<_5--2u~HĹ䤪06kX?yx{,ݣS0:蹴*LzGDl4␥1oLmI Wӿa]Qa-zH[m4E&xAT`ialӏ@tYtS2* c'RKkpƚaq!q|&W !+f VN OTumK=TN y[b0Lfno/7T=8ŎDbU0L_1-fg@>^Kʘl9 .*pO_qm&mFs#qhkzJˎ'B'Y53#sL`^8pCܢE>{\NٳSxx>D7#%eσXk M vlWݬ}Vf+R--Dq<=C%IcO({x`iuB1)zD4w)ثe%rfَ/[Y "y Km ̂T,-fQKuY fP}UU61 *f`?ܔ{?g_a1SѦ|3%}%tfIK}^u MeH~zS Kdpe0}=,k]TB3L% UmE5;s>U5YJ`37p#!m08t!S >c8|Ƕ /x#DT*qg1]TWUllX-=('agꃀ TCD95@5m,-%xAbXm%l|ăq*/Hz֗R1uskuvә.OxE}K1''t W_'7c~sCZ̮W9'arӒ6Qn74BhrS%pM4Jg4OB[vh FtHC"giKh6wÓVV5>6#~#.ԯyzK8O&v&ĵ9a(pzjHs>qpJ[ޤk&ﲉiݬTҖ6 G&)Of8wOxljGg2J9mtYZSj< -sZD5s 3)+uŠ) fĀ E%ŮH[Q)KDKDBbk%~q}ԣ+C#'tr[r7 <7#s7N"'Rc`]4&I_)Z|;-ƝM@It7TAVԒ{!Ra>N4FAGk8k_eWjIm賚6Ejn'=eݜl3m^tCѩ$W6jKWxVaZ>-0W1:Lca΢_'wx+ibspWK89(?5& T2d].ǥ6, 9Ypo4ۄdhԯOY2ONfe4Iб7]nݏSe֫T pLl'T8y&oG&d&-i?)JMA{<'+^)ɠ Z ZǪ3:IٷXX }U;RJ72 2 \J,b\kPOJ۪TىnG":Q(.97j&{$#vw Ň^^'#7>.UZŗ^n>lz]3.kr -.SxsVhA6bZ ('A26odU =7A+bgbӓn$z67Ii_+7A3'@Y&~=Z?D扱x홶VYڭά8e.m=~TDH R⚖$QDt` ׋4t49&HExbS7~+[Z6bZpV*W-4F.$D7 ԷE!a_,/øWVDv&(zb44I#&较"泧Hǥ|Ppma TԎ &dS"BDIk4ͧGu~erO׭juܓm -+c=(1ك_VsStj᪋BE,wѕgb,˼'3!O71R?2k\tNo),E|ũ`n4!4:7"yfw678o&nSi_(i@hMBS5 &,P@gT- "|nʃ*fxZc]v YUV*k_O1jNDk-Y(*4pE\i}Rz;!t'50ǪL;v83c7*mOA釄,Sl: Hi˛IgIyoPz?PBMRI#E2q"Zso2Y?5~.SXqyTN5lʎԋg2i6j=]=^,Zɟ/_Q}\KδlВm%˓+8QOٙe%9Mo54P]V; M@ԉ@ly P@j\ݐzW[/2Ұys-S@j{$pouk|>kk4HGtY ܁bsl#XhS+X<6c8a;2Ƿsrqv#%>6W0kmU8q|ž:dV={j:ǡQǎ?Bjhno-nʐFPh1TcHA+7 q#?^U\CFѐMr^9Tؠtg(ڴ1tuu=nz[Ŗڞmv)і[lOTbY%; FO 9JpTUYLgCUioK L0z_k"<9fBm2}tFUvji0ZxI5T iL=bPo9h@S(tVsGm&FLU7B#k$n)7],S$c\D ʀ)s%Q$$$z%uv (L=Wa0~1ˆF,ϊ1XSV<+O؇ 'M4ֿYg?bɩ]q=Ǣ/];v)4YLk$udTv A[?W:DZO1yۢAOtH7db CRyn!L>=8\r1ۓ}#I(}r c]ֱ>y賚00<8t 6EJ otǯ\|yph s.p:H[[֎ymh]L.VmmP#:HRSёlN%r >MI%iA}=T. L.%zYt+ͩ֐+B)(Z)k&l;3M-k[[g3A/6 ۇ (%_x0OYeZUdÌ:G yu5ĩKt#n?OXT^: \] ..qOU=UΗrte ܣ.9c{v7Wa4+,TLz*H5LّWپ'5r^i%u\ %5/Z4{0Qd"D|Pˌ _iIZ*3ƙ(1BO 1Bg#jWid#oh[ \A#0gLݒ#x) e @dYQHt2Px=U-ߜ?c,;uJaDèp A5TMj @z= 4:`PhH@HPraR1-& ( ö@mA1d2Gt7;J4R'". o*TcU|-`\Jy li'Y1<3]äC^T@䉾7$$If!vh5 5 5 #v #v :V l  t0<6,5 5 apyt-$$If!vh5 5 5 #v #v :V l  t 0<6,5 5 ap yt- $$If!vh5 552 #v #v#v2 :V l ``` t 6`1110,5 552 p111yt-$$If!vh5 552 #v #v#v2 :V l ` t 6` 10,5 552 p 1yt-$$If!vh5 552 #v #v#v2 :V l ` t 6` 10,5 552 p 1yt-$$If!vh5 552 #v #v#v2 :V l ` t 6` 10,5 552 p 1yt-$$If!vh5 552 #v #v#v2 :V l ` t 6` 10,5 552 p 1yt-$$If]!vh55#v#v:V l  t 6,55/ /  / Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If]!vh55#v#v:V l t 6,559/ / / /  Ba]pytT~T$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytPT$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytPT$$If!vh55$ 5~ #v#v$ #v~ :V l t06,55$ 5~ ytPT$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytPT$$IfX!vh585 5 #v8#v :V l  t06,585 aXpytjA$$IfX!vh585 5 #v8#v :V l  t06,585 aXpytjA$$IfX!vh585 5 #v8#v :V l t06,585 aXytjA $$If!vh5 552 #v #v#v2 :V l  t 6`0,5 552 pytz$$If!vh5 552 #v #v#v2 :V l  t 6` 0,5 552 p ytz$$If!vh5 552 #v #v#v2 :V l  t 6` 0,5 552 p ytz$$If!vh5 552 #v #v#v2 :V l  t 6` 0,5 552 p ytz$$If!vh5 552 #v #v#v2 :V l  t 6` 0,5 552 p ytz$$If!vh5 55#v #v:V l  tYYYYYYYYY0%,5 5apYYYYYYYYYyt;T$$If!vh5 55#v #v:V l  t 0%,5 5ap yt;T$$If!vh5 55#v #v:V l  t 0%,5 5ap yt;T$$If!vh5d 55#vd #v:V l  t 6`YYYYYYYYY0,5d 5pYYYYYYYYYyt;$$If!vh5d 55#vd #v:V l  t 6` 0,5d 5p yt;$$If!vh5d 55#vd #v:V l  t 6` 0,5d 5p yt;$$If!vh5(55p#v(#v#vp:V l  t06,5(55p/ pytvT$$If!vh5(55p#v(#v#vp:V l  t 06,5(55p/ pytvT$$If!vh5(55p#v(#v#vp:V l-  t 06,5(55ppytvT$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55p/ pytvT$$If!vh555#v#v:V l  t06,55pytvT$$If!vh555#v#v:V l  t06,55pytvT$$If!vh555#v#v:V l t06,55ytvT$$If!vh555#v#v:V l  t06,55pytvT$$If!vh555#v#v:V l t06,55ytvT$$If!vh5b5h 5d #vb#vh #vd :V l     tI}I}I}0.6,5b5h 5d / apI}I}I}ytjA$$If!vh5b5h 5d #vb#vh #vd :V li  t0.6,5b5h 5d apytjA$$If!vh5b5h 5d #vb#vh #vd :V lW  t0.6,5b5h 5d apytjA$$If!vh5b5h 5d #vb#vh #vd :V li  t0.6,5b5h 5d apytjA$$If!vh5 5 5 #v #v :V l ``` t33306,5 5 ap333yt;$$If!vh5 5 5 #v #v :V l ` t 06,5 5 ap yt;$$If!vh5 5 5 #v #v :V l ` t 06,5 5 ap yt;$$If!vh5 5 5 #v #v #v :V l ``` t33306,5 5 5 ap333ytjA$$If!vh5 5 5 #v #v #v :V l ` t 06,5 5 5 ap ytjA$$If!vh5 5 5 #v #v #v :V l ` t 06,5 5 5 ap ytjA$$If!vh5 5 5 #v #v #v :V l ` t 06,5 5 5 ap ytjA $$If!vh5r 55^ #vr #v#v^ :V l  t 6 "06,5r 55^ / e4pytjA$$If!vh5r 55^ #vr #v#v^ :V l[  t 6 "06,5r 55^ e4pytjA$$If!vh5r 55^ #vr #v#v^ :V l  t 6 "06,5r 55^ e4pytjA$$If!vh5r 55^ #vr #v#v^ :V ln  t 6 "06,5r 55^ e4pytjA$$If!vh5r 55^ #vr #v#v^ :V ln  t 6 "06,5r 55^ e4pytjA$$Ifj!vh5d5 5 #vd#v #v :V l  tYYYYYYYYY00,5d5 5 ajpYYYYYYYYYytjAT$$Ifj!vh5d5 5 #vd#v #v :V l  t 00,5d5 5 ajp ytjAT$$Ifj!vh5d5 5 #vd#v #v :V l  t 00,5d5 5 ajp ytjAT$$Ifj!vh5d5 5 #vd#v #v :V l  t 00,5d5 5 ajp ytjAT$$Ifj!vh5d5 5 #vd#v #v :V l  t 00,5d5 5 / ajp ytjAT$$Ifj!vh5d5 5 #vd#v #v :V l  t 00,5d5 5 / ajp ytjAT$$If!vh5(55$ #v(#v#v$ :V l  t06,5(55$ / pyt&^kT$$If!vh5(55$ #v(#v#v$ :V l^  t 06,5(55$ / pyt&^kT$$If!vh5(55$ #v(#v#v$ :V l^  t 06,5(55$ pyt&^kT$$If!vh5(55$ #v(#v#v$ :V l^  t 06,5(55$ pyt&^kT$$If!vh5(55$ #v(#v#v$ :V l^  t 06,5(55$ / pyt&^kT1$$If!vh5555#v#v#v:V l  t(֛֛֛֛0.6,555/ ap(֛֛֛֛yt&^kT+$$If!vh5555#v#v#v:V l41  t(0.6+,555ap(yt&^kT+$$If!vh5555#v#v#v:V l4g  t(0.6+,555ap(yt&^kT9$$If!vh5555#v#v#v:V l4^  t(0.6+,555/ ap(yt&^kT9$$If!vh5555#v#v#v:V l4U  t(0.6+,555/ ap(yt&^kT+$$If!vh5555#v#v#v:V l4C  t(0.6+,555ap(yt&^kT+$$If!vh5555#v#v#v:V l4U  t(0.6+,555ap(yt&^kT+$$If!vh5555#v#v#v:V l4C  t(0.6+,555ap(yt&^kT$$If!vh55 5 #v#v #v :V l ``` t1110@,55 5 ap111yt;=T$$If!vh55 5 #v#v #v :V l  t 0@,55 5 ap yt;=T$$If!vh55 5 #v#v #v :V l  t 0@,55 5 ap yt;=T$$If!vh55 5 #v#v #v :V l  t 0@,55 5 ap yt;=T$$If!vh55 5 #v#v #v :V l  t 0@,55 5 ap yt;=T$$If!vh55 5 #v#v #v :V lC  t 0@,55 5 ap yt;=TY$$If<!vh55 555j#v#v #v#v#vj:V l&  t20t"6,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l41  t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4   t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555ja<p2yto.~f$$If<!vh55 555j#v#v #v#v#vj:V l4*  t20t"6++,55 555ja<p2yto.~$$If<!vh55 555j#v#v #v#v#vj:V l4i  t20t"6++,55 555j/ / a<p2yto.~t$$If<!vh55 555j#v#v #v#v#vj:V l4*  t20t"6++,55 555j/ a<p2yto.~t$$If<!vh55 555j#v#v #v#v#vj:V l4W  t20t"6++,55 555j/ a<p2yto.~t$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555j/ a<p2yto.~t$$If<!vh55 555j#v#v #v#v#vj:V l4  t20t"6++,55 555j/ a<p2yto.~$$If<!vh5 5 5#v #v #v:V l$  t06,5 5 5/ a<pyt$$If<!vh5 5 5#v #v #v:V l @ t 06,5 5 5a<p yt$$If<!vh5 5 5#v #v #v:V l @ t 06,5 5 5a<p yt;$$If2!vh555 5;58#v5#v #v;#v8:V lh ```` t(33330<6,555 5;58a p(3333yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T9$$If !vh5G5 515#vG#v #v1#v:V l4  t(0<6+,5G5 515a p(yt;=T9$$If !vh5G5 515#vG#v #v1#v:V l4  t(0<6+,5G5 515a p(yt;=T9$$If !vh5G5 515#vG#v #v1#v:V l4  t(0<6+,5G5 515a p(yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If !vh5G5 515#vG#v #v1#v:V l4 t0<6+,5G5 515a yt;=T$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytJWT$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytJWT$$If!vh55$ 5~ #v#v$ #v~ :V l t06,55$ 5~ ytJWT$$If!vh55$ 5~ #v#v$ #v~ :V l  t06,55$ 5~ pytJWT$$If!vh5N 55#vN #v:V l  t 6`YYYYYYYYY0,5N 5pYYYYYYYYYyt"$$If!vh5N 55#vN #v:V l  t 6` 0,5N 5p yt"$$If!vh5N 55#vN #v:V l  t 6` 0,5N 5p yt"$$If<!vh55@ 55#v#v@ #v:V lh ```` t(333306,55@ 5a<p(3333ytq$$If<!vh55@ 55#v#v@ #v:V l4 t06+,55@ 5a<ytq$$If<!vh55@ 55#v#v@ #v:V l4 t06+,55@ 5a<ytq$$If<!vh55@ 55#v#v@ #v:V l4 t06+,55@ 5a<ytq'$$If<!vh55@ 55#v#v@ #v:V l4  t(06+,55@ 5a<p(ytq'$$If<!vh55@ 55#v#v@ #v:V l4  t(06+,55@ 5a<p(ytq'$$If<!vh55@ 55#v#v@ #v:V l4  t(06+,55@ 5a<p(ytq$$If<!vh55@ 55#v#v@ #v:V l4 t06+,55@ 5a<ytq$$If<!vh55@ 55#v#v@ #v:V l4 t06+,55@ 5a<ytq$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ /  / yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If!vh558 5D 5t#v#v8 #vD #vt:V l 6`6,558 5D 5t9/ / / /  yt1$$If<!vh5 5~ 52 #v #v~ #v2 :V l  t0<6,5 5~ 52 / a<pytK($$If<!vh5 5~ 52 #v #v~ #v2 :V l ` t 0<6,5 5~ 52 a<p ytK($$If<!vh5 5~ 52 #v #v~ #v2 :V l ` t 0<6,5 5~ 52 a<p ytK($$If!vh5%5n5#v%#vn#v:V   tM6,5%5n5/ /  / 22 l4 apyt=T!$$If!vh5%5n5#v%#vn#v:V   tM6,5%5n5/ / / /  22 l4 apyt=T$$If!vh5%5n5#v%#vn#v:V  tM6,5%5n5/ / / /  22 l4 apyt=T!$$If!vh5%5n5#v%#vn#v:V   tM6,5%5n5/ / / /  22 l4 apyt=T$$If!vh5%5n5#v%#vn#v:V  tM6,5%5n5/ / / / / 22 l4 apyt=T!$$If!vh5%5n5#v%#vn#v:V   tM6,5%5n5/ / / /  22 l4 apyt=T$$If!vh5555#v#v#v:V l t06555ayt.$$If!vh5555#v#v#v:V l t06555ayt.$$If!vh5555#v#v#v:V l t06555ayt.$$If!vh5O5 5 #vO#v #v :V lJ  t 6`| 06,5O5 5 pyt_$$If!vh5O5 5 #vO#v #v :V l t 6`| 06,5O5 5 yt_$$If!vh5$5[ 5 #v$#v[ #v :V lC  tPPP6,55 5 / /  / apPPPyt.$$If!vh5$5[ 5 #v$#v[ #v :V l,  t6,55 5 / /  / apyt.$$If!vh5$5[ 5 #v$#v[ #v :V l  t6,55 5 / / / /  apyt.$$If!vh5$5[ 5 #v$#v[ #v :V l  t6,55 5 / / / /  apyt.$$If<!vh5 5 5$ #v #v$ :V l  t0<6,5 5$ / a<pyt1$$If<!vh5 5 5$ #v #v$ :V l  t0<6,5 5$ a<pyt1$$If<!vh5 5 5$ #v #v$ :V l  t0<6,5 5$ a<pyt1$$If!vh555 #v#v#v :V l  t 6`J06,5&55 / pyt$$If!vh555 #v#v#v :V ll  t 6`J 06,5&55 pyt$$If!vh555 #v#v#v :V ll  t 6`J 06,5&55 pyt$$If!vh555 #v#v#v :V ll  t 6`J 06,5&55 pyt$$IfX!vh5U 5 5 #vU #v #v :V l  t06,5U 5 5 aXpyt,\'$$IfX!vh5U 5 5 #vU #v #v :V l  t 06,5U 5 5 aXp yt,\'$$IfX!vh5U 5 5 #vU #v #v :V l  t 06,5U 5 5 aXp yt,\'$$IfX!vh5U 5 5 #vU #v #v :V l  t 06,5U 5 5 aXp yt,\'$$If !vh5V5# 5H #vV#v# #vH :V l$  t06,5V5# 5H / a pyt"ZT$$If !vh5V5# 5H #vV#v# #vH :V l4  t 06++,5V5# 5H a pyt"ZT$$If !vh5V5# 5H #vV#v# #vH :V l4  t 06++,5V5# 5H a pyt"ZT$$If !vh5V5# 5H #vV#v# #vH :V l~  t 06,5V5# 5H a pyt"ZT$$If!vh5 5#v #v:V - t06,5/ / / / 34-yt^T$$If!vh5 5#v #v:V - t065/ / / / 34-yt^T$$If!vh5 5#v #v:V - t065/ / / / 34-yt^T$$If!vh5 5#v #v:V - t065/ / / / 34-yt^T$$If!vh5 5#v #v:V - t065/ / / / 34-yt^T$$If!vh5 5#v #v:V - t065/ / / / 34-yt^T;$$IfX!vh5555x#v#v#v#vx:V l  t(0 6,5555x/ aXp(yt5$$IfX!vh5555x#v#v#v#vx:V l4  t(0 6+,5555xaXp(yt5$$IfX!vh5555x#v#v#v#vx:V l4W  t(0 6+,5555xaXp(yt5$$IfX!vh5555x#v#v#v#vx:V l4  t(0 6+,5555xaXp(yt5$$IfX!vh5555x#v#v#v#vx:V l4  t(0 6+,5555xaXp(yt5$$IfX!vh5555x#v#v#v#vx:V l4w  t(0 6+,5555xaXp(ytg$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l t20g6,5 5# 555/ aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l41  t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4   t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4  t20g6++,5 5# 555aXp2ytf$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4  t20g6++,5 5# 555aXp2ytt$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4  t20g6++,5 5# 555/ aXp2ytt$$IfX!vh5;5b5q5?5#v;#vb#vq#v?#v:V l4  t20g6++,5 5# 555/ aXp2yt$$If!vh555#v#v#v:V <  t6,555/ /  / 22 l4 apyt/T$$If!vh555#v#v#v:V  t6,5559/ / / /  22 l4 ayt/T$$If!vh555#v#v#v:V  t6,5559/ / / /  22 l4 ayt/T$$If!vh555#v#v#v:V  t6,5559/ / / /  22 l4 ayt/T$$If!vh555#v#v#v:V  t6,5559/ / / /  22 l4 ayt/T$$IfX!vh5 52 5 #v #v2 #v :V l$  t06,5 52 5 aXpyt$$IfX!vh5 52 5 #v #v2 #v :V l  t 06,5 52 5 aXp yt$$IfX!vh5 52 5 #v #v2 #v :V l  t 06,5 52 5 aXp yt$$IfX!vh5 52 5 #v #v2 #v :V l^  t 06,5 52 5 aXp yt$$IfX!vh5 52 5 #v #v2 #v :V l  t 06,5 52 5 aXp yt$$If!vh5(55p#v(#v#vp:V l  t06,5(55p/ pyt[ST$$If!vh5(55p#v(#v#vp:V l  t 06,5(55p/ pyt#xT$$If!vh5(55p#v(#v#vp:V l  t 06,5(55ppyt#xT$$If!vh5(55p#v(#v#vp:V l  t 06,5(55p/ pyt#xT$$If!vh5 5p5 #v #vp#v :V lb  t 6` 06,5 5p5 apyt,\'$$If!vh5 5p5 #v #vp#v :V ly t 6` 06,5 5p5 ayt,\'$$If!vh5 5p5 #v #vp#v :V ly t 6` 06,5 5p5 ayt,\'$$If!vh5 5p5 #v #vp#v :V ly t 6` 06,5 5p5 ayt,\'$$If!vh5 5p5 #v #vp#v :V ly t 6` 06,5 5p5 ayt,\'$$If!vh5(55p#v(#v#vp:V l  t06,5(55p/ pyt~9eT$$If!vh5(55p#v(#v#vp:V l  t 06,5(55p/ pyt~9eT$$If!vh5(55p#v(#v#vp:V l  t 06,5(55p/ pyt~9eT$$If!vh5(55p#v(#v#vp:V l  t06,5(55p/ pytOxT$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55p/ pytOxT$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55ppytOxT$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55ppytOxT$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55p/ pytOxT$$If!vh5|55p#v|#v#vp:V l  t06,5|55p/ apytl{T$$If!vh5|55p#v|#v#vp:V l^  t 06,5|55p/ apytl{T$$If!vh5|55p#v|#v#vp:V l^  t 06,5|55papytl{T$$If!vh5 5` 5P #v #v` #vP :V l  t06,5 5` 5P apytBT$$If!vh5 5` 5P #v #v` #vP :V l^  t 06,5 5` 5P ap ytBT$$If!vh5 5` 5P #v #v` #vP :V l  t 06,5 5` 5P ap ytBT$$If!vh5 5` 5P #v #v` #vP :V l^  t 06,5 5` 5P ap ytBT$$If<!vh5!#v!:V ly  t 0!6,5!a<p yt1$$If<!vh5151515151515151#v1:V lL  tP0!6,51551a<pPyt1kd$$IflLִ2 c' X$11  tP0!6    44 la<pPyt1$$If<!vh5151515151515151#v1:V l t0!6,51551a<yt1$$IfX!vh585p5 #v8#vp#v :V l  t06,585p5 / aXpyt!_$$IfX!vh585p5 #v8#vp#v :V l^  t 06,585p5 / aXpyt!_$$IfX!vh585p5 #v8#vp#v :V l^  t 06,585p5 aXpyt!_$$IfX!vh585p5 #v8#vp#v :V l^  t 06,585p5 / aXpyt!_$$IfX!vh5 552 #v #v#v2 :V l~  t06,5 552 aXpyt)8[$$IfX!vh5 552 #v #v#v2 :V l^  t 06,5 552 aXp yt)8[$$IfX!vh5 552 #v #v#v2 :V l^  t 06,5 552 aXp yt)8[$$IfX!vh5 552 #v #v#v2 :V l^  t 06,5 552 aXp yt)8[$$If<!vh5 5+ 5 #v #v+ #v :V l  t065 5+ 5 a<pyt"Z$$If<!vh5 5+ 5 #v #v+ #v :V l t065 5+ 5 a<yt"Z$$If<!vh5 5+ 5 #v #v+ #v :V l t065 5+ 5 a<yt"Z$$If<!vh5 5+ 5 #v #v+ #v :V l t065 5+ 5 a<yt"Z$$If<!vh5 5+ 5 #v #v+ #v :V l t065 5+ 5 a<yt"Z$$If<!vh5 5+ 5 #v #v+ #v :V l t065 5+ 5 a<yt"Z$$IfU !vh5T 55#vT #v#v:V l  t06,5T 55/ aU pyt1T$$IfU !vh5T 55#vT #v#v:V lp  t 06,5T 55aU pyt1T$$IfU !vh5f 55#vf #v#v:V ly  t 06,5f 55aU pyt1T$$IfU !vh5f 55#vf #v#v:V l  t 06,5f 55aU pyt1T$$IfX!vh5%55 #v%#v#v :V l  t06,5%55 aXpytgt#$$IfX!vh5%55 #v%#v#v :V l^  t 06,5%55 aXp ytgt#$$IfX!vh5%55 #v%#v#v :V l^  t 06,5%55 aXp ytgt#$$IfX!vh5%55 #v%#v#v :V l^  t 06,5%55 aXp ytgt#$$IfX!vh5%55 #v%#v#v :V l^  t 06,5%55 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l  t06,5Q5p5 aXpytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#$$IfX!vh5Q5p5 #vQ#vp#v :V l{  t 06,5Q5p5 aXp ytgt#;$$If<!vh559 55#v#v9 #v#v:V l  t(0X 6,559 55/  a<p(yt"Z3$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/  /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4^ `` t0X 6+,559 55/ /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4^ `` t0X 6+,559 55/ /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4^ `` t0X 6+,559 55/ /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4. `` t0X 6+,559 55/ /  /  a<pyt"ZA$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/ /  / /  a<pyt"ZA$$If<!vh559 55#v#v9 #v#v:V l4L `` t0X 6+,559 55/ /  /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/  /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/ /  /  a<pyt"ZA$$If<!vh559 55#v#v9 #v#v:V l4p `` t0X 6+,559 55/ /  / /  a<pyt"ZA$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/ /  /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/  /  /  a<pyt"Z3$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/ /  /  a<pyt"ZA$$If<!vh559 55#v#v9 #v#v:V l4 `` t0X 6+,559 55/ /  /  /  a<pyt"Z$$If!vh55@ 5 #v#v@ #v :V l4  t06,55@ 5 af4pytl{$$If!vh55@ 5 #v#v@ #v :V l  t 06,55@ 5 ap ytl{$$If!vh55@ 5 #v#v@ #v :V l^  t 06,55@ 5 ap ytl{$$If!vh55@ 5 #v#v@ #v :V l  t 06,55@ 5 ap ytl{$$If!vh55@ 5 #v#v@ #v :V l  t 06,55@ 5 ap ytl{$$If!vh55@ 5 #v#v@ #v :V l  t 06,55@ 5 ap ytl{$$If!vh5(55p#v(#v#vp:V l  t06,5(55papyt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5(55p#v(#v#vp:V l^  t 06,5(55pap yt$$If!vh5~55 #v~#v#v :V l  t06,5p55 apytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$If!vh5~55 #v~#v#v :V l{  t 06,5p55 ap ytO$$IfJ!vh5F5$ 5 #vF#v$ #v :V l  t06,5F5$ 5 / aJpytA@$$IfJ!vh5F5$ 5 #vF#v$ #v :V l  t 06,5F5$ 5 / aJpytA@$$IfJ!vh5F5$ 5 #vF#v$ #v :V l  t 06,5F5$ 5 aJpytA@$$IfJ!vh5F5$ 5 #vF#v$ #v :V lr  t 06,5F5$ 5 aJpytA@$$IfJ!vh555u#v#v#vu:V l  t06,555u/ aJpytA@$$IfJ!vh555u#v#v#vu:V l{  t 06,555uaJpytA@$$IfJ!vh555u#v#v#vu:V l{  t 06,555uaJpytA@$$IfJ!vh555u#v#v#vu:V l{  t 06,555uaJpytA@$$If!vh55 5 #v#v :V   t6,55 / /  / 22 l4 aJpytA@$$If!vh55 5 #v#v :V -  t 6,55 / / / /  22 l4 aJp ytA@$$If!vh55 5 #v#v :V -  t 6,55 / / / /  22 l4 aJp ytA@$$If!vh55 5 #v#v :V -  t 6,55 / / / /  22 l4 aJp ytA@$$If!vh5 5 5 #v #v #v :V l  t0<6,555/ apytq$$If!vh5 5 5 #v #v #v :V l^  t 0<6,555/ apytq$$If!vh5 5 5 #v #v #v :V l^  t 0<6,555apytq$$If!vh5 5 5 #v #v #v :V l^  t 0<6,555apytq;$$If<!vh5 5+55#v #v+#v#v:V l  t(0X 6,5 5+55/ a<p(yt"Z$$If<!vh5 5+55#v #v+#v#v:V l1  t 0X 6,5 5+55a<pyt"Z-$$If<!vh5 5+55#v #v+#v#v:V l  t(0X 6,5 5+55a<p(yt"Z-$$If<!vh5 5+55#v #v+#v#v:V l  t(0X 6,5 5+55a<p(yt"Z$$If<!vh5 5+55#v #v+#v#v:V l  t 0X 6,5 5+55a<pyt"Z$$If#!vh5!5 5 #v!#v :V l-  t 06,5!5 a#p yt)T$$If#!vh5!5 5 #v!#v :V l-  t 06,5!5 a#p yt)T$$If#!vh5!5 5 #v!#v :V l-  t 06,5!5 a#p yt)T$$If!vh5 5 5 #v #v :V l  t06,5 5 / apyt$$If!vh5 5 5 #v #v :V l-  t 06,5 5 ap yt$$If!vh5 5 5 #v #v :V l-  t 06,5 5 ap yt$$If!vh5 5 5 #v #v :V l-  t 06,5 5 ap yt$$If!vh5 5 5 #v #v :V l-  t 06,5 5 ap yt;$$IfJ!vh55v5"5 #v#vv#v"#v :V l  t(0J6,555p5@ / aJp(ytA@$$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ / aJp(ytA@$$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ / aJp(ytA@$$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ / aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@ $$IfJ!vh55v5"5 #v#vv#v"#v :V l^  t 0J6,555p5@ aJp(ytA@sDd2j  FA?Picture 1"`-@q2|T@=`-@q234~*Wx}pםF8qW'IeVU\`F\q|6r՚1k⬁uG\%@Q%{Svb+FHSA߭&\k&uy{g4 ! zݯ_~~L^^޷J~^^g쳼ƼK!/$:/3yo0o).;( ;U].ysy6B"!uVοm~q^vT]R'i" ? Տ +pnHußuY^D.hՀy7jBWWRp2 7jj0 9zˆbt xTNJ7 ha\\ dрYf5f4{ڬ3.VrW\/=ʱX5-I^~Nw_B{wj|р'\9 yy쟽{eMxnp5j`~i4Rq#03z?>:$^ sQmy/]-> 溳C_ROྦo4-prv+"Ҁa>o~qO]'UBI"S332ue AEwB]v"Q>G1ǥN~QJ1cҦks8^rNzr]>/D^݉wJ!3eU`y0dfiZ}B -*L\ov."LLfdi5zxo;Ga $#GO2ag&*.[]X⨓^.SFvԙY2 $= ?1[zeǓq'%"gaxI_+iܓ'+NƨOyL%%k#K^aҢ/M3E̸IŎ7 -zL^".c[*Αe8"~?*3% ]癊;aw*CZ%5K.="d(us.1Hf>e|I6f]{B؎bFLKI;TITlr%\'d4cx`irZBfHէ0`ɖ΍grSB淆קf~oπH˞n$@nz_NO$cDÞ4Ϝ{Y:dB*gE P(tgD+RjrAd2~׏NIK_n멫XFT/i-j-W\.=yScvJ%& BvSgr<?};v\e)Sv ˜ UdG'eĠZY!$9ٴRvXcN]ǰ]pɞom%bt9Rg'+WEb%)*i~&@]2CM)', nRn|BF6R@.1i2oV ޞ~TЧ3xA}P؟7:Gq "N3H^َ1@"5;_?Fjq`,Ϯ/UĽýoi=atkOtK?ox~$dH<5|׿Ӿ|yg~jc`sܪ?xn#+66s$=OQ]-:ΐfᦟ=LhO]V}Mζ2{c\uCm~܃v] 9}=t\&,0Ń -|O([Z^|8Ӓ>+Oy@leߎ?0V FE]&M٦Ԇ{F3ɧ_CX&cCѓR+:xtJYhɵ]zUfXi|i>|cF/S_[h]ԇw }2z؈9~ċXBG%JI{,)e<_ɻdiwZ+E MCT$# TkץߨlC MQlwN)-LeVMlt|_2ΟO >>hd_x`k"'K)Kb5\W'}I#E)9sb{}~\^I8%4,{θoU%}dk ZNƍryJb(dPuxy6E<@˽}SWŌg4˔e&Eŗ?3-ri|r 1G<,mcWF,z\KʱhxY&\ 蚆o.tW [=2x'KuW5z5?lCh]lcq}!~?>@g}{`h{`O_=΅f6g[=o]wZʋ^! Лj*z=v pQ/H7"74}e@Z>Xz嶏,I2naPRk:SOWO\~GΕ"R%hEgCoe@Qu VuE(] (L ?l\ЪM Z:ۮ:qkȲ>?!-FzɪBBњ yEX'N3h4QgZZoV~%-3׀)ydnxZ{httd7Q> #Wf{27-&l?m"[*8JZ9OB#zJۊߨ$%Aj.zLǖm3z"t^<ı1ę% `a^1N,Cl*M\fHT#e _ Dr"*І߀s:uŴk ܌geyoVPcgRf8-/Xn3k|o,LW猣C͎3W[ɕ^Y=<ۯnUñ屇*6Yn񢕯nU(o =fgtx7Dkhb+~TҎOѶ-ꂫ^PYrJHĜ/\m UǗR y)sL-O]+e0"V>h~^ep+ Xj(߀oR48t rK+?2z ?=+ķjt` lN|2L#Hݦ2:-b5WY?%f+Wm¾yK.$21i4Aؼ2R![R+?3*}S_ Ғ< 8(5ڳe%yEo@[lU=u;vN;%-\SϚCȞ+c{f0z"H̆ - fe }q[Ht|pކ^&Q +7u~dTD^'>".rf%A ʢCDM1(l=u4$<+sz~ҵK#ȢX>f/}~A/O֌cXE=(-aM(q&P ׃q7OX,2>kD5mU \OTTqNk%Vor"A)z+z|caS⛾s4W^|fi=IL&\$ K#7COQ:$mO=҂ 07A.f #CscIbY5m5,3ĊѾƵbrԩ_-?nYqH>31!"ǐ[V t!xᛐoxLڃu}هb$>0< Or}m/A%1"@7_@&>?\ybˠoj-{=djLYxgj|~Z/7?aMU~HVqOEs{nTWT$Z0+aM- /@Ia]T0SaUع+>\Ug@SAT%.PnQ,EpFڊ^NJ 'YAQs-?ܸSZZ ӷ}E^ =۴ s,ӲZ֞??}iyym[*+˲lUмJwߨd_87c@ ,O>w8;s.&G#" vria@Ubn5֣)j5OeqLJaO>aQv9l/.R0Ш{x@0Ϲ`?/G@@s6#yP6\TW(kCCnmku/ˢ.ZJfzWq1CZ&"ðr!+&n@̆p;<#Zjl3V>zg{6T $ ¬ 0m8P,:)@=- tVxkHiuAzb,]Ԥ'r|ɓo! D}#(l]org)Ғ})y}]CcIgDr%2tc'7^.[[ubu7} DC+Ͽv;Һ]ɂ*.^ӛe_Zґ6NR @{籷vMq COn(i!ɍ+WfF4(QGjS뷯*C;_ s& #{+U^ӷd D~ny>u`;TD*U<õv$sk+~WX]2=۵wb5M".Y|NWCE<^P8"M@1Eoc'g V{ƹ@$eoUĖ/3^ Aqw5uPax[%l5$fC{*I#\ AzgÞ-1һG*F]q#s &# O}/~oR.+Fkɴ/ txJLz]tݦRTrЦqeQ挃1i=X[kÿ; /ѿ}eB_ ߁w}>mDяBD&B_kv//Ec 3x%?4f<2X.>oI(F"Hh bL_~ްO]Ż _}J1zt׊RZ Fk-5k89^Ъ VlK8ZтJ$'-qgn^X*i2Zq͙eSid%vb.7 ɓGT;qG)/+DKL_JWEj$}JgEZDțTmj^EQT I$sTqSԘi.7(}.,ɳKԒumͻŪȖ{&}ddAU^qE19$}G9K҉PMO|ӗֿ{CƜ񝌰 0_4?7T#ljh{k(-f~*žsxX%9E$e˽ y1pIejRQ˗С+]n1}2 mEx[g s/|f mRfa>cc3^^gVKst J7= |_xfE^r&e D˳O^1zf"b6"/_n7֪xg<]\%~-'::Z[{q9#:yZhax7f8nٟs;zp_s|Hkzm3 9@A }l7RQ*s2Tb;y֋+XߨmvZ8YAZI yZ1|**("kKL?S)DLm'l;rDpf";l ZqŬokO#UG)ӿ~I("N?ӊv_S1 6/U+Gr*ƨ#%Ż/$єJMkjHzWb޻m-裌T]:V9: ~;D_ZLl^>@V ?GHB]gR[&l`pEƚevYKC[)O@ wDTˢm@Jb5I#yI٤^:9Q7*C,/!]@ 9{Ɋhr_Wg= fVŜ_-[$tC ?U4 (M '9ԌQd/~ k F;GN1K(N5|̨Ҏ9x?y'ZgG׀#&:c}b r~9=/݃WG>dO.)gZVx^lb&@yq!pŜ|>O=Q/;7j*ݒc5z.nTeJXNz|T7pw%hq@]TEJVD\;ʵX*A*˕,4)H)e>vl ,bORY TB l#~PJ-hoNLDqڒ!IM97˫N}bND{N^LoO,OeH3B`\Zݨδ#;#*Ŕ<<熹^&>UoIQiN1x8Xa+k,X-A).ԊP9l;aMy: ,6FX;\݁dG$a^y޴lTUǺ Y`?7#}Fҥ\:ZȖHV'3 qa{(K#eׯ&fSQE HDʢ\Y&J,A^)| ?-jcRɻ~FHlsf9 zMm*ZMg{nhaK=3ۍsձ3%X%u 귤'W#!ZwKEX38|2zdB͝? jZ ^(B6A'/ˁ3zkxJAsRv_!Fg6xj#}ZU^2 U䙊*¿! $ S"[u_RjZ&ݱfۉ5FgPKʱ{MlLS5=B᜿s~YXOĊ<,y(?2J/o؜ba×/9b'#3|>|z<>w㍘Qw8WXjce3BFn_ҿD~W—FWJZ\a}[eIj|&~1T$[üJFP暑l|ܤxdjZSB57hҿ$X>棇Ta@ ezfv;O`-, ),& 3nZ0*GI6X)' o1_A;;=klն$:&S'#{j`[Ž0 V[ H ,W;/u׋+ ҿ,@+Ėh1l6%8t=َg zE-鄈vKaa̢ҿ$-_Wz/Okb5Fփ;|#@ș7!eyJ w1B\-`PŞ;oxm+jp@Ϣmq}n1~|"6H¾#$53oxc<_lBV!k-gq5f7:5}}!k^RHs͕|Ң քO-+V?x׃7n=6+mҪ%Be+T5*K f=/l[7g(0_4A5p]C9[ىpT!b6|f{PBK|yL(=[_SMc~>L/ei6Yp"`h2x>DԳ*y |ݦ(zmH8χѰ'rӄO{9h $hU~2hݏw_Kp?W49V?Mk x-yL /4/rF^Z.Vd)'L}Wg6 n wVYE~>WG݁c~D]-Y|}BD~TV"nUrlޗJ֦ vkq&bJ̜g,G`l}̝cb>Tx|uatg8""g1,Zld Ks =z@rnяymeJ5tʖ—%xa~W{o)QTEhʧRA/=qfӸ LqX]\E# t2Ca_T_{#S"_?;Ad#ѾrCjPXNrn)j*9TO<+]vHv1 M&%=O_%i;D3J;{^B@%Elk Aoie,×L{^BY҇Gdl&$G.yQ8&_]wSv,++߿;\奜Ÿ/g__^?ЗDݠ_I; zr *$:ja8e^_6 gEF\;ڏyq)FJ'|iKE.kxJ>?vKY훉W1<8hBynQ^ ۂQT97ђu6@iE/ HR+Nk=6{x>[u$EWn^kw=Nn8g)E/J_,qyUW1LK 4-cV_YD}the3O-)/ I3 # CvrLBڇ&+`L!̞­N߲v1fka$N\$> & ~M(?Y)z@O&Yk/8_ !F; }*1T ==ڽK^3X p+qb«FAS >d/'AU[˕t_ͷG9I1ȶT'KR,eV`>i_.kdĺLuc#b{\K+VI;:Z|2qJ>0p*6mJu}5\ xvzkG%Rũ^̲<Pdd hZYJyw7Oa9Exd .wwdt졨ccߦ_YiYC ǙcRN3mLkě"gR#K뗮oGxX4\cVE5\*]JmZ߂_&RO$n@6jqE:̆ OKSzEj@UoQGYņOZ# JH2>7s%a5 GƊCO oބ/ƕ䮸AE܅5D7ס2F$Uym~Yos@Th Dhhu45*kFl\[,qLœ]u?B.ȳH=`sxf/C.8f!- mN< /5T,mrM djq坅lt%R3E靳HK22HܬKzxӔU h/ 07j/*l2e#y΃\B;8y^=JS)Y.vxs]~%D'l#5Ɨ{Ld! $Vl>2\y3Rr<9Pljلĕi!74YXIWGvikZ25Dr _z߮~y,n!WծIeYe_c!ݱZ][5 ځˈ]Vb?[ʖhߘ$R NQ:Vjp lؕk*IC<J:Ǘe/mCh+_8ǔǃN0%n,+kkׁ)EbRDJ2@F{x@k{RI2 ǘo<%BC*/W/c/v6V(suj+3Uo~t's}Q/F.Jx䐎z'4H ة^*J4@}eW&z2'V 3:6,~ߣ1UJ%ե1yMw'r Z[OdX>+CR-5gja֎/~3G\=[#]wS; _6Z2T %a!#+IΘEUDÇ3~5P?G#uX whY8+,󘵀'+.e5KHwYЧXC|9dϩ{U?DgG,[*-G]/̊_6Cj֒kdg4 :(v3O?ҷ ; (B-.| (8p5Ki')4u1QcqҥB;9EZZkxB#>P=9ճ ‹ ;[@/2빚˲qNP[DcZ5*7 =GI0[UQYTA|*p di׷DS.V'= EAxmpLklkϮ~nF˰4Zߚԗǰ|~ z؈ƹNRp7v0ܽJ_T[O6ԭ_')vLow7gݎ(i{}3pbQ6tŷRKNKP/r_j HPbul~f!MP˃33ixSEL2Cs$5u]Ul2$Ȏ0^7^sDWG(`wҺuhS7;PupD I;ċ^v'5LtKeyR7UT&FHMR!+G OP?!NRRj`\I:)C9#oLu,ɯe:>~؃#%uY$V^×Y:KCa^—r ~َЫeҞ^N*/mQ\͛—1>T\] _n_^N Fro)-8A}l+~9Y(rKq0i-E_!LeYI\(R cp,Pa]S;H'^UR]UzFDzZ2XTF4g!POcXyC=~~ry/%DspQI>@SIWv"eOnL/K+| y/С]1]ory˂-{~\\//fKznZ\Se(yko1S2IpKx&geWi0׼&Q)4I(HsmiD3#f 0hnx@v:ƈ9(] -ϒA{sie*oq˾%>C1*MH oɖS-},aֈw[锗OyZ}|6GmX#i_/G!v,i _z9Oӥ@/_WybX@po#T];OUAU-I/ !#=^VT6Ns#=i#ўNЁxp]Psoi%ZnZ!7E=tP)*,A(;ŗ oeAq0C͋XONv_Փ $GfM-c|yeˉ\ ]${:D;͡8|+,A*I\K`)TdNycfU-ֽ'nIoH 7} oI:z&Nqhѧ_l0E$x`&; :?U oO2] |R];&)KRT`Gg2:L:q5Sfl;B1F7ƗF/Br:F`OA‚d~9 )܀.]_o,Q*I:)RJhE Qcq͍Pn*$5 ⨍tM_9—.U^͓xM_Q× K#T6]qIu/H%`>qfd[1&L^jQ?)4|6s*nWa!=(.ǗSRj Z^5o']JCˀ(A;|h]^:1Y}Vq+w2 ?/_w٨s9)x؀ǁoy^3'Z_Śh=늬3 PQt|6tܻ,i>͡l׮vCYSP-VL`Z3C7JGtn+bMVH8փ񗯏wʪP+*oP\*~7 ZRI[/~ :E#U,^ Wr!) >3`SQ 11J -Lꠍ!$߄j N=_D̩藣c{G}(]`-zY%Z]aX[-eG* \7>NqU^'<_-挷*>R?'Z"4*C%hJ>v%2KK* ~er?L){Nu"#VVԕ1%~Գ^W1?!I|*l1^PVo _zK~pPlHKu֢'+.}l3'Yf:5.G%KOeYs}7j953>xBo9|/n/_!i=}ׇuMbw: c;TzxD{K֓xϻ'R-q4sA!oGߢ P:&^Vߢq`|k5'[p3QѴۯ)*W2; < oo}r߁a"+`m5 PwQzR{v&=ۄ7PQW.g|yz'v8pI'Mkkuk+ 7or-^|r^e_[z@S+wOɻt\f7-q+x-iߴQ%I>@l_jLҸuVMJdaȾ\'PވS9,`/Kg/`t՗̾%՟Hu3K8ա;LM߭EG˺~rO8\LvV6zf:EQD-mp_Vz{T쪫IA4GTtT2KKlw{v×'1alJ;2>ߧ6G`_*_=k[8at{{ՈQxD(hQ./!DLeϢo :%ߗ~G{k_MnY}MM:\*_qfӁ}[ )5ǖav$ĕU+67PKQ:8'C]~kP_{sZ<+V;cbi=kٝ@OVT8u/q}` /p?IE9Evt:,soqGZ1~UK>\:'Mڹ1}tZ-6Q!K}4;*,]Mc+V\оB},Lk[f*ͦƩ4-,$2v e%>1VY[j ˁ#fc4Ygni%Ȁ՟+=}yޛ,TOsjga#M `fʼڕߓ7>RgC{C=)O/}Bv~]a5كJkWlpTm8:g>P+x3'Z+>'IfÏaYEdx2K}ѬqmɠäяK %}i3-8i䪵me"#+٥x&ѷ㛵--Y?:+/!g:+wهSZy-DލieՀv4-|&+p@;RCtH|%BKϵԓoBi\r.R_BuB;[ g=FXKRiRLYxI8朇N'HVK) b!G=#@fW3'7*vY=JR6c,BBs ZqS_jr_b/J8$~9Sϳ?lbюUVAO*NT_'QN_VHpL˷Iܟ>Jއo΁wϔ?_;s~s˿([q#y̧qSevQ;d Sk O _ հ6 ~Y=?^{D5D+m[A*~mPaޣ/-s-d?iƭl|yl^?U\FÖy/iˀ$86V[ cjgFno^ 5V|Ͼ,r)`o?x vrYp҇4磝)]J9?y7^˔7_M\o$pvpq1xOPK<: kK)MKFJ_qM<RCfU'Q̜c@i~5FmAܞq6]&9O/sX_QsH!]w،1P)2^5wwh jomORp{U÷+ΛyUΗ\ 8_-XbjKCv+b!_&u= 3=rs[4r+ |ǵswFz$E2 ";#9w.cv. The/Sa@w8f;v/){>VK⎾Wl|?zLh#eɎm|YY:Y-Y 3o 4gΊrZ2Ljs$z=TCaK?Gف#F c~Y}3,ZXMrD)ny(eG*qX`.4/Ov7Bolzͯ¶AqVQ}K#IbuZ'$L*)$r<+J~y\Z8Ymri6ꍙYGTQYKlK2lh~nK|Ga R߼7([kforyjjw/o-BM%ǃXo&1ߧ N: v_1&^a>Cc^'fKqIJi+^ֱރqvxwq8`lwcZ'/M{ⓕN:΋|` UsOǗ5_rE=5e#/la%ۓucxDɗ9ǣ~!Li/m"\G/c bV9e8gKsU2{_*EQiTߍ߉(r+\77o.$(dsh2@na#sUsLcTQj΋8Trؿ-@zJ*=U4^/.Ky.QGU—Z$v/3x3Ou!=801y3{jxsϸ3}s%2~>Fjz Axvwk9e *TzF"nT%&z=Zz$2իܾzf ~!L[6nScKqK,ư?"o5w}^ҡ~v2A杖NeݒҌwܙAVKґoD*?1Z ~,ܴ 8; ߚϼWTρ>͟|.OFo U|A|zGh4L7'_UXǗt̵BV0.éd~e2[R1ɥc_.j[MҨlc/6ef5hӀO͠d߲ܻ]s/B).\b/9[Ή/g/SrzkIbs{ug<2c\ޟXO[rI頥xN-1T2[ݡ&F0-ʌl94K$<)rPwkW{Yky_> ^fQwhXU7iq/zg/&)SМ$,`Gx-UdZJK×هI8v ME?_b|:%z(xץOk L['].rt~ާͳVRl] y񽵴65Hb0.JTEzƁ_U|4eYzɞmґ鞰\+Vyw!(WmcOuQ{p\AmDVsR\GeNCQ&r2F9Ko=^=׳wzXyh{ODmc܋YׅW^&ym /"l[[I9?3 6ocW\?[Li!{,xĒ$WMCv@D.s{$U>eANs?sLQv_tNԕ$MVmTWz%/7"iKo/e—V9%>s!*.3c3pL+#ҮũVIFWx |!cw?ٚLĝ_44+ӱqmAear<6/}^.2HJ/<|ąbݶGsp}Q|I$X/\ϾU$$Խ /\~Cs/{:///cgڷ;-Ԗl VlPkA GٯAR!z,@>a\s㹎>㝡(0Qju/7& 4,܋u62~9gcn)kׇ[Y}gxj=GK:l<*ĞX~Vf | ̱]X+z½>>sv2J=>ؘ- ~5ߛc1ƗfǪl?qhhvloT~kXFL>\7)y5vħu}u; XO=/m5F6]MB,䱽/-}5ws_ w6ܧ/~-;㹯Tޟ -y'~|pW9Ai&u#':,ٵB//!—:@Ze*\L5]8ME+WGZ8ΗTy\Sx/_{^GW~)y!KO|1S)g._l5o<*e@LKv~RC$P_K?_$jX>'g.?=\\a6՜tTk/KrZK|ORV^`gag?Vpݮ9U []~#{?:61 ciaEpFFZ>tdkK//9eѴnlfʄ)LY֒K0zr{΍k@ wO?(#ˊ/TG43bau. LjWi<D}V'.fB7!L|hf,Y/w#Gu{6aVv{Wv `)?npoK717@!-X77vD1s1 CBH)#M<"y~?Sկy?lVQ9SultRe=Cj%o'i/E~<LK^y? ?,q7h̘/gSٹY}@)~?Dλl}K=z3R( - :&S5=/ K*_"/_[^}3;|u ߂9xM*6ioQ+ /;5lA^Tg'>=ag5I&x%2mܝι[v޶ܿf8Se-._#-`ĉ6ˏ/~yϔ|䑍 [zi[ >*ߠPṮ|+F'aeˡ1_eyfhO Cb֫dQO6qoXe=*iӁzz,9E4&z&'%tMm+zw%qpiB|)lsT\[_NegoXYrɄ3J|_<ᵼ:>]VTP% !4o]޶p~!:쭅"b;Ѷn&}e97|FOݧ+e\trN مq|_QS_;* 8]=0R{[+\r4u2XUޑ8f]s^\>V+\~V~,g S?A,n S IWK4BFr|I0v+jL0UuIX$.;HR-=kl2Uz['=EZAԴjwlLc-nUХq{}cPh1 _VO/_20 Eg&%?>@J|l'Q` IN:s0v:}\sR֡O9jYdyW?ux+=sQIQ=(zZfF*e8fFr!d!? _vYu ֶ| !IΡP2-VhǗ;WzE?&{kcG]~"! K&h쿪_ʯHcaqD<;nq #Kb?9%8V*~_ ?3]t]CT<1rW.T)?ΆqMzk=`+4ǩMZx?Bp@@Np3wMBC쐻+ğcp:Ӥ/ѝ%ĝQ1|^;Qp4ݲiB'swId?_k٭#Om+T^6GX85kք1ta))Qcxdt_kQ"e"|9 <>bqy [;urDä~7zg\T|nsFJYė\#iL2-=2#[.)Wea3kI3LBk⹪B duc:%Y_32:z~TNkBNwV.ӳBO|L"]aOT~CKP&/g~HQR=_F}y|TrKCXM(1K:&:G,.{kK?rĵE>v5˞'1D®M_/x\GN^q3x[qy}_"ݧ_ sM!vSP1ݱɼG\ė㻞ݶK<)7 Dw9#OfB-c=TiPj=/e~}-/̋b Y㑖/]n>߷LOc+A~l^+8.zl1Ue{v*3Xse?T_(wXCϬmkuO Zuaىx\?|!;!@@H9үJ 0A χ ]KbA֧w>hh+w^sڊ/_J_m`8I[f27 G_=͍Șb٨n\eA>87.OA"CgñVvpߖ{ht^=`ϵ>L룊BER`\ q=rטguT; D|mpt @Ou|UH̤JE~6~/n|u_|O,?ҁ<՝_yY }*/zzs]4ʾ♫i{D8<6ǻb~縔ۘYS򖐧J"afsXE icoc7ְ/e_J,##q&d}DZj͐k~OO;2,26e$F77sff5;[wŠx) jv=lc:6f\znμ#(S@|皻=r~tc".YC;j)km8[/oyˮyh\=ټV/;4y-ӥ]*+y?|z]FOͳe/;#e]>NmWxc_s7V΍6aƤ{4G_ewyn.@zI+´o/%IvO;vz_j8rJ/VyE*J>KЂ(gFZz^rK}F_:|ywM̔IHܱӮﴅ=ƌAC^HqDn9y_"amN5b)" ×q/'t}ϝ}ҥM_-K=f-SO\eqK]9Pn-|@k@:g\K+.%ݛ[+:W<#/k'8y 6\]r}W/'_lXGeEq+B{3|%9N- 'EU{ePf /sG'FɃ(eQE(b0SRg,ŗ\G-Pn&&.Ϣ,z*ꌗ#'F~tvP,hQGD謫sW%57hWwxKRCV+GӉԒLS>'q3L֒%3w{^g/ҸeL>d37%N#ٲs:Խ/,>'Hd@G'Ƴ =;_wp0XI*t/K&<|ݫKFa6>(.>-0B ovٞ3j3kt?!Xo˭r𝉷^ɏ\z^^^n^ق#d"rWDѢ+rm6q=7g|ޤIFሄb&) ~1uF)cs|(n褲8_|Ĕ4|韯_W^X6`1F5,ri6(௥/z\O_/l|FG~g<2N_P5rgx0@7 /OW2l0`@͞Y/is9SɐFFzѳT4ֿN=?@>>1цz 0Z2o&*pY}W/Nް&Er[X֓ߗ)T͌}3BK*n[-푗ݒЖO5՗n8 hIsOM:ܶ܎}EI\mSN̛dV 9П^#U+/":hw2y5_QesRDqH&ЭUr h?S~QlQf<괨jd?h.i/d/ _ਂ=$Q j[l:5=畜) R_$b M-b4;_5\/A‹ڱ}.t EB6=NУTtaW|Ky 7,ápFec̓bWz_"-oԪʧˢ-jqi D]D[$ ^I[垑g hgeشEm=?l_Yq:fakjg;1f0\-X}$8@ 7cu/1~r1|iO]ۻQ:&[5R'F7Y+GCRY\ACP$Б11{LmS'DW +EOJT9×zxXLi˵ZayEi}:ygf !AƹVj/cU9v엕:([ 4v}6|t"=*hA"}\9=]KQZc8.jg^k͟N9gcQI1e~{I%=hfc=~ȕ/J%z&}*׫Q=E؍k/uGg:W8N=7 B:A.~lh8 zZts &=eD=<]z~r| &rj|`"<_i5δv4|3-S~]>v>5dq!'ʯc[~CT57pߍvo*Хkbs) Y[Ī0 9j=#uK$Ζ ]p 7/+—L7.nFҶ99U:_n^j=b\]OyTN;}Im$v<,nwY(f+̛K4/-t(JLeY mnt cGBjEILlpDrj1EǤm uMw:,MZ8#]Gvf4뫎amOJmāPtvWFt a]䣫/UBd+mOeG7 0È_BzY96){1ćl8שL,gne ?sPmk1mx6cuGGǵϝ,:qjXJZ!}>"0Ke gw- ctױ qÅWP_zm B <].^In]yW׸q=Zm l&׏gwmK26]N]7S)//qd<#f|WIb elm[O?T1vޑ>`۟_5tKl}UKAUB}Q?78D?C!+9˖EĀ2[oo~j%Bi굆G\ ֮Px"HRȪl/doȽ>z"o)[Lk`4߇R_:#))r4_*S(U~} mѬEIB]܅^SvKgQΌYi+㯣Μeo١a{Ues[D7<(Y/ AzPwfkg-4 rjuW^ɜ9)&Oid:|L{V=O& &~, f(u<pL}kU^\tgWope Gf*EwF*u+<ϭ>]::a򲻮ahnA?t&Pz}3%ُŋ66'^rCج#F+ /uaaxVNY9f5=\#L2])#YnNbaѡԤ,V|SqQ_1[J1J8KB )xZ =ވVQM 1޳}e?fD$ C+b_qu#_-ծ')#z,z;rL.=/+ėH&&ieXY; zlq"Yӫhݖk*/ۭ_JGmaJp9A"لLzlݨoY^neFRxzm]=#a&_3^plJ%xK/Β;>RN=#̤TfHx^-s}4RٟrX8? eT#CE%7 G&u?m'@$;39pV]̞'?:V(~Jwҵ˸e)u 0<>w+ WYA/uɽmF3}#:s\j2W䎩W+y!{X 7!/N ˂ݐF'Yrݙ>1ڬnjKUh-Y2RhOFJNdm# _:{ &4Ee$ZǸZojn!R]gp+ߟ)(Yl_Nwf<,PST_̙d֋4xs}X=Ϟlued۫#{/Om/ľ SfL4%ݧrD qBfV/T9YO-ȷ[xKm h97q&8~HЮq܊o:q;٬BLAl/7K^ 1=lS[.H%~ [$)3(%_G;- lע^Wؚ%E$&J'EPh|(/n^_Vbp fI}Fr/՛.V /Il_8$|)3[jg9ѧl?r/C|{mg*khEyC+UҒ܆|>?>97B O^K5wY+",] /mZ2=e^؈?kOKJ]Q^n#GY?u-@: rr3}]BcK@NfOÑ҃ӒtBBY<~9qY1:{NJ $q?tՅ VI^"F{a3 Byqg_J(i;K3G5'z˘)A5Ŕ \z[[5/HGğM}@j]pKĮn4eFE^ t@{Yx,0rs:;_}ZZK$")y ,$Ie7nLE&ėem<1Q+U_? $1dKgy\;w7' byD9;#ӿюLu/cGRu?,yy2XӘZ'Kx&#:1R{vv~0&@ D~ٴU|ҚpH7\G:qW^_&jͭlubdw?wԸK5 =BFԌo鮻 .Ko#wJ2jusnujmB?䩿4i tq.S {w 7B]q Ax_~v"+bJѺ^ǗS_[D\.]Y6|#i |2Mf$H C~ᯰwE~9e̅%ك\l9$y">FsQz"k6dmlUוKӝ_Fm|(f@Iɠ[t4؎(ݠ'ɰѹz6I#^hܬ,מ8}l }lhi_鸎_G#k$v.9zLT4߲gQɑ;3RTIMh6g\7+/=띤c`RdeͿ::(뭐KB9IK')^jl _%ڛf[خ?dվuM.K+{_}WztRNL!FKtf,tNK<'x2q q8Os`"Eja*)lٖ`ݡLbo?_::9n.h~Y&de*?&-]#| Z[Ka=E4ܟ/Fǝq( 4?$'1w&ė=QVCtּDzi@Ow79/7+\e~I=NeOUrOuYIi7+[e'3AۗǕŵAk>bT9/_&zO^W>KFu1^ӻ1wLrY\szlȝbMѾ|9]UaY2< z{)OU~i.E#[/򏁛3“9Y/f}| Z'oAϤ{kW{D23a4T^K*naŸ|V^N >Ũ[FǛx>ėb!e^5m]8$]|]>Q5Ҹ@eOؗPTIu B~jN11l*ٿͲ?w휰.ʺ!e8i$ٍhd sZkZwÆ\'}ZU OW6Vm9oVʴ,Pz6$b`j)b3%me~)G?o{ȘF'h*"L2է:B|"I~jͷ+n.*͗o*o5M|9|`ˣ_L!u(Fu PGB>VxH/3F7?FӕP! ,Nj7Gů^+Y~)IK\엖 ׎?W.xB]UV WߗYT*4惊m|W`j깃˘ ~;k;WK:_$xvʱk`&/]FWr1E>s\F=ҁ#^G'TmaR(zCJ;he3̳/p\,̱i^Oknv1r^{#imI5\a?/!;&hMe's aWKß=9>!Wb_q+RSo|qT9EE; HCt }7:;sM3'0d]ۡ9[gK|T/jBLB&ApqhbGV lQvC}Ӵ Ōʾ&]G寱2A-m#ZEZ[W ˀ c@-ʧ8䴅)x^i6&Qyu7G~czSݱYyX+vJI&hUesCd/Kklɣ`}V9KW$QBX/g\u~^LIWHjkK׏f,ͳK$4Zhh ËJHM$xtLh0>^UJ^SNQ "B_ifjYS;3P7W6F!e*ϱ B^"15D:(e뒯g S}ȩ?]3.ψ$[:Ҳ Z UsV:#D;siσ/i'{:GFgD{ݫod#@όٛG5iug]4˵wKB@ز }P.żi:|003{^ݴSdX$. av׽fYfZ^?rIK1~EU_;l}euy TkMucIs\GJ7_a}q>qA;mC]CMwe-:N SU9҂Ct"?w~zua&1-knTC'U KG0R0Fǭ]Z2p}0,vWwFudž%{䥤McXE×~ssV'Y|1r ;XQGbV羓16c?VWmx~C ˰:uww%Kw64}Xk Ks f(x~$j5LBu2:#yɜbuV=%;3B[,YKrM~EJi'ʻݻ0qeS 'f·N2#]ҫ~Û ̆TT3ӆ\ZK9VB8&wxz7nmzꄲu>IŠeIUND>~wPh=M ǗWw ˻ǭq=G-QQu턾]3!ź&|W*ۍ;),Ml{Lij3Oϥڼ"nyPڤVkp]Օ]X5C )>-ɒz Sy%O;]Cے\ La(Cm($6Z3H%@銮kwpȌ{[C:sڏ>w{oIQIkS(5sGVo+#j$&-ɖ>*r($drIDЍ0^YF_kB.v£+.~Y JH~Y$N!~b5]3ITɄצ? 87xhdֲ4~/ۢ?Oe/_ KG75ќN~itZ9;/ŧ_vJ v.UjV&~1RM^cC3_Pz3,V/Ngdn-6`Ya=m<'_Df%z9ҩ ֦bƲ1t>7ttvrЖ/~vd.z+Vk_zyb>~nUBdk{lvӀ9;uNY$抽7},1,؉^ /J, o dvnLyr1;c\vR BUa^y[%jz.R,Kl.Α`zPo穮 Bx}^픾V ̿Ì eJJb+c}C7kE e2B3ҙ6?(/u<,3alY-{`TK^^ك#Q*0b@ouM$bFSR?4rm3k G%)=$Dwljc5>~hk+sJ*_^k!ۖg&< l!K1J ݆(\nY,l=Y9Ǣ2rr4aVzWh uò-1^\w\3uj.W2oK}JrA}U߿ӡY џbyzui*Oh#ȅ﹯g{͆QwXZ5U6->zQYi|OogнZ[cOB9D5}yX-]S;1emᥲƟgssenEv:t@mhCݼy;k#W7@!Sk: [~[R>G¨]3!-uW{\C\O=u/*Yx ?Y3:mR̶5 u^ƆcQ_ z&xkeXXYR$ϊޚsZ2%Qͯe@^QzSFc]<9]RmP l&8`0قLo1?@`U k~ѥ3xo vhݧϦF;M. hwKNcC<2*%ډ_"wGVH$UJiJz+Rkl[-RPMA'D>epsKꃴJZj1'38qD㗄(eʳTRq٫, %6}Lڗgj7:w؞>s /zīr㗺~WO~t?u?Ǻ{x/C7!ḦY+ [r08X=ayX_󭊣ԅ4R}CxE6էf5^^fO{ ,UlWFFDFjD7[Z\@'jozKџ> /ў_⥮c |YH~GN,ꚰMJy|WKΞ\rld<ױU ]hJ7:G9iyg.?+Ha aZv*m'{ C# {B C!oJZnjgn2X߫A4t(3C9;搂g7#3N"PɒEj6?0Mv9hȡ駟w+RZ3}#xpMm~:W3Ho}A4ɃbHP% mRٜw0Y-a4tJO*Zt'4#&D})kU#'Yk0i k"J~$,^JGబ[ >VIKFkVHB; NUԣZ?gۻbpm6 9:įdj>i^n-9[Rt[oQ|%k]s芞ǵy|E$Ѝ>kEpË u0s-BV߮k 9}a>IT ODC.'->%zo1ѧpq QsK Kҟ>:TM_rNT 4r Ɓ5/ 'w'dmX*g5PBWNvK C+e [AzSs 2#(L&'l3/[WǼɶs!:G~} ;܁Pt͆` eXWe'0ueZ0%7Dw;d"@}R'ΧSAF_|PJRK9pX{]z3#AhtJDdbvKǂ|OWj|z.$5҇]O4 Db~Ӣ^taA+?nxW}y;3͑~^9E^6[bgN\Fs D٫E&A>6ķ= U`z(ЫIҪZm`Ԡw t_jkVt~ƺ| bwԿ=%<}/ Hb) //O#_+ oUnf,/GB^MMEʟz_oQz[?-p'֛j{'vxxT;] e^%K^YN }hS.7#֐ͨN[5M%:z;e7^,S<S7dY["7gd|:؞Xx= ןcOn8zV/+-7 /HxD^g~W;=7zZ<Ll?79ME6n&gK̳0tIibvT+>gKui=d;_o F/KUgDB ]z+G8:4zVc̳g7nV{Y}j[+5*藇&T^闿a6ՍJ#[;\) WV`b:eĚF㱫trʩl\ |t#ivCazH)\:v0.;~>B%Ҋ[kUe{sߊaŎN|a-BFebK߹}o@0X.oESHݲ){bW}g$~NGg<*.ݧ4{m35uKw RٳP7C`_:) )-c)z6 m[>~b_ksM0`˛1X,-C4[uo%sUOץs[{VE"O֓p nݐ맻y*=W~T1TKnIIlfл9"NFh m&q!JL@ilG+s'%QO?]\};YmjQ뎒RN" %=O@^G^NJ?AY'ĺg^M 1K-J+ I׏/w?NBU_f^/ )pgdreI)M%&H|b):pHҔ/srwe~i֩NW$GYF 2C^:A-;Ex|T#|[W㾠||l|T:ERz/c0{*zD-SyDkP=}~O'⥅(ȋ%g߀]Ұr9Ry / 7Cha*ѭUS|W.oD-eW1z3{<6Eold~œGԅ u̗4E1OE!ouH7B={Y Ao^D=vO|@:]QHsWl^yUҏKo1⃨h`<*0i9 \R} 7j\q+ūU1~[aٞ}ôflo fŇ5ZLL?[kYzUmI'O6 FA$;7_KhJ$ 75 $I9w{Hn?62${! Z&[ON\ԯ,bڸ ZڡAV/ihD*6iuYR٭/ SNtJYbd.*|\^jq8t(_jܗzsoMTㄮ^~,Y^*Ww+<O6~xd2![RKO];XI}8tgÐ.q6~*[߼5HמMץl^7ٷtCc/Ոz*rTMyy/.˂:%JK_Rt6jtx{)_:D~yWJB=xHAl*7۞Sc{ zM^Zn7i2V~7]{քipu9\3D5u{J3ORxjuQv›+f6p6>KJ$zD7qc(qP{(Ynl}߻,+o6Yxؼ|\/7֛MFsWРj&JGӡ󪲱̪ўN;1o+6E1A'-xY-&w?^4'! s `19ѕ<: T=! x+NJl&D>Ϥ_HQ^dbl#{yg@X4?TAHh*ORɯxQb!* YmWˤfD*]VnceZk5e "BBw qwd+Wq?BPEh;ZC#;Z閱Z kZt- |T~.JG]!:VrF$V_Z}Xڧɖ.?T>R1l5T{%2rTIwʿX,ݺV$,h/F)8^w=j^7Hѝm 6Kv($]/޳ly褛߱=4CýW{+/._sbMC~cszԲ|kcEGzЃ|.l. J^Q~\%zO/_x?!١_?۵WyjYto P|}J#{"y$^zq!^Wo瞺)˕lƻ,eČ6zݷWw@δ~=n2_>zB+GlCF둸oc~l.CzˇDs'%WDOcEYjvm,MyA \qbum: fWC+@H/nگJO οd}؀b*\sG$WI))I*5y4]zd$񿓾&YILzh>ݟpZIWLYg,X4G]Ez=,6Ʌ$!^ uŮW ų+}Jj%?#s2Vʣ*|D?5qx\[Ƶe! HaVkN/TLc|]S@:ZʃT=cs:y{?kj[=-J}X8|&΋1MϪb=kdz%O#rŠHߕyթեF.?je+eǬmD¶kv>e ?!]`s^~yew;$]]œmϢg뫖̛GlB\4F*sÃ/!yg`QA:=(ܝ]-YҼj2x{ˡpw,f=љy|^qCaPӐf*D]xvZ(yV<a2^-#%vp57g\3AnPw07o&xjUr޼WQvئ%-ղ,k sKNZ +j$yQϵmzL9.V ?L @KUsBR_,u5 'urRi s;өL?&Ջ34e/hv}wKoGF(ho|IbΣ KWK"uQf"gæR$P(1LhPd$ГdM4%@ %_>-yL  vT҉6Ȼ'6'<НN089pJsHп&.ݟ6[}&TO{{:͊\[C5ڄBCV-1́2.JXcmZܠ5ٯ3A}2I_z,@Ky-k_T{ضן- y|Hi6#mҾ~S=:@9dO^ s"W,)'>9؝R]yz'/r`Z3{/% v~XI>tṾ}WЏ{)ҿ`k(+LToi8]cûmW݋e4 C$8@!1>W ݋y: 99wb0wz.O]LcV j$ic?X^g#ќ0=cQyd[x2ulS%ѷ:vN%uV& E'G43L5kf^E3Ǟ[v3{e8^, =듄=a{Ϝ`] v$:ēTwH^|P.mM^ĚRz Si5ū|Hռ3L??U;tG(nAKS̮M-h1{U/77k5jtćGz\?X]5V8pf$w+/)bvޫj{DL _<5>;4Ab#;aX*?}>.,G۩J vgel^)$.䢕P|R/{'m#Pp-.ju@%p.'6h,G-!$w 9UV{v+u~?SK'2O{uw϶A@#XbH b74f_M$GmBu]S 50}X$CZ )&yNs5lhj.j:y@[уї&sZrD/!]f u w}!݌OfOބz0P6G PzƧ6^fiw-h  m}_oK=巑꺺 ~?OIE3'kU&A'n璄+V.Ze(3L;`떣GmZaP@rgZvY,o z]]3"ym+/LE[ *)]䢱 Ty&r/Z!3\h|chs6V~•fm6ǚ zz6L d`aE6hA]eo4mJwU-# n-!Zxrm[KoV*;3?ޣ l%*|i>aߝj|2cqE!A &V2E)e+w阈9q =&j#MTu>%[)i+S ,ʷ@}nђ|@8͏ˇ#ѺڈZm=2fItOʻ-H.@KU}O /?Pl4_:C"ղN~W^S$$,Amk*c_8&{a6ٳ{8c]ه O {_zciw:pꆳa2I؆SobpvG g]瞮<;Ou ~] R;xWw.YBͦ0h=r[NAdL>xWQbׁS;s?ԬO)=~ufj 5s'I,&VR[ZU TgoVmmx`h$MڳT㓤=Lj yfYlH4;bb Z{RI y2!e:(S#j}TV?;Mɽm$Zy2[)oF7~$uDoBy [CNC ywg񣁈Dȃɓi {C;u/Z*g2fK1dT}E}@ł +q?iEu>Ym8&d[9,uvZjAD{NIKdZe.N]:\oá}ʭ%*=r%YcW&թKp+xM͜Jvk}m=jF-ZE_(yJH Ҷǃthr jH$ι]fpAc_g_h޳}s/ 4\ %i97mxa9NUxGyyHgc* Oia=a *'D\\wQN˿p3ٺ "r=n&w߬Y],27;5DcTκ=9Md)|z5ܢU1NcbNjtοhbmHe yinա79xti;p>~Ot=-8%t1TTnQ&N$>K][9I<$lS4۲OZc q˿t1ɖW&(/co~`ޛ/Y^w<#r|)/Ai; J_L ^zsWQ}'}3*ur!2C}'1kWRfȥbޅ&?/4+\nQƆuew}W3wu遻Ew]aȋoMz !p 9Ȩڽ tR VeNa9{B=&+ t0ܖ0-y&˒N]gX0U.cˇݘ^zP5Qh'#cfbDή;5?I<%iZA\9gcsJm }J؂ °^&H) U)/?aA6kfwvofqM>"3m,g# u8SwpzQ\L4 Dvؙ{ynNS's3_zfLzCKe] 0c&.gsp;e$5# { O]tr1~9nsq]ž0Tk2ys8\f t˜IH}_&H5D ^}|/r)$6ni0G~lzI̯2آi%ZdSH5©ZY)|`a9;EVO9Wj2kopL9re,C̞_Zjl+yIhr0ͻxH@ gpHslݏDTDK)r/'+p`vH&Fe=  eaygk-~JḪX]*wJQXn5.Zv7/,JÍ_bn>Ɯ5-v*"ZӖ…dqWX`^Wrz%+(K%~Cg/$jXY`-ۛ5fS`NJFG˴pw^gd}ORn Ʒ}ElPQ=JJf!03kτĚ=c3-5GN4G ^N㓸 f[G{=ŏ% 57Xy=U25 73ڃ,V'k~_6/ BKK\*hBoސ'yHV ZI.ֳ*EtdC2LV u~lWK;I ˏz~)}ol&`RE=ܷJn{_kRqb܇%Iqbm\e]]춱$E.bIb)).bj‘/q$H:T=PLIL~Cf8yg_7VC?]%%{Eq-ЗK擤WxJ[ier  M'&acl.  \-h 9ļr/7k~]Cfŧ֗#"6TO=LVL4V*b=~pqu'xأ=6~ ZSSۆQG 'i/SWƚ^L_"WuWt~LuGo7~|LˊnsAmU2 P$c~th@^&4]Ϥ<GvIP?2Q>zCzt=fn-se6QPg:ubSk]xVT RǾv:Lgq%%X7KB_^XE{tUWp`$ꯢ=jZ\rl;*˱~샨&5"gu ?,Y_ _>1kN=9Tx~X|ќqؔߜ<尬mԗEp%~qw]&2E`}ыB/_)oD\K} ` P3 DŽ֩ӌ}=lS.޶嶕^7Q+T,`KݐhA=k7t~3{Ɋ&ny}>;>&m̐Eѱ9xt]kߎیDn~_T7@vYї62 @w;oHv ߣ/$l A8>舗j<_j}GҌȘJos)U4;]G(VhL@hfZZc Y($-/*v[-VLFhaz[4 d0fzѫ@4?ЗZS_vem ̀%]qdK+./ #5f?tVeDQ_oEhL5;ݏTpG[~^CMړJ%,VfN:'ʠ;sQg0MZS[cWX1WDKSͳZwReZSmiT_VSq#0(3 `j >MY1bON?}EіFG6[yc]ecS>5a9翌mh;q0_} c>OjKf^sl e춨QqlGpc("xV#˅{{PF`_m'wrxA掸{-=o(ڏXv7Ts""r&rjd(̝h ]KF ~jmc37P:lϒ]3Ɯ;MY迄9`,˲hUkeq=@?ch53ӆ__؁ Ӓ\YES`lKQgVr1aE9?^nm%,Qǖ16 F g^ s%Q_o`?pΉ` QdcKeDc,x—끲v(gyLb V10M! Ԩ˕2(̎hCtZ=\>A$ȃ F'McYpb8TɥPPc5{"cRAb=``'/jQڧPqxh>]a ]Iݮf]JeHl7˕%{  (i9$g|Z.VS+ A*xohoH%bnr}Q02V^H.,lBa,G;+]j m1kYڗT=%cf`ˏS%ʳmz=J\g+|(9jog 1F,HQ#{0TcF]B?%gr*Ho_^XYV\؃:4ԢN :FlYWPk/Ŀ)IX)ZSwc&*!uTkN#r#F.-veҝK/9xnŰ!4 :G7'qÈDsGG8U9yJ؝ G+ej32ԗiy /UM=P=*ZTN?VIS(- _כ.,jᕪJHwEmo/*Q!>.6tciGj];uYgc2>lRSE?sNcj~ZQr?] umeX?_ɟ@ڑ_VSq!`-mPENز LH! t^&ZHSb^VtldK軣=1X"d &k-,1՚wXsn`bL:_v^]w{{1vaMMٌ xeJE_Gδ5n{+غL6 |Y AtK?LPMhM4r(Ƈr^ynjŸ(:P_B?}ZЃJ<),xsc]$;VUkh֐7wdo80s!c2#\r/v1_^/kI}lZϽP_2&sT&e;_ʳlW+՗|cJڃhtR@_rxe %k8_` [48XǞYCkqoQُg_pzܥz,mFTH݉CG@_/9`̸_Fݺ{PlCv|i,42|"H52hm!;3HI;~T KF p8wf[ķߒk|9Kٺ]/>ܒ_j{+ *@Gf%· 5q)7xu0tT防R_.|&TG,wijژZ6DONCg`U-T[/"Ra2 W/N~]}xRէe8sV}rrݛ^2+7˰MrSg&VQXy.7aL@f[ln>H! ezp;ib;vׯv@@r!<Y[ptY0!l R޽EG @)—hȺ R{5pr0".s6b{-jDbwXodpWUo+ژ`r[zx^&<—5^(m %RkM2&몆6&7ۧ{aܭldLQaA`\+de찥ԒAU8LjNM?M r (tK=܎-w}}w/w*+— Fߜͦj.>6j٨-9NV~6y*39iit"c;gOT'&G sP^TWYⷄ?ﻹF|Yt_;3CD zj!07è,,/3M,ug#^;0S{ϲOB]R2$]:mG~K ! @_V&G З+zl $@;-ufP%"lFzu~4oڗ9=9娟.{nM ){Q._n'-QP'"~:C+,XDc&',?/)W!U="^ ڵ\pyeG+E ucM?L^'t^sFP`VNR{3iSܯ _n rDy 9d7jJ\I%u{ìaQ0?*1LKw֙%{&ͅzr5[9">睲ƇQULD6R`K\L.KgXm/=#؎| 5U c_hEB\~B)W.lJ/7c:,R5͈[2 gs;j% dV`?+NP%sK/=ڨQԙ#ӛ&A*I]SPQ'c,_%XY(YsN[܆Lp&^ ZD;$ǽc8+Mrr@" |YVlcӳoSIB8T"%dsyǤ2 ֞QK58<r9f[@cnG@F!0;ScVK%Za#`KW2gQWLUB}ɞ'con/?RGI9 m6ZntCd}!T=/ 1ɔfx5C;it֦IkR.hਲ਼^oI܍έʚ #—.,T1x?mO[*sWQQ`df&=2 @62^#^-o /{.DĝA!or|!c:N /"5K7sS]!bK* P/ "h<\:IO Y {O P1Cd3Yd(&92iU41\Jc.->l޺?*Kj.xFVX—M>,ԋ+YQ56X;y걑K*eX%Ml,,PNՕE^˺/@e6܍JE\ނ (—B#@ 1IoCOE?MDCͧIw Eᱤ$S2nX ܶEV-ozDQ}םLx2 \lr6BLYde.g| x?SI dC#^1w'n/]oIfw6:xCܨ}t,=gpU | mޯa'ƪhPS~٤cw$[.jH9su^Nς3YPB^8V,ɊjL%f0a&m{}:yѲ<)=&I(@lI눶o{LޗlE `򡑫Scudxv73UY Tc.cIMX\6%K1o_ba27#A`/H>!ƺ#˱<|:H>h=vu_ڙF=taŦum=g;Yf0r@K2dz,kY8d:Q!D1TbA^Zd ,bvA߃)tiUP`/>0m+Xe[%T 1&Dc.dA`/F6 |Aթ:>BS5XBw;C-f2kE<s7mOir$م̘d2\g|ї&w5ff2ͨS1{|쓈'-,eE/D>y_΃C *zniX'O6(WI30jNeZy{`-T)fevo2O#uXG[f s:F6`LjN8A,eշ&\W`A@rPU^)fYnb#-r{٬Ksrf̟v֔a\2:1-NsR8^&A@X-—ENۚe]hG?G}^5j6WFXQN9nԉTnpw3px*jF?4y7t0V?]mQNZ͋ٚOZ8/7{9!X8ӸQpL>S| &M41Y9r2F6좃1SPď{fRs~#7* N1Csl&&,; [-W@q9!WgVPE},GsrNEd6X]e^ ITˋ dIsdY[EFL=I\?)lYADJ308W*E@RdA@k41X4{C>aiL&+&%5؆qf\4ύGC}|otǤԼZNˍ`r[-W֗fٓe2M(ʈKlÞ xQm}Y' XwpG\8X20fŠHPۇ~a K1{ ?~2 ^[efQ+'ÇYfZ+uM^%Gʪ ˕%n}hIem9CdK5Ak#en`ڬTչ/SFM8bB[*hZrJ?'Ȝqoir2;&\y{\ap!jZr,ӋGaT.G:_W hZ_RcrnrܘVC{2h!]߉y-UX^E0ᱽ M:—UTܼ-#uլ;م |9܎|7CѪz+,c=}/כ-51@;Bl%s`K\wǨ<|#U)IVkv$Kˀ16hԚ :=`%ӛV]Xٌkm,|Hp _nG%O.}Y5E ԕdEnDmٚ Oإf Ԓ^u?\ {-ZM*F}6CC#T_ڡ%tB]2J\+ٳ5[K [iJ#|XSpe?03цnQuvY8eGJpHEVv=&r&#l#v -Z[ʝT{N@! |YkOT<d.Wb; N![ff+jː-?>6 lSugWb]\W2>Z_ N\}$[~7&_."{# |86Im!`GN*m "~4+.ԙ|gK5?35|=ഩn_R7g_?{k׌idB ֫kor@ #r_a {ح{jS!"/v4}8kKe-?3`Ldfb Q^!Pyҟ9"&LO3^4s^CK{;"Kt',@$A@ب:8(,×]7c >L0fK,lF&ۘiBJͽ:SGa-e؅U*+;R :(d)F@rɁ[V&?aK#Yڒ1\;㪉AaMvfUVǧ5pl6.F'K g-yOj_ȂC@r=m}#_F[Ln.,h|dQp`8shLpfLjK_ Im nHQ+XJ{aϮߝ/fOuXICAz_VKi#c;`WwaIrsvG VX7 d kG;=iV?&1kWˈ=8$rA@r<** jx/;TYc;" e,p?/ћƯ`lrhxB4QɦZ:pmb|9_%z״ԑF~_+ 76A@rPB,ѿUA p%zi ̨X|ݸӢom!^}v؀-(":-[˭WSA=%[Åo1*"$c`eMgƌZq; z<~AN܍9ޛ=ymu6ۺ?k %'#P*C@2d@Qius}"LJPN;ܦhIYJ%>_n^E5ӆcCvYYgugmxzie.A>)—o{@'XllݙRǿޥ+ɖ+jiDfLuGΖfd=Ț}{{*|_*KUE@p`QX-=`ڝ`$d3XRCjpR 8&'d8(aK#Ƨɚdp^Nv{Zh7Y ka+#oN~ EB\>&1u]gn{b?NR:Y8鶨U ziido&rfSȲ ,D@r!";]L-ԔEd)~y~L~^<L@`^n4_B'cO+> ʲٴ*#EpdE:—UTܤ̓_{j`HKuli k4ZXjdʬcɰK֚Wt&gj^R}ֻ' dӕYh ,Rgu<|{ߴTS_d,_dDsa 5eQr`:3 7^7бzl\g9dW7't|) —녴g.C}b& vZK\Ѱ֫`F=f5?yTm&g5M`v|Dp,g6$B@ZH8N tyz8,(5l%r}AL_`(fր3~ԘčW岙zMytH>{ e-?_~e7حbEWL "qf, |LYy}QCEe-ϲ#t^آdU˵@U.P[4GSz.{T1SwcfЛD ?lh4gS8?1dbjXJ.>aPS wsJګjmG}:Il/"}5 ka+#oF / |UOAe^zY&@,9`FeENZ ԗhS0me 4 g1S)͝+v˝Wj#@kk(T[AdLbxPzVH$9"ڕ{#=htl_Þ3 7X|RjV r.ҦibkOon]}a4щh6uE1q,[w+sp6X[-_o _-O|avQ{ 7'h`Px3i}|hW3B 6RW#qEzcOcZ)ZjD2Նk<&jDi՘ڳ049Լb8f?s4m*z^Wr@Tz29xOyd5;&Z2aF #FG6q>ѸeL0siϴ~-D@|`U;.ԚdC}j*I&tԊih/6%u&}^[K.MhMɾ~9_!1䔍.A?@5_v`I$㳳 WOY +{d4b @̖%0cMBr#`Цk5U[F {T2@cՃwO=ghjB`/׋ߥp2 yK{ M3{9gk8G}ɕ5g:rL-SИFvޙA4Z3Z{rPGTkB`}/ׇh|ާ7ʸg;ύv3Edf6hK%4e\dԘr4:7٠W4!/aBtTl Qt y2z<:&g͠7_,{3{O%pxVa@.SnB@ @R.F> 3f2ɳѿVh>߯>*wgJs Qx={>է ! \nz{(,񩅨.e͋К{kN殝6ϙg3L4P_&ƄE׻t 2FԻ~qМ5/`e! " \΄\eugDGoLf-hY6sn=|h숑XƺYNL#mϐj^D!:ėKbF|j=&C GM )FO1.М>8OK}olc]yTn2s o1v/ !e{\tUG[nԛ {p䅟;c[X?NKB rևӄi64'uf'}^IeKY{WWxOa쯟*ޜxOPe_.n 5 @dTV3!rBusiA|>(O>F SchHjD q nuKjD[ZhGɖ-Ac{'ْ+pDQe\pWפ07U.F@|;WL%s3yIsjMu_y~DaƉ/M왖*mMBbm!;ӗ=+P+ lu#G0%!Й/;_Ԫ݃rqt dIo¯L4qmܕıcn0xԄԉugӎg}Ala]9b׈K6«ʻ2r"3k᫕q3 'E˗niBl fZ2aȦ2֝rs)\cv}ݝwmLp_CEׄ![0"G0:{oҸgzT?j@Σ-Rɀζ7cvLs#CdmLa8ݪi# ŝO`ȢSؒ|'SPxh ͞3Ƈ fw%YY! \@͘gGjys  (ɀa0dXjLkt9PVԳPK/ɕks_vnߨeBәS%3 Ϛ^/4Ƙ+XlZǸc^rXpЫu.  nF@|ͽo|L'ЁocۥfAa;Һ(ڒ܈5qg{1;VŸI0V! !B`;XdwE X/e,?z/9ڒA𭅺D eNsxEi^{G! Qݥv# 8xY |dp}d-6Ж`K^Wm:lHft#f!JėLŅ"Вi/.ح`U! t0\MWaD֯xD4ye%x"ߨ}QVN.j/@e  #0/s RebH~e+>`߳66q+la˝jė^)ք@C <=|vd?=Aq.SMW`d#䞞:w8fb!rė+J%@'"0DQodW`L,dLqMOG7矁Fa;KզE@|١f @5Ff8(]ǐaBXjδh\no߲~b:+@@|TDl#Fa[3uksKfW[%daf\|08棸xX_. GV/όԗMCc9CڑB':eZ$Vcfp4Z1aÄQ6`K iOB`/W mEv%cPz33a Md3m>-P%_.. Fm>z,:V,"Z~w8kV:< VK[vpi;'X O`d?nAka3?\珕f×ɮP/6F:&#@ƌY1ߎ^~9fq {0_=P?P텮|ٌ_ǢWcmVz!_u>-Ldc2!|a]}ѽuy`2cƽsޫ,Vr#PTB`ĺ1a)#F~}v,Np 0c$4^F=+a !$% ! 4XY+M ĽҘkD  JX8'1k)ASF@|nUXԍaT~|):~2&k?oV!jEv^!FėkN A\y ޮSݚu*s3,﫝n^/Z>nΚ9:e8+Vu,6F#hA7zjW/)¯!̯sfU}fZw>ylz ,mWzB`/W MA+oh#>>X1əA3{O%.-eܖ[[ !ePtIl%Е?%1h_lQ?ٔG"@Wc\RRSjB`k_n-zXW`}ѡ/0?Q{Q5c|;Ku0%yU[r1b =D}xM~Pyvk`KTC. !/7PU'Ve0dlϿ{=g{/#"Ь1O5>jmB#@w|;26.*DdGCj  FA?Picture 22V)GD5p?s0-2)q`!*)GD5p?s0-7 (x߯eǕO8L`P`xex@b2՚_gV7o~+_z8?ܟڻCs{/AէZԞ~巾껟ϯVY}~Ndkn$iHHZC}=K?VƗ?ſ^]xw?Մ._$j^}!{y`T{I __Y_{w#)wlп}CWVϑ_ y88lE4'X^oO$>9g{ 5XVf 6dݻӣPD#V$adgNP8}o%i}aĶ: PtǸŤ¥̆?&Z"9E?^$ֶ4O32"4$]|vƒ3xFȁveqIˏJ DXZ#QKxēqwĺ#q9(xFEQ Irh&-kQ`+G-S`6v9Z0mZQ,Ivۑ͑Q3."!0 fy[G4W0TlQ)@:])v<$O{ XQa;D(69QKEkVjeH0myvbPefbsҢNiw0mH *FDJďK4uB pboa'zvZPVSL.vXi[DEZ1[90@y B3p9?ZʌA?E 7 QqFv Cwd1cn- DhwFކQh.Yu;f"iTҒU ?C}ӨbGX,Bj&?}FEѢHK\0V] (v Bmml-zY]g;ְqtjqp%߷>e$)#h9v:Jv(viU#+ C".&6d!u:2vK6'jŖ2֗0e5f8՗b9];Dm̭Ĉd>7 A YKNvÜhaCߘ‘bDX$6K4bl⏷F~`a_QVK58G!tzh:1VoNb3F䏷.ٕ{ZJOQ4/dBI!IW&$h8ac~Rkg D(ҵʱr0:RQ։hu4]0ɡ÷E9_71vi,.ԵK1(3eX0% Hov,6 fMC}xD}FUg8r"-Dok::U6Zc{xE+Fa!Qk+?1!YZU .!SѢK#haL؜9;<uo̿nA:µGcCnL4] o$a"m[xCwbma7(FűеEv)ۑG2n6#I~@Rgaʊ;VÑQvzH@ADŋb :<!ZzCcCmb&$_Cj_m"_&d4hI"s⒡߈TwVkBFiMgFEQ\^o<*CaԍV9$lEˢڭ,ZQFn-y9FjVcnn !ڥ@ox[sP9tԅ9w u[GgpKPX@y-a1!Y!G#\r-ڙ!E{ՑdHQв%5*\dRKhZ'b6'":D_<+iuyhB4 sԿv"Z)hoUFMfU܍DiQq+Z('##[s?(]rLf >*.Ē|TGK*Dʸ| _6'C^.c[I3cpIvpZBA^EVĶFc^A[p-!#0mOF"!tcNdf-NZ%UJcCr ys:Lv㐴dF&];Spl9uwMثeڨ1Tf%"!+nE8HDV> s8 XLZqCi:lyXDm 2{.>H bFܐ~'bFO0j6ӄ3;$Iƨ쪵c9oiH i[P챍Z5-Fp;v"i( _+.|3HԵb!PEI ףHz'de8δ5a[/HtrᏺM@ IHEMu3-Htk#’Atb7L )aڴ Fuh+ϓIKDǐ,oN1ɁF-&"A[ 'vDr 1cB6fZ& :&z+EWFÈ THrE+:3bH²4*_bNdW GۊD]/cvOġhK !iYW:F ֢V8@ b #8I7K ÿ[2軷Gp07 }FGeȃ#K2`{"GquŌC'{9i͆BE6KVWJ|(<)k n4W]+ַn?Y>ReIÌB]/Pk;Zd^ɗ#t!lL a0ݕSVn:4ւHzP`+] DĀ؉wTbts/+O-jH);ehÇU Eb9's[%a&LZ}$Zxr (obkD9K2(F c X/Q > rL(I5^߸H Z}9{Y‹ϝ{;+騵vQD$9Z0J>&͊GhtODŽ65ATbiѲ #gEhV qPFF〇,o[rҮv+bYAWr_~R^ן8ES Rpn1'&3*q62Bح͙3HHq&&ֹPӣEj"YtRK)ݱhL҇K5TQ}n. G~gM hK4ZZ*@ 4-QװBhK#![|Æ݊p×^>KOSa>ٗ>s3W9{qH)2 2-3ğӅi>5V.!4ŘA"6W7vx8Bt4 u>cCMHF,|n}aF[ȌXe"Y4K 2ߝfg8~3o|̛y1&[?~ 1d.\y T5BwSG<.dҊ?嚃lEł3F^j ٱJ&NaKXmvbbM#L㐟Ih z}۷Pɳo6AX!(I$ϽL #ykz[s`"D1 96#V fM &.6لuk2D0S2z#L5轰vIDu-ov u\A ^gRKƣdZ0 gǢ ߇X_;BwʫRrixh:GZ#:r"?Q 5㐙9Qfw-$H772|FLLSLJ]A\z,͏o|=#RkԠEO̿v7sF AK)V\V[G '%q"mfA,ƒ-$5QЅt#3~ZJ8D4ú0fWEδBMq?̋s :=1?sm2t;yXadfկ-]+>m;Bώ NľRA%Fw?}q+UPYq)/+H6!صK_nl+{g䯥Cti^[wy>'ic7N3&5Ƚ̞#b6+6{=ވ?q pG)9qبKDSLYvMօ(b E{M^R9tM`R^Z|7=E3 #5007Q4%ŋuiyH{tBш9_}9͜D{DIZq M1; d- \_KӜ|qy74W[;?1k*;'9=A]^5)Nu 嬐aަ=/ٍG`#xd[ӎmuky\{썖a8vԭ̷l;_wļGLyrQyV9|婂:nTcՅ2ĐKAYhޢ y)Kx>dnLwB1~{έ3)(5-'{tCPĈx\>5%LbƮiV1b| ӂ'+i>wg S&Ȫ晫 s_Zۤ,􍼶( 0Uo~-[e(@tQ#kbErdWuf::XD3:F%`)vLl2dђ*J`+# ;&43!?1Bͱ??.A䬒~>)M/?G*C^X /kbɅ_xtJ0i4`Zὣ\SBf_V9{[֠BpPBh$L/iw?;Zטqt tQq踭(q"-YKF{Mz$L73^ZJʯJcʚ9f[eA*dL 9n(&ɦg+?p4 #gal=v DjNGtvdj0aL)!wm+pڴ(чp`vr;4="̩|qpTӪKzzrSp1 O tvkYMކ5JLgI[B&z+؝da&|Aq! NWi]cW͓<i1?`'S=;Hm3RVvd`@zcL>ʷ-TzDY[Ƙ|t͂Js;yf0]%j hrʣJ z'A+dtwdq߭voPO ޼/]nti`K 29M^a3_5EY.\l.7`tbȌ>=EyY+".K49x/(@!]T^P̓ZIŕ *Ǣ)B~,$Tk̀kTx Mݶ}{suqYz* IjiU\QA0C;VʳHO e,鶙4"Lj>v x4aƲ\YOӯJsiǙB;='h4ڧLeJTEm捈V}@۷YKYQӵk0?S=jihY&1t2L3`^GI Mg|v-Ըhj@n0}-MzXRKW:5̘I>k@ |[OOǢ5\r;\a>OՊ᎗s{d ]XϿygo}-94g{ZҡfxEܭ]R>׃ns.]nܗ'dh"?ݛ+Tᝈ] N~T\1kt[, "j3ϏTjvknk&&+NTJ7 ~v<5 +$N)URY2"k*ה֞j0 Jz:!σ}4>W.] >{}pkwh cvU\+L_:_?7o?]`hؿ9}Wաi.S9=NyI 2t 0͡k&|^?X4{1jz\az[z8k^z_ݘu4[>ϣ\u2_{bR|Rqn9 ܱx;"O!vPwe@wwx_r0._׻{%3d&"4iG]~=;{W8L͋ޘ8I+R~El` b+E~n|w/v!q0 }wT0M9cѼ̢uN͞sYy; ˽hq{6gA|Y־t{v Pe2Zp N/->NW D‰$5gIǷ%MK4sp2pd M\.;iIUj\Mo55Ug~y)^VZWkǴ{=Wȼ=v. hO`gqnz |vJ--ȔPU52̓//Vk0]+;Hyg{ x*5A.U/мK!?N%tOQ弲<̫+ٻLZǫ7ϞNz-4v.Gyp:]F?p:güZ;dXԻ d&=;?5jO4u> /; Heading 2 $@&a$5\XX /; Heading 3$7$8$@&H$5CJOJQJ\^JaJBB /; Heading 4 $@&a$ 5CJ\>> /; Heading 5 $@&a$5\:: /; Heading 6$@&5\F@F /; Heading 7 $@&a$ 5>*CJ\NN /; Heading 8$@&^ha$5OJQJ\^JDA`D Default Paragraph FontRi@R 0 Table Normal4 l4a (k ( 0No List 4@4 /;Header !4 @4 /;Footer !6U@6 /; Hyperlink >*B*phB^@"B /;0 Normal (Web)dd[$\$FV1F /;FollowedHyperlink >*B* phLB@BL /; Body Text 7$8$H$CJOJQJ^JaJ6PR6 /; Body Text 2CJLCbL /;Body Text Indent^h 56\]>r> mPChar dCJOJQJaJHH < Balloon TextCJOJQJ^JaJ^^ uUBody Text 3 - Contemporary d8*$aJ*W* ' Strong5\VYV qf7 Document MapM CJOJQJ^JaJn n _ Table Grid7:V0PJ |:,Char Char Char Char Char Char Char Char Char dCJOJ QJ aJ6>6 |mTitlea$ 5CJaJ@@@ u List Paragraph ^m$bob &Default 7$8$H$-B*CJOJ QJ ^J _HaJmH phsH tH B'B Comment ReferenceCJaJ<"< # Comment Text"CJaJ:1: "Comment Text Char@j!"@ %Comment Subject$5\F2QF $Comment Subject Char5\DZ@bD 'J0 Plain Text&CJOJ QJ ^J aJBqB &J0Plain Text Char OJ QJ ^J PK![Content_Types].xmlj0Eжr(΢Iw},-j4 wP-t#bΙ{UTU^hd}㨫)*1P' ^W0)T9<l#$yi};~@(Hu* Dנz/0ǰ $ X3aZ,D0j~3߶b~i>3\`?/[G\!-Rk.sԻ..a濭?PK!֧6 _rels/.relsj0 }Q%v/C/}(h"O = C?hv=Ʌ%[xp{۵_Pѣ<1H0ORBdJE4b$q_6LR7`0̞O,En7Lib/SeеPK!kytheme/theme/themeManager.xml M @}w7c(EbˮCAǠҟ7՛K Y, e.|,H,lxɴIsQ}#Ր ֵ+!,^$j=GW)E+& 8PK!Ptheme/theme/theme1.xmlYOo6w toc'vuر-MniP@I}úama[إ4:lЯGRX^6؊>$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3ڗP 1Pm \\9Mؓ2aD];Yt\[x]}Wr|]g- eW )6-rCSj id DЇAΜIqbJ#x꺃 6k#ASh&ʌt(Q%p%m&]caSl=X\P1Mh9MVdDAaVB[݈fJíP|8 քAV^f Hn- "d>znNJ ة>b&2vKyϼD:,AGm\nziÙ.uχYC6OMf3or$5NHT[XF64T,ќM0E)`#5XY`פ;%1U٥m;R>QD DcpU'&LE/pm%]8firS4d 7y\`JnίI R3U~7+׸#m qBiDi*L69mY&iHE=(K&N!V.KeLDĕ{D vEꦚdeNƟe(MN9ߜR6&3(a/DUz<{ˊYȳV)9Z[4^n5!J?Q3eBoCM m<.vpIYfZY_p[=al-Y}Nc͙ŋ4vfavl'SA8|*u{-ߟ0%M07%<ҍPK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 +_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!Ptheme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] mm m  ""BBBEg q  "4$%), 12>456$8&9>:.;T=>-@DEFGMIKK&R VWbXe4il?@BCEFMOSV[hos   #%')37DIRSY[`fknpqrtuvxy|~ $'+.467;=>@FHIKLXYZ\ac U v x !.!@!a!s!!!!!"""##*R222255566C688$9>:w:::|<<==> ?D?g??C+EXEEEFFFGG:HsHHUJJJJJ3KYKxK{KOYfBmhmmmmmnno9odoxqFsbs~sssssssssst tt ttt:uruuuvvvvwwwwwwwxxMxNxxxxxxx#y$yWyXyyyyyz{G{r}~~u~~~./\]jȀmvևܐX˜4xRTѝ}Π:9&LuB2Rt-޴kʸ#޼J˾q3SXi:]@T{ +,^_ -.@fZz DaBkMx    .R\xx!z))**J-o---./^//L0A3333 4l4#5]5555"69:;#;>;V;E<<<<<<'=K=?ABNBZBBBBB3CBCtCCCDD>DoDDDDDDE=FOPPxPPP Q)QRUUUUV-VIVfV|VWWWX.XKXgX}XvYYYY3[e[[[]dXdwddfff(gcghni~iiiiiWjnGn~nAqTu:wVwxwwwx~.q;̓ދ۽    !"#$%'(*+,./02345689:;=ADGHIJKLNPQRTUWXYZ\]^_`abcdefgijklmnpqrtuvwxyz{|}~   !"$&(*+,-./01245689:;<=>?@ABCEFGHJKLMNOPQTUVWXZ\]^_abcdeghijlmoswz{}     !"#%&()*,-/0123589:<?ABCDEGJMNOPQRSTUVW[b():)XY_YY$ZlZZZ2[J[[ \p/ ?\ ]]^mXXXXXXXXXXXX)(EXX( ,R$ܔ_>DXYuH8# AA@ (  H"  C >N  3  H"  C >  zA?"holdinghandPicture 2holdinghand"(  TN # -* "  c R.S`TS`T# Z%A" T  # $i)-* B S  ?<2m +X45t t "EQNHt0*U<uDL,~u baxterinfusion OLE_LINK13 OLE_LINK14 OLE_LINK1 OLE_LINK2 OLE_LINK11 OLE_LINK12 OLE_LINK5 OLE_LINK6'66BpBpKKAAn h:(::KpKpTTiBiBn*pq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCpqCpq,CpqlCpqCqqCqq,CqqlCqqCqqCqq,CqqlC-a-a?an`oWqWqvuvu0v0vww~~::zzff"")11wXwX}XYYY\\=y=y=yn      !"#$%&'()=aAaAango^q^q|u|u6v6vww~~==ll//)11|XXXY#Y#Y\\CyCyCyn  !"#$%&'()= *urn:schemas-microsoft-com:office:smarttags PlaceType= *urn:schemas-microsoft-com:office:smarttags PlaceNameB%*urn:schemas-microsoft-com:office:smarttagscountry-region9)*urn:schemas-microsoft-com:office:smarttagsplace9(*urn:schemas-microsoft-com:office:smarttagsState8**urn:schemas-microsoft-com:office:smarttagsCity  C*)())%)*)*)*)*))))))%))%)%%)))( ) ) %)(*)FMV](2 ' ] e    # 8 @    2<GNZagh pz ,4!!!"w#|#####;$  "#%&(*n|") * . //1;2UUs*tG{J{ɍ̓xuVe  "#%&(*n3333333333333!!77n$L*4'jo<PR=>0Hptc8nGeZ{LO n(RD\ZRvBDxL&(Ȳ8FZCN@5G MP ) QW %= yM z$y 2W -6 >tL< eZ1 ,^d 2gqM ^[4l;Bl]H.̼[Sw0nk#xu0(I'oGGeg(>%s)tx^Eo&F`(>@+4!,u>/y NGTT$ _JHܸ*ctlXx(2F$MX> )+9"xL5gFV1@|0O]&rve(_<2=Tx(~ؐhk_^ r*j/ &O_ :Dlv ʾK !y!xHg"4(!" (='#^!K$r|R{H$NDH$P3l1%B`]'&a$J&S}:'oxTj'r4P@-'Pc`l(l{(z6$QX(4\_)*~[)xef+@v{+1A*,8 0#,dbknS.r%.bkl_/W+[/dM/08nT1,=Px1XV82T4t]v4ՠ4@n!4b梊5rTn55$ 3<%7`TVZ78n7[|c848ZK8PI9:JL:!;}V<)=tT=L#= lv>4<c?`}?js9Rzk2S4.,RoTPs0tTQ ;T~I)UmEVL2 ?bV tdV1h$CVD$=|W\)BW"BXPtQXȩ%WY<PxHYoZ/E.[]^9]FGHqB7]䯨$]o2\ _]1]ti~p`Q9sL} ex>$e|Qe*Zyfk*.g(Z+.gt42gX\gX3gR PgNR- LhءVn[hlh^ȦiNgjJ 9Bj,*BKj|k֣q.kxvWlkvTlNmL$7nt[_#Zo:p\pvNqhE3q<$H@r:3mrT^s|fZKsnB:5tf9jBD,u @8Ku@cp#vxv*v6<twX!}w|)0hw UBw(xS'myR6f*z.NXozn|]{> ^uM{B[jG|4'|\&Ta|eHa}K"3~yȨ[P^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( 8^8`OJQJo(^`OJ QJ ^J o(o  ^ `OJ QJ o(  ^ `OJQJo(x^x`OJ QJ ^J o(o H^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(88^8`CJOJ QJ o(q^`OJ QJ ^J o(o   ^ `OJ QJ o(   ^ `OJQJo(xx^x`OJ QJ ^J o(o HH^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o( ^`OJ QJ o(^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( ^`OJQJo(p^p`OJ QJ ^J o(o @ ^@ `OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(P^P`OJ QJ ^J o(o  ^ `OJ QJ o( h^h`OJQJo(8^8`OJ QJ ^J o(o ^`OJ QJ o(  ^ `OJQJo( ^ `OJ QJ ^J o(o x^x`OJ QJ o( H^H`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJQJo(pp^p`CJOJ QJ o(q @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o ^`OJ QJ o( p^p`OJQJo(@ ^@ `OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( 88^8`OJQJo(^`OJ QJ ^J o(o   ^ `OJ QJ o(   ^ `OJQJo(xx^x`OJ QJ ^J o(o HH^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(qTT^T`OJ QJ ^J o(o $ $ ^$ `OJ QJ o(   ^ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( dd^d`OJQJo(44^4`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o( ^`OJ QJ o(^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( h^h`OJQJo(8^8`OJ QJ ^J o(o ^`OJ QJ o(  ^ `OJQJo( ^ `OJ QJ ^J o(o x^x`OJ QJ o( H^H`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(88^8`CJOJ QJ o(q^`OJ QJ ^J o(o   ^ `OJ QJ o(   ^ `OJQJo(xx^x`OJ QJ ^J o(o HH^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( ^`OJ QJ o(^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q ^`OJQJo( p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( 8^8`OJQJo(^`OJ QJ ^J o(o  ^ `OJ QJ o(  ^ `OJQJo(x^x`OJ QJ ^J o(o H^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(PP^P`OJ QJ ^J o(o   ^ `OJ QJ o( ^`OJQJo(!!^!`OJ QJ ^J o(o $$^$`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(opp^p`CJOJ QJ o(q @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( 8^8`OJQJo(^`OJ QJ ^J o(o  ^ `OJ QJ o(  ^ `OJQJo(x^x`OJ QJ ^J o(o H^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( h^h`OJQJo( 8^8`OJQJo( ^`OJ QJ o(  ^ `OJQJo( ^ `OJ QJ ^J o(o x^x`OJ QJ o( H^H`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( h^h`OJQJo( 8^8`OJ QJ o(o ^`OJ QJ o(  ^ `OJQJo(  ^ `OJ QJ o(o x^x`OJ QJ o( H^H`OJQJo( ^`OJ QJ o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o p^p`OJ QJ o( @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o P^P`OJ QJ o( ^`OJ QJ o( ^`OJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(qTT^T`OJ QJ ^J o(o $ $ ^$ `OJ QJ o(   ^ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( dd^d`OJQJo(44^4`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o p^p`OJ QJ o( @ ^@ `OJQJo( ^`OJ QJ o(o ^`OJ QJ o( ^`OJQJo( ^`OJ QJ o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( ^`OJ QJ o(^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(qTT^T`OJ QJ ^J o(o $ $ ^$ `OJ QJ o(   ^ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( dd^d`OJQJo(44^4`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o ^`OJ QJ o( pp^p`OJQJo(@ @ ^@ `OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`CJOJ QJ o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(qTT^T`OJ QJ ^J o(o $ $ ^$ `OJ QJ o(   ^ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( dd^d`OJQJo(44^4`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o( 5^5`OJQJo( ^ `OJ QJ ^J o(o  ^ `OJ QJ o( ^`OJQJo(u^u`OJ QJ ^J o(o E^E`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(88^8`CJOJQJo(^`OJ QJ ^J o(o   ^ `OJ QJ o(   ^ `OJQJo(xx^x`OJ QJ ^J o(o HH^H`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(hh^h`CJOJ QJ o(q88^8`OJ QJ ^J o(o ^`OJ QJ o(   ^ `OJQJo(  ^ `OJ QJ ^J o(o xx^x`OJ QJ o( HH^H`OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o pp^p`OJ QJ o( @ @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o PP^P`OJ QJ o(^`CJOJ QJ o(q^`OJ QJ ^J o(o p^p`OJ QJ o( @ ^@ `OJQJo(^`OJ QJ ^J o(o ^`OJ QJ o( ^`OJQJo(^`OJ QJ ^J o(o P^P`OJ QJ o(- Lh%WYP .k|]{$]yfLIC0oA OL} e;T!;g?bVD,uT1knS.vNqs)Wlk]HL&I9:RoT4!4Xoz8eO|=9Bjk#xBKjlh _]E3q(-6 vuCwE1NJoQ'|#=GRhDQVn[h*I)UlJbcZH`l(HY,Tc]@$5zk2S:'=V82Ta|48[)a)+9='#pZKs=X>@ d-Cs9]hbdbB7]!K$5G lFNmu< "bZCP3;bvl1%qM GK !H$Px1L5HPgct0NX C\_)= y!f*z^D<%7[|c8CV(2QX}w+.ggQW y1CCKo<s$H@rhw$7n'gcX$4'Ngj/y8xvL:G|BW VZ7l;QX(n7[Ea}9R\Z\p[Tj''a|kibwIef+oZcGZ1 kK*vl_//E.[`}?&rI'(_v 1]kV1*,eA$ s0tTtwK!N,uUP%.c8`]'&xoNBj/ 55#ZoM/H42gcp#v}V<Geg~p`PVE'my                                                                                                                                                                                                                                                                                                                           N                                                                                                                                                                                                                                                                                                                                                                                                                                                        N                                                                                                                                                                                                                                                                                      N                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              N N                                                                                                                                                               N                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            S-5WjZx[z{&JpJ'Fgvj'6F.~hN1"CGpB t#1+e?6'`Wh  L0 &W g t ; ? DM R Y b | 9 A  Cu 1 "()+5&V[0w#o,0+eLFv_Q49HRq~x6$8.OC(,1DDp1 )+6DKd'm,7> n*C:yPR^q~\q"+;C<^iVy|_ x V !F!`L!X!""<%".Y"e"#-#^#gt#%>%j%&GG&la&s&|}&a''',\'z'(K(O([(Fu()Y))0i)Vr)**1*@*T*b*+$+ 5+B+_J+b+~+m,$+,4-W- k-%s-.1./&/0 0"080O015D1cd1Ow1272]22$2%2a2k2 333]'3k3=4k@45j#5tU5X5c6 I6Q6X6Z6_e7qf78N_86e8m8lu8H 9.9u$9d9B :0:q;/;<;;<;>;$e;z$<B1<Pb<r<=;=?>^>w>?~'?6?6?N?Y@E@8@xQ@h@au@}A[,A5A;^AszA*Bw1BS;B CBTByB{B C@$CP)C_C D*7DNDHYDe[DrnDzDEBEKEUEkEVnE#FF FAFIelIxIAJ)iJ)K .K]KhKzK~K0LYL!*L;9LqNLULXLJpL5xLI|L!M$%MTM[MoiM NNNZ%NWN)tNUO-O2O7ONO~OOP^PgPmP QgQQTMT U@(U6U/IUuU~U8V#VJWWWiW Xb6X 9X%Yf2YYY,ZIMZQZSZ-[7[-7[)8[9[E[Oc[u[\M$\b\H]j]7y]^3^WB^G^m^_!_-_h{_ `abbx!bc&bZbjbO.c1cCc_cmc;sc=dXdgd1jdGud |de#e~9eN@eEeNeVe~e}fjf4f;gAghg+igRsg{gghhuhioi' jw@wzHwNwqw#x~@xQ y'y*;yRy*z.zAzrzl{{r3{#>{u{y|P ||1|F|m|}+U}i}p}~#~o.~|~ebEJZ]kZbt}A@G@|KaY{-Sfe.7`fjO&UFe w 2 <#>}>ApL]^v- ]6R:5`A$9HTU5A?D_VX_A_} "3).z0"C w8u/0=>QIYT\ k>jNt <hr#Krz9o#i,OY2atsy~#!AF>}E7m' #/8X<FaLi^)R@PaEmt)r%|:eQ4>Z%?O4h(ST&BM[_xzzeH,-B/80VdCl sk!1`dA{;=CS@&Zac.K[qrS `N\kFR3fIr17Se3B 67@UXd S;>O^]yC5>L.`=fOdez|=0q9vcxsJOQV}w128 S_Afv| -:(b-gt~L&28wHhw:< PcIDKp-; e0epPhGw`r,7;{FAtCN p wf=2y44E>+H}lq*r;m-&Dq+1CP0L]J{"GmOx`5ZFAVusQQj3?-#&/f&mx h$ZIV}H[aO!Ybvz{( J+1>=p+pSv*As$+ DIa3pq.!I,OBRfnT Y L6#<ak^v<rwp#'>(Vd#$X@OSOT"Z_k4s,(3deb^pO5CN8gv K )B] HL"Qt 1aTjj _&b$h@(CHd w}B!"<lU2x\]?6:I^^N2{i4u{z 'VOHw\f%uD LpdtAQnP*q:?+@3Cm[!Wz)7g '7$NWY ]|"VXBcik"#N4\ raC8M9SW pY\8c #4|X)R;b/3_a5T+V;r68R:gt{@|45TTRRMmX@X<X|@XX@XX@XX<@Xx @UnknownG* Times New Roman5Symbol3. * Arial?&Arial BlackG  MS Mincho-3 fg7.{ @Calibri;SimSun[SO=MS PGothic5" Tahoma7&  VerdanaK FrutigerFrutiger?= * Courier New;WingdingsACambria Math"1h:F:F`:F90J290J2!0WW2HX  ?UL2! xx;Brookdale University Hospital Standardization Opportunities cunninghamMichelle DeLong                           ! " # $ % & ' ( ) * + , - . / 0 1 2 3 4 5 6 7 8 9 : ; < = > ? @ A B C D E F G H I J K L M N O P Q R S T U V W X Y Z [ \ ] ^ _ ` a b c d e f g h i j k l m n o p q r s t u v w x y z { | } ~  Oh+'0, DP p |  <Brookdale University Hospital Standardization Opportunities cunninghamNormalMichelle DeLong2Microsoft Office Word@F#@ȫ N@Ć۟N@Ć۟N290J՜.+,D՜.+,H hp  ((Greater New York Hospital AssociationW <Brookdale University Hospital Standardization Opportunities Title`  8@ _PID_HLINKSA TtH!/mailto:productmonitoringhazelwood@covidien.com#9#http://www.premierinc.com/groupbuy]F%http://www.hospiraadvancewithus.com/.Kmailto:KSchumak@its.jnj.comHxhttps://purchasing.premierinc.com/sca/catalog/ViewContent.action?contentId=/Contract_Launch/Surgeon_Gloves_Launch_Effective_05.01.10.xml 6https://purchasing.premierinc.com/sca/catalog/ViewContent.action?contentId=/Contract_Launch/Exam_Gloves_Launch_Effective_05.01.10.xml&Mhttp://www.baxter.com/press_room/press_releases/2010/07_13_10_colleague.html$2 Hhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm218889.htm7? Hhttp://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm218753.htm<4Hhttp://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm210768.htmu{'https://www.surveymonkey.com/s/53S5LPC.%http://www.premierinc.com/VUsC:\Documents and Settings\schoby\Local Settings\Temporary Internet Files\Content.Outlook\74EW74NV\schoby@gnyha.org=mailto:glennon@gnyha.org  !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLMNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~      !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLNOPQRSTVWXYZ[\kRoot Entry F?NmData 1TableWordDocument&SummaryInformation(MDocumentSummaryInformation8UCompObjy  F'Microsoft Office Word 97-2003 Document MSWordDocWord.Document.89q